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Global health crises such as the COVID-19 pandemic clearly show the need for novel and
better diagnostic and therapeutic tools. Additionally, understanding underlying molecu-
lar processes is crucial. However, current methods face several problems including e.g.
the specificity and spatiotemporal resolution of biomarker detection or in vivo targeting
of drug delivery vehicles.
Single-walled carbon nanotubes (SWCNTs) are all-carbon nanoparticles with the poten-
tial to tackle these challenges. They emit near-infrared (NIR) light (> 900 nm), which
leads to three distinct advantages. First, NIR light can be used for enhanced in vivo
fluorescence imaging with reduced background and deeper tissue penetration. Second,
their NIR fluorescence does not bleach or blink enabling continuous monitoring over
long time scales (hours to days). Third, the light emission is responsive to its chemi-
cal environment, which in combination with the SWCNT’s large surface area promises
high-sensitivity optical sensors for e.g. disease biomarkers. However, these beneficial op-
tical properties can only be utilized when the all-carbon surface is chemically modified
to generate selectivity either for biomarker detection or for targeting the SWCNTs to the
desired place of action (e.g. cellular receptors).
This thesis provides new design strategies for SWCNT-based fluorescent biosensors and is
organized according to the nature of conjugation (covalent/non-covalent) and the type
of the conjugated biomolecule (DNA, peptide, protein).
In the first part, the SWCNTs were non-covalently functionalized with different DNA
sequences. It has been known that such SWCNT/DNA hybrids show a fluorescence in-
crease in the presence of the important neurotransmitter dopamine. Here, the correlation
between sequence and sensitivity/selectivity was quantified leading to dissociation con-
stants (Kd = 2.3 nM - 9.4 µM) and allowing the detection of dopamine in the presence
of structurally similar neurotransmitters such as norepinephrine.
In the second part, such SWCNT/DNA-based dopamine sensors were modified with
small antibody fragments (nanobodies) lending the required specificity to create tar-
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geted dopamine sensors. These targeted sensors were not only fully characterized in
vitro, but also applied in vivo in embryos of Drosophila melanogaster for deep-tissue NIR
immunofluorescence imaging of the spindle apparatus. Furthermore, this new tool al-
lowed for the first time tracking of a single Kinesin motor protein inside a living organism
giving rise to deeper understanding of important intracellular processes as e.g. the ve-
locity a motor protein is moving at in vivo (v = 610 ± 330 nm s-1).
To expand the structural possibilities for SWCNT modification, peptidic barrels were
introduced as a new molecular entity encapsulating SWCNTs with matching diameter.
This new strategy, where de novo designed peptide barrels can be chosen to cover the
corresponding SWCNT species, allows not only for chirality enrichment, but also for the
subsequent attachment of functional units with applications in targeting or fluorescence
microscopy.
In the last part, two new so-called quantum defects were introduced into SWCNTs gen-
erating an anchor site for subsequent covalent functionalization. In contrast to other
covalent functionalization approaches, quantum defects create red-shifted emission fea-
tures corresponding to exciton traps, but do not quench the SWCNT’s NIR fluorescence.
By combining this photophysical advantage with anchor groups for protein attachment
and peptide growth, it was possible to generate functional, NIR-fluorescent and covalent
SWCNT-Nanobody conjugates, multi-color SWCNTs as well as SWCNT-Peptide hybrids.
With the superior stability of covalent chemistry, these anchor-quantum-defects can now
be used as a platform technology for the generation of NIR-fluorescent tools for biosens-
ing or immunofluorescence microscopy.
In summary, these four different parts report fundamental insights into SWCNT surface
chemistry and its impact on the photophysical properties. Furthermore, it shows the
potential of SWCNTs as building blocks for the generation of new SWCNT-based opti-
cal sensors, NIR-tools for fluorescence microscopy or vehicles for targeted delivery un-
der continuous NIR optical monitoring ultimately generating new options for detection
and/or treatment of diseases.
1.2 Deutsch
Globale Gesundheitskrisen wie die COVID-19-Pandemie zeigen deutlich den Bedarf an
neuartigen und besseren diagnostischen und therapeutischen Instrumenten. Darüber
hinaus ist das Verständnis der zugrunde liegenden molekularen Prozesse von entschei-
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dender Bedeutung. Existierende Methoden haben jedoch in einigen Bereichen Defizite,
insbesondere im Hinblick auf die Spezifität und das Auflösungsvermögen der Detektion
sowie den zielgerichteten Transport von Medikamenten.
Einwandige Kohlenstoffnanoröhren (single-walled carbon nanotubes, SWCNTs) sind reine
Kohlenstoff-Nanopartikel, die das Potenzial haben, diese Herausforderungen zu bewälti-
gen. Sie emittieren Licht im nahen Infrarot (NIR, > 900 nm), was zu drei deutlichen Vor-
teilen führt. Erstens kann NIR-Strahlung für verbesserte in vivo-Fluoreszenz-Bildgebung
mit reduziertem Hintergrund und tieferer Gewebepenetration verwendet werden. Zwei-
tens ist die NIR-Fluoreszenz der SWCNTs nicht-bleichender sowie nicht-blinkender Na-
tur, welches wiederum längere Beobachtungsdauern von mehreren Stunden oder Tagen
erlaubt. Drittens ist die NIR-Fluoreszenz von SWCNTs abhängig von ihrer chemischen
Umgebung. Dies führt in Zusammenhang mit der großen Oberfläche dazu, dass Kohlen-
stoffnanoröhren als hochsensitive optische Sensoren zum Beispiel für die Biomarkerde-
tektion verwendet werden können. Diese vorteilhaften Eigenschaften können jedoch nur
ihre Anwendung finden, wenn es gelingt, die einzig aus Kohlenstoffatomen bestehende
Oberfläche so weit chemisch zu verändern, dass sie die selektive Erkennung z.B. von Bio-
markern oder das Anvisieren von z.B. zellulären Rezeptoren ermöglicht.
Zu diesem Zweck stellt diese Arbeit neue Strategien vor, mit denen kohlenstoffnanoröh-
renbasierte Biosensoren generiert werden können. In einem ersten Schritt wurden Sen-
soren für den Neurotransmitter Dopamin hinsichtlich ihrer Sensitivität und Selektivität
charakterisiert und optimiert. Ein Screening von unterschiedlichen DNA-Sequenzen, wel-
che auf der Nanoröhrenoberfläche adsorbieren, führte zu unterschiedlichen Kd-Werten
(2.3 nM - 9.4 µM) sowie zu speziellen DNA-Sequenzen, welche es erlauben, Dopamin in
Gegenwart des strukturell ähnlichen Neurotransmitters Noradrenalin zu detektieren.
In einem nächsten Schritt wurde nun dieser Dopaminsensor mit kleinen Antikörperfrag-
menten (Nanobodies) dekoriert, welche es vermögen, ihr Antigen mit hoher Spezifität zu
binden. Diese neuen zielgerichteten Sensoren wurden nicht nur umfassend in vitro cha-
rakterisiert, sondern auch in vivo in Drosophilaembryonen angewandt, um dort den Spin-
delapparat mittels NIR-Immunfluoreszenzmikroskopie in tiefen Gewebeschichten unter-
suchen zu können. Ferner erlaubte es diese neue Technik, zum ersten Mal ein sich be-
wegendes Kinesin-Motorprotein in einem lebenden Organismus zu verfolgen und somit
ein vertieftes Verständnis wichtiger intrazellulärer Prozesse zu erlangen (wie z.B. die Ge-
schwindigkeit, mit der sich ein Motorprotein in vivo bewegt, v = 610 ± 330 nm s-1).
Darüber hinaus wurden neben DNA-Oligonukleotiden auch Peptidfässer als neuartige
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Oberflächenmodifikation von SWCNTs eingeführt. Diese de novo erstellten Peptidfässer
bieten nicht nur eine höhere Sequenzvariabilität im Vergleich zu Nukleinsäuren, son-
dern ebenfalls die Möglichkeit, bestimmte SWCNT-Chiralitäten anzureichern. Außerdem
haben sie das Potenzial zur Anwendung als Funktionalisierungsplattform mit der Mög-
lichkeit, funktionale Einheiten wie Fluorophore, Medikamente oder Antikörper anzubrin-
gen.
Zu guter Letzt wurden zwei neue so genannte Quantendefekte in SWCNTs eingebaut,
welche zusätzlich eine Ankereinheit tragen, die nachfolgende kovalente Funktionali-
sierung ermöglicht. Im Gegensatz zu anderen Ansätzen der kovalenten SWCNT-Funktio-
nalisierung führen Quantendefekte zu einer Rotverschiebung, nicht jedoch zu einer Lö-
schung der NIR-Fluoreszenz. Durch Kombination dieser photophysikalischen Vorzüge
mit den Ankereinheiten war es möglich, kovalente, funktionale und NIR-fluoreszente
SWCNT-Nanobody-Konjugate, mehrfarbige SWCNTs sowie SWCNT-Peptid-Hybride her-
zustellen. Mit der erhöhten Stabilität durch die kovalente Verknüpfung können diese An-
kerquantendefekte nun als eine Plattformtechnologie dienen, um neue NIR-fluoreszente
Werkzeuge für Biosensoren oder die Immunfluoreszenzmikroskopie herzustellen.
Zusammengefasst stellen diese vier Technologien (DNA-basierte Dopaminsensoren, ziel-
gerichtete Sensoren mit Nanobodies, die Peptidfass-Ummantelung sowie die Quantende-
fekt-Funktionalisierung) wertvolle neue Bausteine für die Herstellung von SWCNT-basier-
ten optischen Sensoren, NIR-Werkzeugen für die Fluoreszenzmikroskopie oder Vehikeln
für den zielgerichteten Transport von Medikamenten unter kontinuierlicher NIR-Observa-
tion dar. In Zukunft könnten somit neue Optionen für die Erkennung und Behandlung




The COVID-19 pandemic, which is currently spreading, has already cost the lives of more
than 200,000 people at the time this work was completed.[1] Together with other soci-
etal developments such as demographic change, which is resulting in an ever-increasing
number and diversity of especially age-related diseases, these developments are placing
an increasing burden on health systems. In order to counteract these developments, not
only are functioning health care systems needed, but in particular suitable tools for a bet-
ter understanding of diseases and their rapid and reliable detection. Over the last two
decades, several novel diagnostic and therapeutic tools have been developed for the de-
tection and treatment of cancer and other diseases, including cancer immunotherapy[2],
CAR T cell therapy[3] or antibody/aptamer-based diagnostic devices. However, a large
part of clinical diagnostics is still based on large and expensive equipment, which requires
not only high acquisition costs but also trained personnel. In addition, many of these lab-
oratory analyses are very time-consuming, which can lead to dramatic developments and
e.g. undiscovered infections during a pandemic. With respect to age-related neurode-
generative diseases such as Parkinson’s or Alzheimer’s, the tools to gain fundamental
understanding are especially limited regarding their ability to resolve small, yet impor-
tant events in intercellular communication and the malfunction thereof. To address these
problems and develop new, better and faster diagnostic tools, more research is needed
in the life sciences. This will allow new relationships to be uncovered, biomarkers for
the early detection of diseases to be found and, ultimately, new devices to be developed.
These, in turn, will enable earlier diagnoses, leading to improved prognosis for patients
and possibly lower costs for the health system.
In the last decade, nanotechnology has been demonstrated to be a great resource for
building blocks of both diagnostic and therapeutic devices. Nanosized objects have the
distinct advantage of being on the same length scale as the systems they are used to
investigate. In addition, they can function as a scaffold for the attachment of multiple
functional units responsible for different tasks such as targeting (e.g. antibody), report-
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ing (e.g. fluorophore) and therapy (e.g. drug). In the future, these multifunctional
devices could then potentially be injected, targeted to the desired site in the body, report
on the disease status and directly release an appropriate drug in a targeted and thus less
harmful fashion.
Carbon nanotubes are very promising candidates to fulfill these tasks. Compared to
other nanomaterials, they provide the decisive advantage of having a valuable property
for diagnostic or therapeutic devices already integrated - fluorescence. The near-infrared
fluorescence of carbon nanotubes is even particularly suitable for in vivo imaging due to
its enhanced tissue penetration properties compared to visible light. Furthermore, this
fluorescence was shown to be dependent on the nanotube’s surrounding and can thus
not only be used for static tracking in vivo, but also to report on changing environments
Figure 2.1.: Design strategies for carbon nanotube based biosensors. The goal of
this work is the covalent and non-covalent functionalization of carbon nanotubes for the




such as different pH[4] in cancer tissue or even small signaling molecules.[5]
The goal of this work is on the one hand to develop new methods for expanding the
reporting/sensor capabilities of this carbon-based nanomaterial and on the other hand
to combine these readout properties with targeting approaches based on small antibody
fragments - termed nanobodies. By combining these two key properties we can get an-
other step closer to advanced diagnostic and therapeutic devices, which could ultimately
help to provide a better and more affordable health-care for an aging society.
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2.2 Single-walled carbon nanotubes
Nanoparticles or in general nano-sized objects are defined in such a way, that at least one
dimension needs to be within 1-100 nm.[6] Single-walled carbon nanotubes (SWCNTs)
fall into that category with their almost one-dimensional structure showing lengths up
to the mm-range with diameters between 0.4-2.5 nm.[7] This extraordinary high aspect
ratio is not only interesting from a chemical standpoint, but also leads to highly unique
photophysical properties and resulting applications, as will be discussed in the following
sections.
2.2.1. Structure and Synthesis
Carbon is one of the elements central to all life on earth with a vast variety of compounds
formed in conjunction with other elements such as hydrogen, nitrogen, oxygen, sulfur
etc. But there is also carbon in pure elementary form. At ambient pressure, it exists
mostly in the form of graphite, while at highly elevated pressures above several GPa di-
amond is formed. Whereas these ’classical’ allotropes are known since a long time and
very well characterized, the fields studying other, smaller carbon allotropes are still com-
parably young. It started with the discovery of the so-called ’Buckminsterfullerene’ (C60)
by Kroto et al. in 1985[8], followed by the discovery of carbon nanotubes by Iijima in
1991[9] and graphene by Novoselov et al. in 2004.[10] Among these nanosized allotropes
of carbon, carbon nanotubes have attracted particular attention due to their unique, tun-
able properties and possible applications in the field of biomedical sciences.[11]
Carbon nanotubes can be subdivided into two distinct species: Single-walled carbon
nanotubes (SWCNTs) and multi-walled carbon nanotubes (MWCNTs). Structurally, they
can be imagined as a rolled-up sheet of graphene (see Fig. 2.2a), i.e. a monolayer of
graphitic, sp2-hybridized carbon. But of course, this imaginary roll-up process does not
leave the graphene sheet unaltered. Carbon nanotubes are energetically favored com-
pared to graphene with respect to less edge atoms and corresponding dangling bonds at
the expense of a high(er) curvature and ring strain. This ring strain is compensated to a
certain extent by admixed sp3-bonds in a carbon nanotube causing not only a different
structure, but, resulting from that, also different physical and chemical properties.[12,13]
In addition, about 2% of the carbon atoms occur in non-hexagonal rings or pentagon-
heptagon pairs (Stone-Wales defects) leading to locally enhanced reactivity, which will
be discussed in further detail in section 2.2.3.[14]
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Figure 2.2.: Structure and nomenclature of single-walled carbon nanotubes
(SWCNT). a) Imaginary roll-up of a graphene-sheet yielding a SWCNT. Based on Kruss
et al.[11] b) Graphene lattice showing the different possibilities of SWCNT formation. The
tube’s chirality is defined by a linear combination of the vectors a1 and a2. In this ex-
ample, the chiral vector Ch of a (6,5)-SWCNT and the corresponding unit-cell (green) is
shown. Based on Dresselhaus et al.[12]
Depending on the direction of (imaginary) roll-up, SWCNTs with a large variety of dif-
ferent diameters and chiralities are formed. As shown in Fig. 2.2b, the chiral vector
Ch defines - together with the lattice vector T - the 1D-unit cell of a SWCNT.[12] The
structure space of SWCNTs is defined by the two unit vectors of the hexagonal graphene
lattice a1 and a2, which upon linear combination yield the chiral vector Ch, that describes
the direction of roll-up or the circumference of a carbon nanotube. Correspondingly, the
tubular axis is defined by the vector T ? Ch.[12] These two vectors span up the SWCNT
unit cell (shown in green in Fig. 2.2b). Linear combinations of the (n,0)-type are called
zigzag-SWCNTs (chiral angle ⇥ = 0 ), whereas (n,n)-combinations are called armchair-
carbon nanotubes (⇥ = 30 ). All other (n,m) combinations are referred to as chiral
SWCNTs with 0   ⇥  30 . But the chiral vector Ch not only contains the information
on the nanotube’s chirality, but its length also corresponds to the SWCNT’s circumfer-








n2 + nm+m2 (2.1)
with a0 being the lattice constant of graphene (2.46 Å).[11] Different combinations of
a1 and a2 thus lead to different chiralities and different diameters. Furthermore, these
structural parameters also predetermine the SWCNT’s properties. As shown in Fig. 2.2b,
9
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all armchair SWCNTs are metallic, whereas certain zigzag and chiral species show semi-
conducting behavior. This outstanding physicochemical property will be discussed in
further detail in section 2.2.2.
In 1991, Sumio Iijima found the first (multi-walled) carbon nanotubes using transmis-
sion electron microscopy (TEM) following the process used already earlier for the mass-
production of fullerene C60 by Krätschmer et al.[15] (see. Fig. 2.3a). He reported on
the growth of "graphitic carbon needles, ranging from 4 to 30 nm in diameter and up
to 1 µm in length" on the negative end of the carbon electrode in an argon-filled vessel
Figure 2.3.: Different processes for the synthesis of SWCNTs. a) The arc-discharge
process utilizes two (transition metal modified) carbon electrodes to ignite an inert gas
plasma used for the evaporation of carbon atoms. Depending on the metal catalyst, the
inert gas pressure as well as the arcing current, the process yields fullerenes, MWCNTs or
SWCNTs. b) The laser-ablation method involves a graphite-target (0.5 % Co/Ni), which
is placed in a furnace at 1200  C and vaporized using high-energy laser pulses. The
vaporized carbonaceous material is then transported by an Ar-stream and deposited on
a Cu-collector. c) Chemical vapor deposition can be used to grow high-purity SWCNTs
from different gaseous (organic) carbon precursors in an oven on metal catalyst (Fe,
Ni, Co). d) The HiPCO R , process is a modified CVD process with Fe(CO)5 as a gaseous
catalyst precursor yielding SWCNTs after CO disproportionation. e) In the CoMoCAT R ,
process, a cobalt/molybdenum catalyst is used as a template for SWCNT growth, which
can be tuned in its particle size by different reaction parameters. This, in turn, not only
allows preferential SWCNT synthesis, but also tuning of the resulting SWCNT’s diameter.
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(133 mbar).[9] In 1993, Iijima as well as Bethune et al.[16] used only a slightly modified
variant of this technique for the first observations of SWCNTs.[16,17] Whereas Iijima used a
iron-modified carbon cathode and a methane/Argon mixture as a chamber gas, Bethune
et al. used a cobalt-filled anode and a Helium-filled chamber. Both groups found the
addition of Fe or Co to the electrode crucial for single- instead of multi-walled carbon
nanotube formation. In general, this arc-discharge method works via the evaporation
of carbon atoms aided by a He/Ar-plasma ignited by high currents (see Fig. 2.3a).[12]
Aspects such as the inert gas pressure or the arcing current can be modified to direct the
synthesis either towards MWCNTs, fullerenes or SWCNTs (with Fe/Co addition).
In 1995, Smalley and coworkers achieved the synthesis of high-quality SWCNT on the
gram scale using laser ablation (see Fig. 2.3b).[18] Here, a carbon-target containing
0.5 % Co/Ni is placed in a furnace and heated at 1200  C under a constant stream of
Argon. High-energy laser pulses are used for ablation of carbonaceous material, which is
then transported outside the furnace by the Ar-stream and deposited on a water-cooled
copper-collector. Side-products are, as also for the arc-discharge method, fullerenes,
graphitic polyhedrons as well as amorphous carbon. The SWCNTs produced via both
methods also contain a lot of metal catalyst impurities, which need to be removed for
downstream and especially biological applications.[12]
Fig. 2.3c schematically shows the process of chemical vapor deposition (CVD). Here, dif-
ferent gaseous carbon species (e.g. hydrocarbons CH4, C2H4, C2H6 etc.) are submitted
to a CVD oven containing certain (transition) metal catalysts. These catalysts are mostly
iron, nickel or cobalt nanoparticles formed on an aluminium substrate. Upon catalytic
dissociation of the hydrocarbon, carbon dissolves and saturates in the metal nanoparti-
cle leading to carbon "precipitation" and formation of a carbon hemisphere followed by
tubular carbon growth ultimately leading to end-capped carbon nanotubes. Depending
on the diameter of the metal catalyst, carbon nanotubes of different diameter are formed
giving the possibility of control over the chirality distribution. Iron, nickel and cobalt
are chosen in all of these methods as catalysts due to their phase diagram with carbon,
where carbon shows a finite solubility in these metals at high temperatures giving rise
to the possibility of carbon precipitation/growth.[12] Due to the lower process tempera-
tures compared to the arc-discharge and laser ablation method, CVD-produced carbon
nanotubes display a higher density of structural defects and thus also weaker electrical
and mechanical properties. On the other hand, the CVD process is advantageous with
respect to upscaling and mass production.[19]
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This potential for upscaling also led to the two processes which are most widely used
nowadays for the production of commercially available carbon nanotubes: the HiPCO R ,[20]
(see Fig. 2.3d) and the CoMoCAT R ,[21] (see Fig. 2.3e) process. Both processes are ad-
vanced and refined versions of the CVD process leading to higher selectivity for SWCNT
production on larger scales. The HiPCO process operates with Fe(CO)5 as a gaseous
catalyst precursor, which, upon in situ thermal decomposition and iron cluster forma-
tion, provides the possibility for catalytic carbon monoxide disproportionation. This CO
disproportionation follows the Boudouard mechanism/equilibrium:
CO(g) + CO(g)   *)   CO2(g) + C(SWCNT)
Via filtration/separation of the formed SWCNTs from the unreacted CO it is also possible
to drive this process continuously instead of batch operation.[19]
The CoMoCAT process was developed shortly after the HiPCO process by Resasco et al.
in 2000.[21] Again, SWCNTs are produced by CO disproportionation over a solid sup-
ported cobalt/molybdenum catalyst. At low Co:Mo ratios, carbon nanotubes are formed
with a high selectivity (approx. 80 %).[19] By precisely controlling the different reaction
parameters such as CO partial pressure, the amount of catalyst (precursor), temperature
and others, it is possible to change the size of the catalytic particles. This in turn allows
to drive the synthesis towards favoring certain SWCNT diameters and thus yielding nar-
rower diameter/chirality distributions compared to the other methods. In the last two
decades, a whole research field evolved investigating the SWCNT growth mechanisms
depending on different catalysts, SWCNT precursor caps, growth conditions etc.[22] In
this work, mostly SWCNTs produced by the CoMoCAT process and enriched in the (6,5)
chirality are used, further modified and brought to different applications.
2.2.2. Optoelectronic properties
SWCNTs possess many outstanding properties as e.g. an extraordinarily high electrical
and thermal conductivity as well as tensile strength.[12,23,24] In addition, depending on
the direction of an imaginary roll-up from a sheet of graphene, SWCNTs can be either
metallic or semiconducting. But what makes the properties of SWCNTs so fundamentally
different from those of graphene and why are the electronic properties so sensitive to
structural changes? This difference can be understood using the band-folding picture.
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2.2.2.1. Zone-folding and density of states
Graphene already has a unique electronic structure near the Fermi energy with an occu-
pied ⇡- and an unoccupied ⇡* band. These two bands show a linear dispersion and cross
each other at the Fermi-energy at the K- and the K’-point of the Brillouin zone (see Fig.
2.4a).[12] These properties render graphene a so-called zero-bandgap semiconductor or
semi-metal.
Figure 2.4.: Carbon nanotube electronic structure and excited states. a) Band struc-
ture of graphene as derived from the tight-binding model showing the valence and the
conduction band overlapping only at the K-point at the Fermi-level. Modified from Dres-
selhaus et al.[12] b) Depending on the direction of roll-up to a SWCNT, discreet wave
vectors are obtained leading to either metallic (wave vector crossing the K-point as e.g.
(5,5) tubes) or semiconducting (wave vector not crossing the K-point as e.g. (6,5) tubes)
SWCNTs. Modified from Graf (2019)[25] c) Density of states (DOS) diagram showing
van-Hove singularities and a non-zero DOS for metallic SWCNTs as opposed to zero DOS
for semiconducting SWCNTs. The size of the bandgap depends on the nanotube’s chi-
rality leading to different excitation/emission properties for each SWCNT chirality (d).
Reproduced with permission from Avouris et al.[26].
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When the graphene sheet is now rolled up to form a cylinder, the band structure gets
altered by periodic boundary conditions in the circumferential direction. This in turn
results in only a set of allowed wave vectors the electrons can exhibit following





, with j = 0, 1, ..., jmax (2.3)
with ka being the reciprocal lattice vector along the SWCNT-axis and kc the portion
along the nanotube’s circumference.[27] The circumferential boundary condition (eqn
2.3) leads to discreetly spaced wave vectors and a series of lines crossing the band struc-
ture of graphene (zone-folding, see Fig. 2.4b) depending on the direction of roll-up and
thus the SWCNT’s chirality.[12,25,27] If these lines cross the K-point, the SWCNT is metal-
lic with a non-zero density of states (DOS) at the Fermi-level, whereas if the K-point is
not included, the SWCNT is a semiconductor with differently sized band-gaps depending
on Ch (DOSFermi = 0).[12] In line with theoretical calculations for a 1D quantum sys-
tem, van-Hove singularities can be observed as sharp peaks/spikes within the DOS (see
Fig. 2.4c).[25,27] Dipolar optical transitions with an electrical field polarized along the
tube axis are only allowed between two symmetrical sub-bands giving rise to S11, S22, Sii
transitions for semiconducting and Mii transitions for metallic SWCNTs.[24,28] These tran-
sitions then give rise to the excitation/emission maps as shown in Fig. 2.4d. Depending
on the SWCNT’s chirality, the emitted light with the energy E11 is in the near-infrared re-
gion of the spectrum rendering SWCNTs a promising "fluorophore" for biomedical imag-
ing, which profits from enhanced tissue penetration when compared with visible light
(due to reduced absorbance and scattering in biological tissue).[11] For semiconducting
SWCNTs, the energy difference between the first van Hove singularity of electrons and





with aC C being the nearest-neighbor carbon-carbon distance (1.44 Å in a SWCNT),  0
the nearest-neighbor carbon-carbon interaction energy and dt the tube’s diameter.[29] In a
first approximation it can thus be concluded, that the bandgap energy of semiconducting
SWCNTs is inversely dependent on the tube diameter, which was later also confirmed
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by experiments, although showing deviations in absolute bandgap energies (see Fig.
2.5a).[28,30,31]
2.2.2.2. Electrons, holes and excitons
These deviations not only result from tube curvature effects, but especially from the low
dimensionality of SWCNTs causing one-dimensional confinement of electrons and holes
generated upon excitation. In addition, the substantial coulombic attraction leads to
strongly bound electron-hole pairs, also called excitons.[24,32] This exciton binding energy
Eb (defined to be positive) is cancelled out to a large extent by the so-called self-energy
Eself resulting from repulsion of both the excited electron and hole by conduction band
electrons and valence band holes.[32] The bandgap energy can thus be determined as
E11,exc. = E11 + Eself   Eb. (2.5)
For many SWCNTs, the Eself is larger than Eb leading to an effectively increased bandgap
(see Fig. 2.5a). However, Maultzsch et al., using two-photon luminescence spectroscopy,
reported an increasing exciton binding energy for small-diameter SWCNTs leading to
exciton stability even at room temperature.[25,33] The excitonic energy levels are strongly
dependent on graphene’s band structure, altered by the additional 1D confinement. The
K- and K’-point in graphene’s unit cell are degenerate (see Fig. 2.4b). Together with
the possible spins of both electron and hole this leads to 16 possible excitonic states
for each band index j with 12 triplet states and four singlet states.[34] While only the
latter are accessible in dipolar optical transitions[28] (weak spin-orbit coupling and low
intersystem crossing yield), their degeneracy is lifted by electron-hole interactions giving
rise to the energy levels shown in Fig. 2.5b.[35] Both excitons with electron and hole not
from the same valley (KK’-exciton and K’K-exciton) carry momentum and can thus not be
excited by light (dark excitons).[25] In contrast, the two excitons arising from the same
valley electron/hole (KK and K’K’) do not carry momentum perpendicular to the tube
axis and are generally energetically favored. The lowest energy exciton has a spatially
even wave function (even parity) and can thus not couple to the ground state radiatively.
Therefore, this exciton is referred to as a dark exciton. Around 55 meV higher in energy
(  , for (6,5)-SWCNTs) is the only bright excitonic state out of the sixteen possible
states due to its odd-symmetry and zero center-of-mass momentum.[34] The interplay
of these two excitonic S11 states is crucial for the photophysical properties of SWCNTs
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Figure 2.5.: Excitons in single-walled carbon nanotubes. a) Difference between ex-
perimentally derived values (solid symbols) for the bandgap energy and those derived
by the tight-binding model (open symbols) depending on the tube diameter represented
in a Kataura plot. Adapted and modified with permission from Weisman et al.[31] b) En-
ergy diagram showing the four different singlet excitonic states. The two excitons with
electron and hole from different valleys carry momentum and can thus not be excited by
light (dark), whereas the KK excitons do not carry momentum. The energetically lowest
state, however, has even parity and thus can not relax to the ground state radiatively.
Modified from Graf (2019)[25]
and is also, amongst others, one explanation for their relatively low photoluminescence
(PL) quantum yield (PLQY, typically 1%[36]) due to non-radiative decay into the dark KK
excitonic state after excitation of the bright exciton.[26,34] This in turn also explains the
strong dependency of PL efficiency and exciton lifetime on temperature.[37] Furthermore,
Perebeinos et al.[38] and Mortimer et al.[37] found out, that applied magnetic fields along
the tube’s axis lead to enhanced PL by symmetry breaking and lifting of the degeneracy
of the K and K’ points.
2.2.2.3. Luminescent quantum defects
A similar and perhaps even more drastic effect was reported by Piao et al. in 2013, when
they observed a new PL peak red-shifted by up to 254 meV compared to the original
’bright’ S11-exciton upon introduction of sp3 ’quantum defects’ into the SWCNT lattice
(see Fig. 2.6).[39] The authors achieved this significant but unexpected finding by stir-
ring a dispersion of SWCNTs in D2O with different aryl diazonium compounds for several
16
2.2. Single-walled carbon nanotubes
hours. Whereas before diazonium chemistry and sp3-defects in general were known to
quench the nanotube’s PL[14,40], in this case an up to 28-fold brightening was observed.
The PL increase was attributed to defect-induced symmetry breaking creating a new,
optically allowed excitonic state below the dark KK-exciton leading to more efficient
radiative relaxation to the ground state (see Fig. 2.6a). This new S⇤11 state is also of-
ten referred to as a trap leading to strong exciton localization (see Fig. 2.6d/e/f) and
thus prevention of diffusive quenching at e.g. SWCNT ends.[43,45] The authors found the
increase in PL to be dependent on multiple factors such as defect density, the chemical
nature of the defect (electron withdrawing or -donating, see Fig. 2.6c) as well as SWCNT
chirality.[39] In a recent study, Berger et al. incorporated aryl defects into SWCNTs puri-
fied using the polyfluorene copolymer poly-[(9,9-dioctylfluorenyl-2,7-diyl)-alt-co-(6,6’)-
(2,2’-bipyridine)] (PFO-BPy), which enables a more detailed evaluation of the impact of
defect introduction on the SWCNT’s NIR-fluorescence. Using this method, they found the
resulting NIR-fluorescence to strongly depend also on the SWCNT length (higher PLQY
but lower brightening observed for longer SWCNTs) and the number of pre-existing side-
wall defects (as e.g. incorporated by tip-sonication).[45]
The combination of the further red-shifted PL with the generally increased PLQY renders
these defect-carrying SWCNTs (from here on referred to as SWCNT*) very promising
for various applications in electronics, quantum computing but also in biomedical imag-
ing. Here, it is now possible to excite the carbon nanotubes at their S11-transition (ap-
prox. 1000 nm for (6,5)-SWCNTs) instead of the commonly used S22 excitation (approx.
560 nm for (6,5)-SWCNTs) leading to deeper tissue penetration of the excitation light
at lower excitation doses.[46] In addition, the new defect-induced PL-peak (S⇤11) is, as
opposed to the original S11 transition, not prone to reabsorption by the SWCNTs them-
selves, giving rise to an increased PLQY.[45] In the recent years, also other research groups
followed up on this topic using different sp3-defects for e.g. localized pH sensing[4],
brightening of ultrashort SWCNTs[43] (see Fig. 2.6d/e/f) or single-photon quantum light
sources.[36] An important factor is the density of sp3-defects created in the SWCNT host.
As shown in Fig. 2.6b, the E11 emission decreases whereas the E⇤11 emission increases
with increasing concentrations of the diazonium salt. At a ratio of 1:100 ([Dz]:[carbon])
the PL was completely diminished probably due to the loss of sufficient sp2-based elec-
tron/exciton delocalization preventing excitation of the S11-transition. This finding un-
derlines the importance of finding the correct reaction parameters, which will also be
of crucial importance for parts of this work (chapter 4.4). The reaction mechanism as
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well as ways to control the defect density and thus the photophysical properties will be
discussed in greater detail in chapter 2.2.3.
Figure 2.6.: sp3-defect related photoluminescence. a) Schematic showing a sp3 defect
and its effect on the SWCNT’s excitonic states. Due to symmetry-breaking, a new bright
state is created below the dark KK exciton allowing for efficient radiative exciton recom-
bination. b) Effect of reaction parameters such as the concentration of the diazonium salt
(with respect to carbon atoms) on the PL of both the S11 and S⇤11 exciton with their corre-
sponding energies E11 and E⇤11. c) Tunability of the S⇤11 excitonic state depending on the
functional group attached to the defect site.[41] d) Single SWCNT (indicated by dashed
line) showing both ’delocalized’ E11 PL as well as E⇤11-PL ’localized’ at defect sites.[42]
e) Diffraction-limited as well as super-localized (f) E⇤11 emission of ultrashort SWCNT,
enabled by exciton-trapping and prevention of diffusive quenching.[43] Reproduced with
permission from Brozena et al.[44]
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2.2.3. Reactivity and functionalization of carbon nanotubes
As described in the chapters 2.2.1 and 2.2.2, carbon nanotubes are a highly interesting
and unique material both from a chemical and photophysical perspective. However, one
can also argue, that they are just a fascinating arrangement of carbon atoms and are
consequently limited in terms of their chemical and biological applications due to the
lack of properties such as e.g. specific binding of (bio)molecules. It is exactly this point,
where (organic) chemistry comes into play to build on top of the unique (photo)physical
properties and add extra ’layers’ of functionality. Essentially, there are two different ways
for the functionalization of single-walled carbon nanotubes - covalent (see Fig. 2.7) or
non-covalent (see Fig. 2.8) chemistry. For this reason, the following section will be
structured accordingly. In general, it should be noted that covalent modification of the
SWCNT’s ends or sidewall alters their structure and thus also their previously described
properties whereas non-covalent ’wrapping’ leaves the SWCNT’s integrity untouched.
2.2.3.1. Non-covalent functionalization
As described in section 2.2.1, carbon nanotubes are hollow cylinders compromised of al-
most only carbon atoms arranged in approx. 98% hexagonal, sp2-hybridized rings lead-
ing to large-range ⇡-electronic delocalization. Consequently, they are highly hydrophobic
in nature and tend to form large aggregates due to strong inter-nanotube van der Waals-
as well as ⇡-stacking interactions (Fig. 2.7a). As a result, SWCNTs are neither soluble in
water nor in any other organic solvent[14] limiting both further processing as well as use
in (biologically) relevant scenarios.
In need for better purification methods, Bonard et al. used the surfactant sodium dode-
cylsulfate (SDS) in combination with ultrasonic treatment to break up the SWCNT bun-
dles and stabilize single, separated SWCNTs in aqueous solution by micelle formation.[47]
This finding led to a large variety of surface-active or amphiphilic molecules to be used
in the last two decades for "solubilization" of SWCNTs, as e.g. sodium dodecylbenzene-
sulfonate (SDBS), sodium cholate (SC) or sodium deoxycholate (DOC). Due to their
dynamic/micellar dispersion mechanism, however, these surfactants require a concen-
tration above their critical micelle concentration (CMC) to effectively stabilize SWCNT
dispersions and prevent them from aggregation. While this is no problem for the means
of purification, it hampers the nanotube’s use in biological applications, where excess
surfactant could impair biosensing of an analyte or destabilize biological membranes
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Figure 2.7.: Non-covalent carbon nanotube functionalization. The non-covalent func-
tionalization of SWCNTs can - depending on the surface-active molecule employed -
result in either static or dynamic dispersions. While the former leads to stable aqueous
SWCNT-dispersions, dynamically dispersed SWCNTs will aggregate upon removal of ex-
cess surfactant. Examples of commonly used molecules for each type are given in the
respective boxes.
causing cell toxicity.[11] On the other hand, strong ⇡-⇡- or CH-⇡-interactions can help
to overcome this problem resulting in static dispersions. The most prominent examples
of this class are pyrenes, porphyrines, conjugated organic polymers such as poly[9,9-
dioctylfluorenyl-2,7-diyl] (PFO), but also biopolymers such as deoxyribonucleic acid
(DNA) or ribonucleic acid (RNA). While SWCNT-PFO dispersion are known to yield al-
most perfectly isolated SWCNTs in organic solvents (e.g. tetrahydrofuran [THF]) with
high quantum yields of 1.5-3.0%[45], oligonucleotide wrappings of SWCNTs produce sta-
ble aqueous dispersions. Moreover, the DNA/RNA wrapping entails another important
property - tunability. In contrast to the other classes of molecules described before, the
oligonucleotide sequence can be varied (by chemical or biochemical synthesis), which
was shown to have a drastic influence on SWCNT quantum yield, dispersion quality/yield
and ultimately applicability in biosensing.[5,48–51] This characteristic as well as its inher-
ent specificity for certain target analytes will be discussed further in section 2.2.4. Be-
sides RNA and DNA, also peptides and proteins such as albumin or different enzymes
were already used to disperse SWCNTs in aqueous systems. Whilst generally resulting
in lower quality dispersions, in many cases the proteins were still able to carry out their
native function, although being adsorbed on a hydrophobic nanotube.[52] All together,
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non-covalent functionalization of SWCNTs has proven to be a highly valuable tool not
only for studying their properties or for their purification, but also if proper anchors
are included for the attachment of further functional units without perturbation of the
nanotube’s structural integrity.
2.2.3.2. Covalent functionalization
In stark contrast to non-covalent wrapping of SWCNTs, which besides ultrasonic treat-
ment is considered a very mild procedure, covalent functionalization by design alters the
nanotube’s structure and with it its unique photophysical and electronic properties. As
mentioned above, carbon nanotubes can be imagined as a rolled-up sheet of graphene
resulting in a susceptibility towards chemical reactions borrowed from large aromatic
systems influenced by a certain degree of additional curvature. This curvature results
in deviations from bond angles normally found for extended ⇡-systems as well as ring
strain and structural defects compensating for that strain. These properties build the
foundation for the covalent chemistry of SWCNTs. As a consequence, the large variety
of reactions already known for aromatic compounds or graphite represents a toolbox for
chemists and material scientists to play with in order to generate SWCNT derivatives
with additional functions. In general, the covalent chemistry of carbon nanotubes can
be subdivided into two fields - the modification of functional groups/defects introduced
by oxidative treatments (etching) and the functionalization of pristine tubes directly via
addition reactions at e.g. their sidewall (see Fig. 2.8).
The oxidative treatment of SWCNTs can be carried out either in the gas-phase by ozone/
plasma treatment or in solution with oxidizing acids such as H2SO4/HNO3 or mixtures
of HNO3/H2O2. While the latter is widely applied in the field also for the sake of
catalyst-removal or shortening of nanotubes by cutting at defect sites[54], both meth-
ods yield a whole variety of oxygen-containing defects. As shown schematically in Fig.
2.8a, these include predominantly carboxylic acids, but also hydroxyl groups, aldehy-
des or ketones.[55] These functional groups can then be further targeted and deriva-
tized e.g. using thionyl chloride and alcohols or amines to form the corresponding es-
ters or amides. This route and other amidation procedures were widely applied in the
last two decades leading, amongst others, to SWCNT-protein[56], -PEG[57], -sugar[58] or -
oligonucleotide[59,60] conjugates with possible applications in drug delivery or immunolo-
gy.[55]
Besides the derivatization of oxidized SWCNTs, there are a whole variety of other re-
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Figure 2.8.: Covalent carbon nanotube functionalization. a) Oxidation of SWCNTs
leads to different oxygen-containing functional groups on the nanotube surface, which
can subsequently be modified further by e.g. amidation reactions. b) Several examples
of addition reactions leading to covalently modified SWCNTs. Whereas oxidative defects
as well as reductive alkylation and [3+2] cycloadditions diminish the SWCNT’s PL (red
box), a [2+1] cycloaddition by Setaro et al.[53] as well as finely tuned reactions with
diazonium salts[39] were shown to yield nIR-fluorescent nanotubes (green box).
actions, which were exploited in the recent years for the modification of SWCNTs. A
selection of those methods is presented in Fig. 2.8b. They all share the idea of having
one highly reactive species, which - when in proximity to a carbon nanotube - can un-
dergo an addition reaction both at its tips or at its sidewall. While the tips are typically
more reactive, sidewall-defects arising e.g. from the synthesis can also lead to higher
susceptibility for addition reactions on the sidewall.[55] The variety of reactions include
fluorination[61], carbene[62]/nitrene[63,64] addition, Diels-Alder cycloadditions[65], nucle-
ophilic additions[66], reductive alkylations[67,68], free radical additions[69,70], 1,3-dipolar
cycloadditions[71–73] or direct arylations with e.g. diazonium salts.[74,75] Whereas flu-
orinated nanotubes were shown to increase solubility in organic solvents and provide
the possibility of further derivatization using e.g. Grignard-reagents or organolithium
compounds[61,76], carbene- and nitrene additions were used e.g. to attach crown-ethers
or oligoethyleneglycol units.[63] One reaction, which was exceptionally often employed,
is the so-called ’Prato reaction’. It dates back to 1993, when Prato and coworkers first
utilized the reactivity of azomethine ylides for the derivatization of the fullerene C60.[77]
In this reaction, azomethine ylides are formed in situ via the condensation of an a-amino
acid and an aldehyde followed by a [3+2] cycloaddition to the nanotube’s sidewall or
end-tip. Prato’s and also other groups quickly expanded the scope of this reaction uti-
22
2.2. Single-walled carbon nanotubes
lizing it not only for the synthesis of water soluble SWCNTs[78], but also for the attach-
ment of peptides[79], fluorophores[80], cytotoxic drugs[81], antibiotics[82] or the multi-
modal modification of nanotubes.[83] Despite the quick adoption of this reaction, it has
to be noted, that the resulting carbon nanotubes do not display their characteristic nIR
photoluminescence anymore. Thus, for biological applications they lost one of their
biggest advantages and consequently could only be used for imaging upon conjugation
of another organic fluorophore - leaving the nanotube being no more than an attach-
ment platform. To circumvent this problem, Setaro et al.[53] made use of a different
type of reaction in 2017 - a [2+1] cycloaddition with electron-poor aromatic nitrenes
(see Fig. 2.8b). In particular, they used azidodichloro-triazine as a source for the in situ
generated nitrene. This nitrene, in turn, can then undergo a [2+1] cycloaddition with
the SWCNT’s sidewall as also observed earlier by the groups of Takagaki (2005)[64] and
Hirsch (2001)[63] for the attachment of alkyl chains or carborane cages. In contrast to
these older observations, however, Setaro et al. reported preserved nIR photolumines-
cence. The authors attribute this crucial difference to the electron-poor, aromatic nature
of the dichloro-triazine, which together with the high strain leads to ring-opening and
rehybridization. In the next step, they used this functionalization strategy for the gen-
eration of spiropyran-switchable nanotubes and conjugation of plasmonic gold nanopar-
ticles leading to even further increased PL intensity.[53] Another alternative for SWCNT
functionalization is the reaction with aryl diazonium salts. This reaction was reported
already by Dyke and Tour in 2004 for the modification of carbon nanotubes (and their
separation from metallic SWCNTs)[84], however, it was the laboratory of YuHuang Wang
and coworkers at the University of Maryland to find the preservation and also modula-
tion of the SWCNT’s PL at certain reaction conditions. While the effect of these so-called
quantum defects on the nanotube’s PL was already discussed in section 2.2.2.3, the reac-
tion mechanism leading to these defects should be discussed in the following.
As stated in section 2.2.2.3, carbon nanotubes containing quantum defects could present
a highly valuable tool for biomedical imaging and diagnostics. The red-shifted PL peak,
which now resides at around 1130 nm, allows SWCNT excitation at their S11-transition
(approx. 990 nm for (6,5)-species) instead of S22 excitation at approx. 560 nm allowing
for greatly enhanced tissue penetration and better contrast.[46] Thus, it is highly desirable
and also one of the aims of this work to use these defects not only for PL modulation, but
also as an anchor for the attachment of other functional moieties such as fluorophores,
peptides or proteins. The corresponding techniques for (bio)conjugation will be dis-
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cussed in section 2.4.1. When Piao et al. observed the PL modulation in 2013[39], they
were stirring a SDS-dispersed SWCNT sample with 4-nitrobenzenediazonium tetrafluo-
roborate for a prolonged time (240 h) at 25 C. Three years later, the same group pub-
lished a revised procedure with drastically enhanced reaction kinetics upon SWCNT ex-
citation (Fig. 2.9a).[85] This is due to the nature of the reaction of carbon nanotubes,
dispersed in water using a surfactant as e.g. SDS or SDBS, and an aryldiazonium salt
1, which proceeds via a radical mechanism with two possibilities for the initiation step.
First, the cleavage of an in situ formed diazoanhydride (2, via a Gomberg-Bachmann re-
action) can give the aryl radical 3 and second, the excitation of SWCNTs with (resonant,
see Fig. 2.9b) light could lead to a single electron transfer (SET) from the nanotube 5
Figure 2.9.: Mechanism of defect introduction by diazonium salts. a) Diagram show-
ing the difference in SWCNT-PL increase of a defect-reaction (p NO2-Dz) with and with-
out excitation. b) Absorbance spectrum of a SDS-SWCNT sample and its influence on the
defect PL intensity (shown as red dots at the respective excitation wavelength). c) Free
radical chain mechanism for the incorporation of defects into SWCNTs using diazonium
salts. Depending on the reaction conditions, there are two possibilities for initial radical
formation. In 7, the radical is formed on the a-carbon, but can migrate over the extended
⇡-system. Parts a) and b) were reproduced with permission from Powell et al.[85]
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onto the aryldiazonium salt yielding a aryl radical and a SWCNT-radical-cation 6 (with
faster kinetics).[85,86] Following a radical chain propagation mechanism, the formed aryl
radical 3 can now attack a SWCNT 5 resulting in a Aryl-SWCNT radical 7, which in turn
can generate another aryl radical via SET or recombine with an aryl radical to form a
doubly substituted SWCNT (10, see Fig. 2.9c). It is important to note, that the radi-
cal in 7 is formed in 1,2-position with respect to the aryl substituent, but can migrate
throughout the extended ⇡-system of the SWCNT until recombination with e.g. another
aryl radical or trion formation.[87]
If these quantum defects should now be utilized e.g. for the attachment of functional
units to SWCNTs or to increase aqueous solubility, it is, however, very important to look at
the number of defects introduced using diazonium chemistry. Whereas other techniques
such as the Prato reaction, fluorination or the addition of nitrenes/carbenes (including
the recent approach by Setaro et al.[53]) lead to one defect for every 2-100 carbon atoms
(which roughly translates to one defects per 0.1-1 nm for (6,5)-SWCNT), the carefully
adjusted conditions employed by Piao et al. for the generation of quantum defects result
in approximately one functional group per 10-20 nm length of (6,5)-SWCNT. This differ-
ence is of crucial importance when it comes to sensing capabilities (e.g. sensor dynamic
range, sensitivity) and also shielding of the hydrophobic SWCNT surfaces for aqueous
solubility.
2.2.4. Application as optical sensors
As described in the previous sections, carbon nanotubes are special from many points of
view. Their 1D tubular nature renders every (carbon) atom building up the tube a surface
atom. This has one immediate consequence: The nanotube’s optoelectronic properties
are highly sensitive to changes in the SWCNT’s surrounding. This can be observed im-
mediately when looking at the absorption maxima of SWCNTs wrapped with different
surfactants varying over approx. 20 nm.[88] This change depending on the nature, con-
formation and surface-coverage of the encapsulating molecule can be broken down to
changes in the dielectric environment in general.[34] Here, an increasing dielectric con-
stant is causing a red-shifted absorbance/emission as well as a decrease of exciton oscil-
lator strength.[34] Both the redshift and the decrease of exciton oscillator strength can be
attributed to dielectric screening of excitons by solvent molecules with the effect of en-
hanced non-radiative recombination or exciton dissociation.[89,90] However, this effect is
not uniform in nature as SWCNTs were also shown to display different PLQY in solvents
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of similar polarity. Larsen et al. found, that the additional important factor is solvent
electrophilicity, which could lead to a shift of electron density from the tubular surface
by electrophilic solvents. This, in turn, could lead to more non-radiative recombination
sites and consequently reduced PLQY.[89]
This dependence on the dielectric properties as well as on the electrophilicity of the
surrounding environment holds true not only for (organic) solvents, but also for sur-
factants, polymers or even solute molecules in general.[34] While (bio)polymers or sur-
factants, as described in section 2.2.3.1, can form micelles around SWCNTs or directly
adsorb on their hydrophobic surface and thus directly impact the dielectric environment,
solute molecules can intermittently interfere with this coating and in that way cause
dielectric perturbations. Using near-infrared fluorescence spectroscopy, these dielectric
perturbations can be probed either in terms of changes in PL intensity or wavelength
shifts. Mechanistically, there are several approaches discussed in literature including sol-
vatochromism, charge-transfer or doping/redox-reactions.[11] While redox reactions or
doping results in increased/decreased non-radiative exciton recombination sites (! de-
creased/increased PLQY), charge-transfer e.g. from the SWCNT’s valence band to the
analytes’ LUMO leads to altered population of ground/excited state and thus changed
exciton relaxation kinetics (! decreased/increased PLQY).[11]
Whereas the PL of SWCNTs is highly sensitive to its environment and is able to report
on changes via PL intensity- or wavelength modulation (detection unit), a sensor addi-
tionally requires both a recognition unit (e.g. antibody or aptamer) as well as a signal
transduction unit (e.g. molecular linker, enzyme) for selective binding and detection
of a target analyte. With respect to SWCNT-based sensors, they can roughly be sorted
into two categories. First, those relying on known recognition motifs or known inter-
actions and second, sensors found based on a screening approach making use of the
unique structural confinement of biopolymers on the hydrophobic SWCNT surface lead-
ing to new recognition motifs.[91] A few examples for SWCNT-based optical sensors de-
veloped during the last 15 years are shown in Fig. 2.10. SWCNT-based optical sensors
cover a wide range of analytes from reactive oxygen/nitrogen species (ROS/RNS) such
as NO[98], OH radicals[99] or H2O2[100] over small molecules as riboflavin[48], glucose[92]
or dopamine[5] to larger biomolecules (e.g. DNA[101,102], glycan-profiling[103], single nu-
cleotide polymorphisms[104]) or even whole proteins (e.g. fibrinogen[50], HE4[96]). By
comparing the sensors targeting these very different molecules, the differences in sensor
readout are very much apparent comprising PL wavelength shifts or PL intensity modula-
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Figure 2.10.: SWCNT-based optical sensors. Overview on different mode of actions of
several sensors and their respective sensor readout (top right boxes). a) Examples of
SWCNT-based optical sensors utilizing known recognition motifs or interactions for the
detection of glucose[92], the neurotransmitter serotonin[93], H2O2 released during plant
stress[94], several proteins[95] or the ovarian cancer biomarker HE4.[96] b) SWCNT-based
optical sensors based on structurally constrained (bio)polymers pinned to the SWCNT-
surface detecting dopamine[97], fibrinogen[50] or riboflavin.[48] Figures adapted and mod-
ified with permission from Yum et al.[92], Dinarvand et al.[93], Wu et al.[94], Ahn et al.[95],
Williams et al.[96], Kruss et al.[97], Bisker et al.[50] and Zhang et al.[48]
tion caused by the phenomena discussed above. The sensors developed for ROS/RNS re-
spond most likely to adsorption of these redox-active molecules on the SWCNT’s surface
and thus show quenched PL, which was utilized e.g. for the spatiotemporal monitoring
of NO-production inside macrophage cells.[105] The same readout mode (PL quenching)
is observed for many protein sensors as e.g. those shown in Fig. 2.10a/b for fibrinogen
or the p16-CDK4/Jun-Fos pairs. While for the latter case the PL quenching is caused by
Ni2+-induced proximity quenching, which is enhanced upon binding of the target protein
(after a conformational change of the "bait" protein), Bisker et al. attribute the selective
PL quenching to a combined effect of molecular recognition by the phospholipid-PEG
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corona-phase and the unique 3D-structure of fibrinogen.[50] In contrast, glucose or the
neurotransmitter dopamine are detected with an increase of PL caused by a conforma-
tional change of the wrapping (GT)15 oligonucleotide (dopamine)[5] or boronic ester for-
mation (glucose).[92] Besides PL quenching or enhancement, a wavelength shift can also
be a tool for analyte detection. Among others, this was utilized for the optical sensing
of riboflavin or the ovarian cancer biomarker HE4 (human epididymis protein 4), where
Williams et al.[96] made use of a anti-HE4 antibody as a detection unit. The wavelength-
shift was attributed to solvatochromism induced by polymer dielectric changes[48] or
removal of water upon binding of the HE4-protein resulting in a reduction of the local
dielectric constant as discussed above.[96]
While Fig. 2.10 highlights in vitro applications of SWCNT-based sensors, the beneficial
properties of nIR-PL such as enhanced tissue penetration depth or the absence of bleach-
ing/blinking led to quick adoption of a variety of the described sensors in in cellulo or
even in vivo applications. The dopamine sensor developed by Kruss et al.[5] was later ap-
plied for the monitoring of dopamine secretion from stimulated PC12 cells allowing for
a high spatiotemporal resolution surpassing existing electrochemical techniques.[97] Fur-
thermore, several other nanotube-based sensors were even applied in live brain slices[46]
or mice[96]. It is now part of this work to further enhance SWCNT-based optical sensors
and to find other chemistries allowing for a more general approach of sensor generation.
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2.3 Peptides and proteins as recognition elements
Peptides and proteins are molecules essential to all life on earth. They consist out of a
set of 22 ’proteinogenic’ amino acids, linked via an amide bond to form a linear peptidic
chain. If the length of this chain exceeds 100 monomers, the molecule is referred to as
a protein.[106] Proteins carry out a whole variety of functions in nature and are responsi-
ble for processes crucial to life as well as for diseases in the case of malfunction. While
small peptides often serve as hormones (e.g. insulin or oxytocin)[107], larger proteins e.g.
catalyze biochemical reactions (enzymes), transport oxygen in hemoglobin, are respon-
sible for movement with actin- and myosin filaments, built up skin and hair to a large
extent with collagen/keratin or even synthesize other proteins in the ribosome. All of
these functions described rely on a precise folding of the peptidic chain allowing for pro-
teins to work either on their own or in large concerted protein-complexes mediated by
protein-protein interactions (PPI). The folding and thus the 3D-structure of a protein is
largely defined by the properties of the amino acids it consists of as well as their sequen-
tial arrangement. The latter is also defined as the protein’s primary structure. Building
on top of that, the secondary structure describes the local structure of a peptide, i.e. the
way single amino acids are arranged with respect to one another. This is determined
by intramolecular interactions such as hydrogen bonding, van der Waals forces or ionic
interactions. Important secondary structures are the a-helix, the parallel or antiparallel
b-sheet and the b- or g-turn. The arrangement of these secondary structural motifs in
the three-dimensional space is referred to as the tertiary structure of a protein. Like the
secondary structure, the folding of the whole protein and its domains is also governed by
intramolecular interactions. In this case, however, they can also be of covalent nature as
in the case of disulfide bridges between two cysteines. Finally, the quaternary structure
describes the arrangement of different protein strands with respect to one another which
is crucial for the formation of larger protein assemblies relying on several subunits to
carry out their function (e.g. hemoglobin, RNA-polymerase).
In nature, proteins are synthesized in the ribosome, a large complex comprised of pro-
tein and RNA subunits. Here, the assembly proceeds from the N- to the C-terminus with
the ribosome reading the mRNA in 5’!3’ direction. In contrast, the chemical synthesis




2.3.1. Solid-phase peptide synthesis
The chemical synthesis of peptides is not just a trivial condensation of amino acids. Be-
sides the fact, that the reaction of two amino acids can already form four different di-
astereomers, the different functional groups occurring in natural amino acids require so-
phisticated protecting group strategies. When synthesized in solution, the side products
generated during synthesis also make an extensive purification necessary after each step
and for some protected peptides also their low solubility can be an issue.[108] To overcome
these problems, Bruce Merrifield developed the solid-phase peptide synthesis (SPPS) in
1963.[109] Here, the C-terminal amino acid is attached onto a solid support/resin (ei-
ther as an ester or amide) followed by repetitive deprotection/coupling steps until the
desired peptide sequence/length is reached. Between each deprotection and coupling
step, the excess reagents can be removed easily via filtration. This one-pot approach
without intermittent purification steps is not only time-saving, but also allows for the use
of higher excess of deprotection/activation reagents leading to improved coupling kinet-
ics and yields. To exclude side-reactions of side-chain functional groups such as thiols,
amines or alcohols, they have to be permanently protected during the whole synthesis
with a protecting group (PG) orthogonal to the temporary Na-PG.
Figure 2.11.: Solid-phase peptide synthesis. General scheme depicting the essential
steps of SPPS after immobilization of the first amino acid on the solid support (resin,
1). In repetitive cycles the N-terminus of the growing peptide chain is deprotected under
basic conditions (2) followed by amide-coupling to Fmoc-protected amino acids as an
active ester (3). After the desired peptide sequence/length has been reached, the N-
terminal Fmoc group is removed and the peptide cleaved off the resin under strong
acidic conditions (e.g. 95% TFA). This step also cleaves the orthogonal protecting groups
(PG) of the amino acid’s side chain yielding the final product 4
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The most common Na-PG is 9-fluorenylmethoxycarbonyl (Fmoc), which is also shown
in the general SPPS-scheme in Fig. 2.11. This orthogonal protection group strategy is
crucial to the success of the whole SPPS. The Fmoc-group is cleaved off under basic con-
ditions (e.g. 20% piperidine/DMF) leaving a freely accessible amine group. This amine
can now carry out a nucleophilic attack to the next amino acid’s activated carboxy-group.
After assembly of the complete sequence, the peptide is cleaved off the solid support
under acidic conditions (e.g. 95% TFA) also cleaving the acid-labile orthogonal PG’s
from the AA’s side chains yielding the desired peptide (4 in Fig. 2.11). This whole pro-
cess is easily automated and was consequently not only established for routine peptide
synthesis, but also for the synthesis of therapeutic peptides[110], cyclic peptides[111] and
peptides containing unnatural derivatives or post-translational modifications (PTM)[112],
which would otherwise not be accessible using other chemical or biochemical methods.
2.3.2. a-helical coiled-coil barrels
SPPS enables the synthesis of almost any peptide sequence of choice. One exception-
ally intriguing example especially when viewed besides carbon nanotubes are so-called
a-helical coiled-coil barrels. In nature, a-helical coiled-coils are ubiquitous constituting
approx. 3% of the protein-encoding regions of the genome. They are responsible not
only for certain protein structures but also for directing protein-protein interactions in
almost all intracellular and extracellular processes.[113] The a-helices are amphipathic
and consist of the general sequence heptad repeat (HPPHPPP)n (also (abcdefg)n), with
H corresponding to hydrophobic and P to polar AA residues. In order to shield their
hydrophobic a/d faces, the helices can form oligomeric assemblies (see Fig. 2.12a) with
dimers, trimers and tetramers dominating in nature.[113] On average, the spacing of the
hydrophobic residues in heptad-repeats is 3.5, whereas the pitch of an ideal a-helix cor-
responds to 3.6 residues. This (small) mismatch is the reason for two or more a-helices
wrapping slowly around each other forming coiled-coil or supercoil structures. In ad-
dition to the hydrophobic seam winding around the helix, so-called knobs-into-holes
interactions of adjacent helices represent a more specific type of interaction explain-
ing also the vast heterogeneity of coiled-coils in nature. Here, the side-chain of one
helix (’knob’) can interact with a ’hole’ structure formed by four residues of a neighbor-
ing helix (see Fig. 2.12b).[113–115] Taken together, these well-characterized sequence-to-
structure relationships make a-helical coiled coils one of the best studied protein struc-
tural motif[113,115–117] and even enabled computational de novo design of novel coiled-coil
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Figure 2.12.: a-helical coiled-coil barrels. a) Helical wheel diagram for a coiled-coil
pentamer (M=1) showing the interhelical contacts, the coiled-coil radius r and the he-
lical offset !1. Adapted with permission from Thomson et al.[114] b) Example of knob-
into-hole interaction of a residue a with a dgad hole formed by another helix (from
X-ray crystal structure of GCN4-p1). Adapted with permission from Woolfson et al.[113]
c) Examples of a-helical coiled-coil barrels showing the increasing pore diameter with
increasing oligomeric state (Structures generated from 4DZL (CC-Tri), 3R4A (CC-Tet),
4PN8 (CC-Pent), 4PN9 (CC-Hex) and 4PNA (CC-Hept)).
structures.[114,115] Here, Thomson et al. showed, that depending on the amino acid se-
quence of the a-helical monomer the resulting peptidic barrels can be tunable in their
pore sizes with diameters between 0.5 and 0.8 nm (see Fig. 2.12c).[114]
In addition to freely-standing barrels, which could be of interest e.g. for artificial mem-
brane channels, Burgess et al.[118] and Thomas et al.[119] also showed the possibility of
self-assembly into long peptide nanotubes (PNTs). This was achieved either via end-to-
end stacking of positively/negatively charged termini[118] or even covalently using native
chemical ligation (NCL) to site-selectively cross-link adjacent peptide barrels and thus
increase the PNT’s stability.[119]
It appears, that the diameters of the larger oligomeric species CC-Hex or CC-Hept are
in the same order of magnitude as common diameters of small carbon nanotubes with
e.g. (6,5)-SWCNTs having a diameter of 0.76 nm. Therefore, the idea of this work is
to use these larger oligomers for the dispersion of SWCNTs in aqueous environments.
As opposed to commonly used surfactants or biopolymers such as DNA (see section
2.2.3.1), peptides offer a larger degree of structural variability and were up to now
only rarely used for the non-covalent functionalization of SWCNTs. In 2003, Dieckmann
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et al. used a peptide folding into a-helical structures in the presence of SWCNTs for
their dispersion in aqueous solutions[120], whereas Ortiz-Acevedo et al. used reversible
cyclic peptides (linked via a disulfide bridge) to achieve a selectivity for certain SWCNT
diameters.[121] In 2011, Grigoryan et al. computationally designed peptides binding cer-
tain SWCNTs species preferentially upon self-assembly into antiparallel hexameric heli-
cal bundles and utilized that for the generation of a regularly spaced SWCNT-gold-NP
hybrid material.[122] It is now the aim of this work to use the well-studied sequence-
to-structure relationship of a-helical coiled-coil peptide barrels for the encapsulation of
certain SWCNT species with de novo designed a-HBs.
2.3.3. Antibodies and their functional fragments
While peptides are a very important class of biomolecules and recently also gained more
attention as therapeutic entities[123], by far the most widely used and powerful tool of
biomedical research are antibodies.[124] Antibodies, the most important protein in our
immune system, are large proteins with a size of approx. 150 kDa formed by a heterote-
trameric assembly. They are composed of two identical heavy (H) and light (L) chains,
each equipped with a variable domain at the respective N-terminus, which is responsible
for antigen binding and specificity (termed VH and VL).[124] The light and heavy chains
are linked together by disulfide bridges (two H-H-linkages, two L-H linkages) leading
to an overall Y-shape of the molecule (see Fig. 2.13a). The disulfide-nature of these
linkages is crucial for the antibodies function and specificity, however, it is also responsi-
ble for some limitations. For instance, the cytosol is a highly reducing environment[126]
with excess glutathione leading to structural instability of antibodies inside cells. Con-
sequently, in our immune system, antibodies are either displayed on the outside cellular
surface or secreted by immune cells to fight pathogens. Researchers recognized the large
potential of these highly specific binders already over a century ago[127,128] and antibodies
became the one of the most powerful tools not only in biomedical diagnostics and imag-
ing (with fluorescently tagged antibodies), but in the last two decades also in immune
therapy or more targeted chemotherapies (with antibody-drug conjugates, ADC).[125,129]
The already mentioned structural complexity and especially their susceptibility towards
intracellular reduction and disassembly, however, led to the development of many other
formats of specific binders, often derived from classical immunoglobulins.[125] Prominent
examples are the monovalent antigen-binding fragments (Fab) lacking the crystallizable
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Figure 2.13.: Schematic structure of antibodies and derived binders. a) Schematic
structure of a conventional full-length-antibody/immunoglobulin G (IgG) composed of
two heavy and two light chains linked via four disulfide bonds (yellow). Each heavy
chain contains three constant regions (CH1/2/3) and one variable region. The light
chain contains one constant region (CL) and one variable region (VL). The variable re-
gions are responsible for antigen binding (with each three complementary determining
regions [CDR], in total twelve) and associate via inter-domain interactions of hydropho-
bic framework residues (pink). b) Fab-fragment lacking the Fc-region of a conventional
IgG. c) scFv antibody formed by covalent peptidic linkage of the VL and the VH domain.
d) Heavy-chain antibody found e.g. in camelidae consisting only of the two heavy chains
linked via two disulfide bonds. The VHH domain does not rely on hydrophobic interdo-
main interactions for antigen binding making it possible to use also just the single VHH
domain in its isolated form as a stable and small binder (Nanobody, e)). Based on Helma
et al.[125]
fragment (Fc) of a conventional IgG (50 kDa, Fig. 2.13b) or scFVs consisting a VL and a
VH domain fused together via a peptidic linker sequence (25 kDa, Fig. 2.13c). These for-
mats, however, suffer from thermodynamic instability as they rely on non-covalent inter-
domain interactions for the correct fold and function.[125] To overcome this problem, also
single-domain antibodies derived directly from IgG’s were tested. Here, however, the
isolated variable VL and VH domains showed low solubilities and thus require extensive
protein engineering to drive them towards applications.[130] Consequently, the finding of
naturally evolved heavy-chain antibodies (hcAb, approx. 100 kDa, Fig. 2.13d) in cameli-
dae and cartilaginous fish (e.g. sharks) attracted a lot of attention as in these cases nature
already carried out the mutations necessary to provide e.g. improved solubility.[124,125]
HcAbs bind their antigen only via one variable domain (VHH) and in contrast to the VL
or VH domains of human IgG’s, the VHH domain is stable on its own in an aqueous envi-
ronment and can thus be cloned from the cDNA (encoding the hcAb) into phage-display
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vectors for selection and amplification of potent binders. These VHH-binders are, due to
their small size in the single-digit nanometer range, called nanobodies (approx. 15 kDa,
Fig. 2.13e). The absence of interchain disulfide-bridges or the necessity of non-covalent
inter-domain interactions renders nanobodies extraordinarily stable also e.g. in reducing
environments such as the intracellular space. This was demonstrated by the so-called
chromobody-technology, where nanobodies are expressed as fusion-proteins with fluo-
rescent proteins (RFP/GFP) allowing labelling and tracking of antigens inside a living
cell.[131] In addition, Herce and Schumacher et al. were able to modify nanobodies site-
specifically with cell-penetrating peptides allowing for antigen labeling in non-genetically
modified living cells. Furthermore, the special convex paratope shape of nanobodies al-
lows binding of otherwise not reachable epitopes such as enzymes[132] while their small
size (1.5 nm x 2.5 nm compared to 10 nm of an IgG) can lead to drastically reduced
linkage errors in super-resolution microscopy.[133]
In this work, a GFP-binding nanobody will be used to generate nanotube-nanobody con-
jugates enabling the labelling and tracking of GFP-tagged antigens in vivo as well as
targeted placement of nIR sensors. To achieve this goal and keeping the nanobody in
a functional state, the attachment to the SWCNT has to be carried out in a mild and
well defined fashion. In this work, this will be achieved by a single, ectopic C-terminal
cysteine, that can be attached to maleimide units presented on the SWCNT-surface. This
process will be explained in greater detail on the following pages.
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2.4 Carbon nanotube-Protein conjugates
Both single-walled carbon nanotubes and peptides/proteins are intriguing molecules on
their own and possess a whole variety of outstanding properties. This work, however,
aims at a combination of both of these molecules in order to blend their most beneficial
properties. While SWCNTs display stable and non-bleaching photoluminescence in the
biological transparency window, peptides/proteins can be either used as a functionaliza-
tion platform or directly for imparting target specificity to the molecular hybrid. In any
case, novel functional groups will be introduced to the all-carbon nanotube. The ways to
achieve this functionalization as well as the current status of SWCNT-protein conjugates
will be explained in the following section.
2.4.1. Conjugation strategies - bioorthogonal/chemoselective reactions
As already described in section 2.2.3, carbon nanotubes can be derivatized either by
covalent or non-covalent chemistries. While the covalent functionalization leads to very
stable conjugates also under challenging conditions, it also disrupts the SWCNT’s sp2 net-
work and thus diminishes its PLQY. In contrast, non-covalent functionalization leaves the
carbon nanotube itself untouched, but coats its surface with e.g. amphiphilic molecules,
which could carry another molecular anchor for further covalent derivatization (hybrid
functionalization). Very recently, Setaro et al. also achieved covalent functionalization
of SWCNTs under preservation of the nanotube’s PL.[53] Within this work, all of the de-
scribed ways for SWCNT functionalization will be evaluated for the use in different ap-
plications. Non-covalent modification of SWCNTs with DNA-oligonucleotides can lead to
functional hybrids for sensing of important neurotransmitters, whereas further covalent
derivatization of this oligonucleotide with nanobodies will be evaluated as an approach
for the targeted delivery of these nIR optical sensors. Furthermore, aryl defects intro-
duced via diazonium chemistry will be used for the covalent attachment nanobodies and
growth of peptidic chains directly on the nanotube’s sidewall under preservation of its
PL with the additional red-shifted E11* emission peak. All these applications have in
common, that it is highly important to generate these SWCNT-hybrid materials in a re-
producible and well-defined fashion. This does not only include the number of attached
units and functionalities, but also their fold and orientation on the SWCNT’s surface.
The latter characteristic is especially important for antigen-binding proteins to ensure
that the paratope is pointing away from the SWCNT surface to allow fast and sensitive
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antigen detection. The orientation of proteins, but also other functional units, can be
controlled by site-specific attachment of the SWCNT to the protein.
Proteins contain a whole variety of different functional groups including amines (Ly-
sine). guanidines (arginine), alcohols (serine, threonine) and thiols (cysteine). The
most common way for protein functionalization is the targeting of lysine residues, which
can be accomplished by the reaction with activated acyl groups (active esters or acyl
chlorides, see Fig. 2.14a). However, lysine’s high abundance leads to inhomogeneous
protein mixtures, which can be especially problematic for therapeutic applications.[134]
In addition, also residues essential for the protein’s fold or function could be affected
leading to e.g. abolished activity.[135] To circumvent these problems, a whole variety
of different techniques for both chemo- and regioselective labelling/functionalization of
proteins were developed. One approach used extensively in fluorescence microscopy
applications is the genetic fusion to other functional proteins.[136] These can be either
fluorescent themselves as the green-fluorescent protein (GFP, 27 kDa) and its differently
colored derivatives (see Fig. 2.14b)[137] or so-called self-labeling protein-tags as e.g. the
HALO- (33 kDa)[138] or SNAP-tag (20 kDa)[139] (see Fig. 2.14c). While the fusion of fluo-
rescent proteins (FP) enabled direct localization or even quantification[140] of proteins in
cells or in whole animals[141], self-labeling tags allow site-selective incorporation of the
whole variety of organic fluorophores with superior photophysical properties compared
to FPs.[142] However, both self-labeling tags and FPs are often larger than the protein-of-
interest (POI) itself and several studies already reported changes in cellular localization
or folding of the POI.[143,144]
One way to circumvent problems arising from large-size fusion proteins interfering with
the POI’s function, but still be able to site-specifically modify proteins also inside living
cells, is the incorporation of unnatural amino acids (UAA) or small chemical anchors.
UAAs can either be incorporated directly during expression of the POI (by auxotrophic
expression[145] or amber codon suppression[146], see Fig. 2.14d) or post-translationally
using chemoenzymatic approaches[147] with enzymes such as sortase[148], tubulin-tyrosine
ligase[149] or the formyl glycine generating enzyme[150] (see Fig. 2.14e). While aux-
otrophic expression allows for the residue-specific placement of UAAs (instead of one
natural residue), amber-codon suppression makes site-specific incorporation of UAAs
possible. Chemoenzymatic systems can, depending on the system employed, also in-
troduce unnatural residues both to the C- or N-terminus or sequence-internally through
attachment to short peptide tags.[147] Another type of modification, that can be used
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for site-specific modification of proteins is the so-called expressed protein ligation (EPL)
making use of intervening proteins (inteins) and their ability to excise themselves out
of an already expressed protein leaving the two flanking regions fused together by a na-
tive amide bond (Fig. 2.14f). Inteins and their self-splicing ability were already utilized
as cleavable purification tags[151], for protein semisynthesis with synthetic peptides[152]
or for live-cell protein labelling with so-called split-inteins.[153] While all of these ap-
proaches enable the site-specific and bioorthogonal functionalization of proteins, some
of them suffer from tedious genetic engineering required and low yields (genetic code ex-
Figure 2.14.: Protein functionalization methods. a) Labeling of lysine residues leading
to inhomogeneous product mixtures due to the high abundance of lysine. b) In cellulo
or in vivo expression of the protein of interest (POI) fused to a fluorescent protein (FP)
either an its N- or C-terminus. c) Expression of the POI fused to either the SNAP- or the
HALO-tag allowing the functionalization with different moieties such as fluorophores,
biotin or beads carrying a benzylguanine (SNAP) or haloalkane (HALO). d) Site-specific
incorporation of unnatural amino acids (UAA) at the Amber Stop Codon (UAG) via uti-
lization of orthogonal tRNA/aminoacyl-tRNA synthetase pairs. e) Naturally occurring
enzymes or evolved variants can recognize a small peptidic tag on the POI and attach an
UAA or modify one of its amino acids to install a chemical reporter. This reporter unit
can now be targeted using bioorthogonal chemistry with e.g. a fluorophore or a drug
molecule. f) The expression of the POI fused to an intein allows not only purification of
the POI, but also the attachment of modified peptides or even proteins after an S,N-acyl
shift. The ligation of the two fragments leaves a cysteine residue at the ligation site and
the two parts are fused together by a native amide bond making protein semisynthesis
possible.
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pansion) or peptidic tags which need to be incorporated for successful enzymatic recog-
nition.
This work will make use of a much more straightforward method of protein modification
utilizing the high nucleophilicity and low abundance (less than 2%) of the amino acid
cysteine.[134] While not being generally applicable for site-specific protein functionaliza-
tion, in the right systems containing e.g. only one solvent-exposed cysteine residue, this
technique can be used to generate homogeneous protein-conjugates. There is a variety
of different methods available for the modification of cysteine with Fig. 2.15 showing a
selection of the most widely used methods. Out of the methods shown in Fig. 2.15, the
alkylation with iodoacetamide, disulfide exchange reactions with electrophilic disulfides
and the Michael-addition to maleimides are the most commonly used methods.[134,154]
Whereas iodoacetamide is often employed as a capping reagent e.g. before protein di-
gestion for sequencing, disulfide exchange reactions lead to bioconjugates, that can be
cleaved again under reducing conditions. This additional feature makes them interesting
e.g. for targeted drug delivery and intracellular release. Apart from that also other meth-
ods have been developed for cysteine-selective protein functionalization proceeding via
Figure 2.15.: Methods for cysteine functionalization. a) Alkylation of cysteine using
iodoacetamide. b) Disulfide exchange with electrophilic disulfides. c) Radical-catalyzed
thiol-ene chemistry. d) Conversion of a cysteine residue to dehydroalanine and subse-
quent Michael addition. e) Addition of the protein to electron-poor alkynephosphonami-
dates generated from electron-rich alkynephosphonites through Staudinger-phosphonite
reaction. f) Michael addition of a protein’s thiol to a maleimide resulting in a thioether-
linked conjugate, which could undergo hydrolysis to the thiosuccinimide or react back-
wards in a retro-Michael reaction with an excess of competitive thiols.
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alternative mechanisms (dehydroalanine formation and subsequent Michael-addition or
radical chemistry in thiol-ene reactions, Fig. 2.15d/e) and/or offering increased stability
when e.g. compared to standard maleimide chemistry such as the cysteine addition to
electron-poor ethynylphosphonamidates recently introduced by Kasper et al.[155].
In the course of this work, however, standard maleimide chemistry (Fig. 2.15f) will be
employed for cysteine-selective attachment to SWCNTs yielding a thioether-linked con-
jugate. This reaction proceeds via a Michael addition, where the cysteine’s deprotonated
thiol (pKa ~ 8) attacks the maleimide leading to an strongly basic enolate intermediate,
which, after abstraction of a proton from another thiol (cysteine), forms the thiosuccin-
imide (see Fig. 2.15f). Due to the high polarizability and resulting soft nucleophilicity
of the thiolate, thiol-Michael-additions with maleimides proceed with fast kinetics under
physiological conditions.[156] In this work, the maleimide moiety will be employed within
a phenylmaleimide diazonium salt for covalent SWCNT-functionalization and the cross-
linker sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexan-1-carboxylate (Sulfo-SMCC)
for attachment to the DNA-polymeric phase around the SWCNTs. Sulfo-SMCC also con-
tains an amine-reactive succinimidyl-ester and thereby enables the attachment of a pro-
tein to an amine-modified DNA-oligonucleotide wrapping a carbon nanotube. This strat-
egy and others have already been employed successfully in the past for the generation
of SWCNT-Protein conjugates and functional sensors, which will be described in the fol-
lowing section.
2.4.2. Functional conjugates and sensors
While in the previous section the importance of chemo- and regioselectivity was dis-
cussed, the following lines will give a selection of examples, where SWCNT/Protein-
hybrids were already successfully used in in vitro or in vivo applications.
The first carbon nanotube/protein hybrids were reported by Tsang et al. in 1995[157]
using metallothionein proteins non-covalently adsorbed to the inside of multi-walled
carbon nanotubes (MWCNTs) followed by Balavoine et al. in 1999[158], who managed to
coat the outer surface of MWCNTs with streptavidin (see Fig. 2.16a). Both of these early
discoveries were proven using electron microscopy. Only shortly afterwards, in 2001,
Erlanger et al. used a monoclonal IgG, originally targeted towards the C60 fullerene,
for binding of SWCNTs, mediated by a large extent of hydrophobic residues in the anti-
gen binding region. They were able to image the SWCNT/Antibody hybrid using atomic
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force microscopy (AFM).[159] The following years saw, in addition to more non-covalent
approaches, a major rise of covalent chemistry on carbon nanotubes and the attach-
ment of peptides and proteins to covalent carboxylic acid defects or those created by the
1,3-dipolar cycloaddition with azomethine ylides. Whereas the former was pioneered
by Huang et al. with the covalent immobilization of bovine serum albumine (BSA) on
the sidewalls of SWCNTs and MWCNTs after carbodiimide activation[56], Pantarotto et
al. used azomethine ylide defects for the attachment of a 20-mer peptide from the vi-
ral envelope protein VP1 with retained structural integrity in 2003[79]. In 2007, You et
al. reported a strategy for the stimuli-sensitive covalent immobilization of proteins on
SWCNTs via disulfide bonds cleavable under reducing conditions (see Fig. 2.16b).[160] In
order to achieve functional electrical or optical sensors, non-covalent functionalization
was often the method of choice as also in a few SWCNT/Enzyme hybrids[162] or SWCNT-
Glucose-binding protein conjugates, which were able to detect glucose via a conforma-
tional shift of the protein resulting in a change of the SWCNT’s dielectric environment
and thus altered PL (see section 2.2.4).[161] A similar readout strategy was utilized in
another striking example of nanotube/protein hybrids by Ahn et al., who generated a
nanotube/protein microarray by cell-free synthesis of His-tagged proteins directly on
Ni2+-nitrilotriacetic acid (NTA)-modified chitosan wrapped carbon nanotubes (see Fig.
2.16d). The Ni2+-ion acts as a proximity quencher for the SWCNT’s PL and is, upon
binding of the analyte protein to the His-tagged protein, displaced either towards or
away from the nanotube’s surface resulting in either increased or diminished nIR-PL.[95]
In addition to the described examples, also antibodies were already immobilized on car-
bon nanotubes for the use in biomedical applications. In 2009, Liu et al. presented a
protocol for the non-covalent immobilization of the anti-Her2 antibody Herceptin via a
phospholipid-polyethyleneglycol(PEG)-5000-linker and used the conjugate for the in vivo
nIR imaging of tumor vessels.[163] Williams et al. in contrast, used an antibody against
the ovarian cancer biomarker human epididymis protein 4 (HE4) as a targeting unit to
create a nIR-PL based sensor for this biomarker operating via a wavelength-shift readout
model. After successful in vitro validation, the authors were able to apply this sensor also
in mouse ovarian cancer models for the in vivo monitoring of HE4 (see Fig. 2.16e).[96]
The approaches presented here highlight the potential of SWCNT/Protein hybrids, how-
ever, until now only non-covalent functionalization approaches were utilized for NIR-
fluorescent SWCNTs and their decoration with e.g. antibodies. In contrast, this work
should also explore the potential for covalent nanotube functionalization using sp3-
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Figure 2.16.: SWCNT-Protein conjugates and applications. a) Multi-walled carbon
nanotubes (d<15 nm) stochastically coated with the protein streptavidin versus heli-
cal organization of streptavidin on larger MWCNTs (d=16 nm). Reproduced with per-
mission from Balavoine et al.[158] b) Conjugation of bovine serum albumine (BSA) to
SWCNTs via a disulfide bond, which can be cleaved under the right conditions (e.g. ex-
cess thiol) and is thus termed ’smart linkage’. Reproduced with permission from You
et al.[160] c) SWCNT-Glucose-binding protein (GBP) hybrid, which is able to detect glu-
cose through a conformational change of the protein and thus altered SWCNT photolu-
minescence (PL). Reproduced with permission from Yoon et al.[161] d) SWCNT/Protein
microarray for selective protein recognition. Upon binding of the analyte protein to the
His-tag protein, the Ni2+-quencher is displaced altering the SWCNT’s PL. Reproduced
with permission from Ahn et al.[95] e) SWCNT-antibody conjugate for the detection of
an ovarian cancer biomarker (HE4) working via a blue-shift of the SWCNT’s PL upon
antigen-binding. The so created sensor was then also applied for antigen-monitoring in
mice. Reproduced with permission from Williams et al.[96]
defects as described in section 2.2.3 as well as the use of smaller proteinaceous recogni-
tion units such as nanobodies to decrease the distance of the carbon nanotube and the
binding event. These efforts as well as other strategies to create nIR-fluorescent SWCNT-
based sensors will be described in the following chapters.
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Carbon nanotubes have, since their discovery almost 30 years ago, found applications in
many different fields of science owing to their unique molecular nature and the resulting
properties that are interesting not only for the application in transistors, as single-photon
sources, fluorophores or drug delivery vehicles, but also as optical sensors. They were
used for the detection of a variety of different analytes ranging from metal ions over small
molecules such as glucose to whole proteins. While a few of these sensors were fabri-
cated through immobilization of analyte-binding proteins such as the glucose-binding
protein, the larger portion was created via structural confinement of a (bio)polymer on
the SWCNT’s surface. This concept was coined Corona Phase Molecular Recognition
and describes the process of the (bio)polymer adapting 3D structures on the SWCNT
surface, which would be otherwise not accessible in solution. While this process has
proven to yield successful sensors in many cases, the screening process remains tedious
and selectivity of these sensors can be an issue. In addition, often DNA oligonucleotides
or phospholipids were chosen as the corona phase to impart selectivity, however, their
structural space is very limited compared to peptides and proteins, which are largely un-
explored in conjunction with SWCNTs to this date.
Consequently, the aim of this work is to elucidate and test different ways for the function-
alization of carbon nanotubes and their impact on their photophysical properties, their
ability to act as a biosensors and the possibility of targeted placement/delivery of these
fluorescent molecules.
GOAL 1 - Competitive detection of the neurotransmitter dopamine
Carbon nanotubes wrapped by the DNA oligonucleotide (GT)15 were shown to be sen-
sitive towards the neurotransmitter dopamine[5] and this concept has also been used
recently for the spatiotemporal imaging of dopamine release from PC12 cells.[97] In this
early work, however, the selectivity has not been heavily investigated especially with re-
gard to the discrimination of other relevant catecholamines. Thus, the aim of this project
is to test different DNA oligonucleotides for the PL response to dopamine, epinephrine
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and norepinephrine, which are two structurally very similar neurotransmitters, that also
cause cross-reactivity in other established electrochemical sensor formats.[164] Using this
systematic study, the influence of the DNA sequence on the sensor response should be
evaluated and eventually used to create more selective dopamine sensors.
GOAL 2 - Targeted delivery of nanosensors
Carbon nanotube based optical sensors have demonstrated their potential for the mon-
itoring of a variety of biologically relevant analytes in the recent years. However, envi-
sioning in vivo applications, the placement of these sensors will be a factor of crucial
importance. If injected, the nanoscopic sensors would diffuse freely and randomly asso-
ciate e.g. with blood plasma proteins or unspecifically adsorb to tissue. For this reason,
the aim of this project is to use nanobodies as a targeting unit on the carbon nanotube
while still preserving the sensing capabilities. This approach should be demonstrated
with the SWCNT-DNA-based dopamine sensors and a nanobody capable of binding GFP,
which would open up the possibility of targeting and studying a whole variety of proteins
expressed as GFP-fusions already in in vivo settings.
GOAL 3 - Peptides as a more versatile SWCNT surface modification
SWCNT-based optical sensors are mainly composed of DNA oligonucleotide or phos-
pholipid coatings. However, the 20 proteinogenic amino acids constituting proteins and
peptides do not offer only a much larger structural variety, but also allow the introduction
of residues carrying e.g. different charges. To make use of this larger structural space
for the development of SWCNT-based sensors, a-helical coiled-coil peptide barrels will
be evaluated for their capabilities to encapsulate SWCNTs and stabilize them in aqueous
solution. Furthermore, recently discovered sp3 defects in the nanotube’s sidewall leading
to red-shifted PL emission will be explored as a platform for SWCNT functionalization.
To achieve this, two anchor-group bearing diazonium salts will be synthesized and tested
with respect to defect incorporation and change of the nIR fluorescence. Furthermore,
their phenylalanine and maleimide anchor groups will be used as a starting point for pep-
tide growth directly on the nanotube’s sidewall and nanobody attachment, respectively.
If successful, this could lead to much more stable SWCNT-bioconjugates for applications
in nIR-labelling and -sensing.
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4.1 Competitive detection of the neurotransmitter
dopamine
Neurotransmitters are molecules essential to cognitive processes and the function of our
brain. In addition, neurotransmitters including dopamine are linked to several severe
neurological disorders such as Huntington’s and Parkinson’s disease or schizophrenia.[165]
Thus, it is essential to be able to detect neurotransmitter signaling in order to gain a
better understanding of these fundamental processes. Although there are several tech-
niques to detect neurotransmitters based e.g. on their redox potential using amperom-
etry or fast scan cyclic voltammetry (FSCV), these techniques are not able to provide
the temporal or spatial resolution necessary to resolve release events.[166] In the last
years, DNA-oligonucleotide wrapped carbon nanotubes gained attention for application
as optical sensors for the spatiotemporal monitoring of dopamine release events.[5,97]
However, these sensors were not yet thoroughly evaluated regarding their selectivity
with respect to structurally similar neurotransmitters (epinephrine, norepinephrine) and
their binding characteristics (dissociation constants). Therefore, the aim of this project
is to further study the relationship between the DNA oligonucleotide’s sequence and
the selectivity and sensitivity of the SWCNT-based dopamine sensors (Kd values, limit
of detection (LOD)) in order to ultimately enable competitive detection of dopamine at
equimolar concentrations of epinephrine and/or norepinephrine.
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4.1.1. Tuning Selectivity of Fluorescent Carbon Nanotube-Based
Neurotransmitter Sensors (Manuscript 1)
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Abstract: Detection of neurotransmitters is an analytical challenge and essential to understand
neuronal networks in the brain and associated diseases. However, most methods do not provide
sufficient spatial, temporal, or chemical resolution. Near-infrared (NIR) fluorescent single-walled
carbon nanotubes (SWCNTs) have been used as building blocks for sensors/probes that detect
catecholamine neurotransmitters, including dopamine. This approach provides a high spatial and
temporal resolution, but it is not understood if these sensors are able to distinguish dopamine from
similar catecholamine neurotransmitters, such as epinephrine or norepinephrine. In this work,
the organic phase (DNA sequence) around SWCNTs was varied to create sensors with different
selectivity and sensitivity for catecholamine neurotransmitters. Most DNA-functionalized SWCNTs
responded to catecholamine neurotransmitters, but both dissociation constants (Kd) and limits of
detection were highly dependent on functionalization (sequence). Kd values span a range of 2.3 nM
(SWCNT-(GC)15 + norepinephrine) to 9.4 µM (SWCNT-(AT)15 + dopamine) and limits of detection
are mostly in the single-digit nM regime. Additionally, sensors of different SWCNT chirality show
different fluorescence increases. Moreover, certain sensors (e.g., SWCNT-(GT)10) distinguish between
different catecholamines, such as dopamine and norepinephrine at low concentrations (50 nM). These
results show that SWCNTs functionalized with certain DNA sequences are able to discriminate
between catecholamine neurotransmitters or to detect them in the presence of interfering substances
of similar structure. Such sensors will be useful to measure and study neurotransmitter signaling in
complex biological settings.
Keywords: carbon nanotube; biosensor; fluorescence; DNA; neurotransmitter; affinity
1. Introduction
Neurotransmitters are essential for basic functions of the human body and especially for chemical
signaling in neuronal circuits of the brain. However, their mode of action is widely unexplored due to
a lack of tools to measure their concentration profiles in a spatiotemporal manner. In the past decades
several analytical methods have been developed to measure neurotransmitter concentrations [1–5].
Those methods range from magnetic resonance imaging with contrast agents for neurotransmitters
to electrochemical approaches, but most of them lack either high spatial or temporal resolution or
they are not compatible with biological environments [2–4,6]. The detection of neurotransmitters
is very challenging because of several limiting conditions. First, many neurotransmitters are small
molecules that share structural homologies with each other and with additional interfering substances
in the brain or in the cell culture. Second, during exocytotic events only 100–100,000 molecules are
released within milliseconds [7]. Finally, the most prominent release sites, i.e., synapses, are very small
Sensors 2017, 17, 1521; doi:10.3390/s17071521 www.mdpi.com/journal/sensors
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(300 ⇥ 300 ⇥ 20 nm3) and not easily accessible by macroscopic probes [8]. All these hallmarks of neural
networks indicate that neurotransmitter sensors should be sensitive/selective (single-molecule level),
label-free, small (nanoscale), fast (milliseconds), and non-invasive (e.g., optical).
Classical approaches to detect (redox-active) neurotransmitters are electrochemical methods such
as amperometry or cyclic voltammetry [9,10]. Many biological studies were only possible because
these methods provided quantitative information about neurotransmitter concentrations around cells,
in brain slices and in vivo [2,11]. However, electrochemical methods are limited to molecules that can
be oxidized at the electrode (e.g., dopamine or serotonin) or make use of enzymatic reactions [12].
Therefore, important neurotransmitters, such as glutamate or  -aminobutyric acid (GABA), cannot
be detected. Moreover, electrodes are large compared to the site of neurotransmitter release, which
limits simultaneous and parallel/spatial detection. Another approach is based on modifying biological
recognition units of neurotransmitters and conjugating them with fluorescent dyes. This method was
used to engineer GABA sensors and glutamate sensors [13,14]. Recently, glutamate was detected by
using green-fluorescent protein (GFP)-conjugated glutamate receptors that can be also transfected into
cells [15]. The disadvantage of this approach is the need for cell transfection and manipulation, which
is difficult in complex primary biological samples and in vivo. Additionally, sensing is restricted to the
cell surface and, therefore, diffusion characteristics cannot be assessed.
Nanomaterials are promising building blocks for neurotransmitter sensors/probes [1]. Among
the different materials carbon nanotubes attract a lot of interest due to their unique optoelectronic
properties. Semiconducting single-walled carbon nanotubes have a bandgap that leads to near infrared
(NIR) fluorescence [16]. SWCNTs can be non-covalently decorated with an organic phase generating
the desired specificity for the molecular target. Examples for sensors of this class range from small
molecule analytes, like neurotransmitters, sugars, and explosives, to miRNA or proteins [17–23]. These
sensors combine specificity for the target generated by the organic corona-phase and the advantageous
properties of SWCNTs for optical sensing and imaging [16,24–26]. These advantages are, among others,
the extraordinarily high photostability compared to organic fluorophores, the absence of fluorescence
blinking, as well as the large Stokes-shift of >400 nm allowing for low-background imaging in the
biologically-transparent near-infrared (NIR) window [16]. Such reversible sensors have been used to
detect the efflux of dopamine from cells by imaging many of them at the same time [5]. This approach
enabled a spatial resolution that was not possible before with electrochemical approaches.
The organic phase (corona) around these sensors plays a central for molecular recognition and
signal transduction. The mechanism and the reasons for selectivity are, however, still not completely
understood. Fluorescence changes were attributed to conformational changes, redox chemistry and
free surface area [5,27,28]. Another possible mechanism could be a change of exciton diffusion upon
binding of an analyte [29].
Although SWCNT-based sensors have shown great potential for interesting applications, there
are still several obstacles to overcome with respect to specificity, affinity, and kinetics. Especially
kinetics (rate constants) and dissociation constants play decisive roles in the fast detection of
neurotransmitters [30]. These issues have not yet been taken into account so far, but will be important
to enable applications in chemically-complex environments.
In this work, we address remaining challenges of neurotransmitter detection with carbon
nanotube-based sensors by varying the organic phase around the SWCNT scaffold and evaluating the
resulting dissociation constants and limits of detection for relevant neurotransmitters. This approach
(Figure 1) enables us to identify organic phases (DNA sequences) that impart the best sensor
performance (selectivity, sensitivity at relevant concentrations, dynamic range, etc.).
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2. Materials and Methods  
Materials: Unless stated otherwise, all chemicals and oligonucleotides were purchased from 
Sigma Aldrich (Taufkirchen, Germany) or TCI (Eschborn, Germany). For epinephrine and 
norepinephrine, the racemic mixture was used.  
Dispersion and functionalization of carbon nanotubes: To generate a stable single-walled 
carbon nanotube (SWCNT) dispersion under physiological conditions, 0.5 mg oligonucleotide was 
added to 0.5 mg of 6,5-chirality enriched SWCNT (Sigma Aldrich, Product No.: 773735) in 0.5 mL 1× 
phosphate-buffered saline (PBS). The resulting suspension was first tip sonicated for 10 min (Fisher 
Scientific™ Model 120 Sonic Dismembrator, 20% amplitude) and subsequently centrifuged at  
16,100 g (2 × 30 min) to remove large bundles, aggregates or metal catalysts remaining from SWCNT 
synthesis. The supernatant containing individualized SWCNTs was used as a stock solution for 
downstream experiments after absorbance measurements and estimation of nanotube concentration 
using the molar extinction coefficient at 991 nm [31]. The solutions corresponding to the different 
DNA-sequences were adjusted in concentration according to the collected absorbance spectra. 
Spectroscopy of SWCNT-DNA complexes: NIR absorbance spectra were measured with a  
UV-VIS-NIR spectrometer (JASCO V-670, Spectra Manager Software) using a 10 mm-path cuvette.  
NIR fluorescence spectra were recorded on a Shamrock 193i spectrograph (Andor Technology 
Ltd., Belfast, Northern Ireland) coupled to an Olympus BX53 microscope using an exposure time of 
10 s and a slit width of 500 ΐm and an Andor iDus InGaAs 491 array NIR detector. SWCNTs were 
excited at 560 nm.  
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Figure 1. Strategy to measure and optimize selectivity and sensitivity of neurotransmitter
sensors. Candidate sensors are synthesized from single-walled carbon nanotubes (SWCNTs) and
DNA oligonucleotides and their responses to the neurotransmitters dopamine, epinephrine and
norepinephrine are quantified. Crucial for the success of these sensors is the discrimination
between different, but chemically very similar, neurotransmitters. In this work, a set of different
DNA-oligonucleotides is tested as an organic phase and corresponding sensor properties, such as
Kd-values, are evaluated to find the most selective and robust sensors.
2. Materials and Methods
Materials: Unless stated otherwise, all chemicals and oligo ucleotides were purchased from Sigma
Aldrich (Taufkirchen, Ger any) or TCI (Eschborn, Germany). For epinephrine and norepinephrine,
the racemic mixture was used.
Dispersion and functionalization of carbon nanotubes: To generate a stable single-walled
carbon nanotube (SWCNT) dispersion under physiological conditions, 0.5 mg oligonucleotide was
added to 0.5 mg of 6,5-chirality enriched SWCNT (Sigma Aldrich, Product No.: 773735) in 0.5 mL
1⇥ phosphate-buffered saline (PBS). The resulting suspension was first tip sonicated for 10 min (Fisher
Scientific™ Model 120 Sonic Dismembrator, 20% amplitude) and subsequently centrifuged at 16,100 g
(2 ⇥ 30 min) to remove large bundles, aggregates or metal catalysts remaining from SWCNT synthesis.
The supernatant containing individualized SWCNTs was used as a stock solution for downstream
experiments after absorbance measurements and estimation of nanotube concentration using the molar
extinction coefficient at 991 nm [31]. The solutions corresponding to the different DNA-sequences
were adjusted in concentration according to the collected absorbance spectra.
Spectroscopy of SWCNT-DNA complexes: NIR absorbance spectra were measured with a
UV-VIS-NIR spectrometer (JASCO V-670, Spectra Manager Software) using a 10 mm-path cuvette.
NIR fluorescence spectra were recorded on a Shamrock 193i spectrograph (Andor Technology
Ltd., Belfast, Northern Ireland) coupled to an Olympus BX53 microscope using an exposure time of
10 s and a slit width of 500 µm and an Andor iDus I GaAs 491 array NIR detector. SWCNTs were
excited at 560 nm.
NIR-fluorescence dos response curv s: Ten microliters of the corresponding and freshly-prepared
catecholamine ·HCl solution (0, 100 pM, 1 nM, 10 nM, 100 nM, 1 µM, 10 µM, 100 µM) in
1⇥ phosphate-buffered saline (PBS) were added to 90 µL f DNA-suspended SWCNTs (0.1 nM,
in 1⇥ PBS) in a 96-well plate format. The fluorescence counts were averaged from triplicates and
plotted against the neurotransmitter concentration on a log-scale.
Extraction of dissociation constants from dose-response curves: The NIR-fluorescence
dose-response curves were fitted using Equation (2). From this fit the dissociation constant and its 95%
confidence interval were extracted for each combination of SWCNT-DNA sensor and catecholamine.
In the case of dopamine, 100 µM values were neglected for Kd estimation, as dopamine is prone to
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oxidation and polymerization at higher concentrations [32,33], which was previously shown to have
an effect on SWCNT-DNA fluorescence modulation [17].
Near infrared microscopy of immobilized SWCNT-DNA sensors: Twenty microliters
of the 0.1 nM SWCNT-DNA (SWCNT-(GT)10, SWCNT-(GA)15) solution were incubated on
(3-aminopropyl)triethoxysilane (APTES)-pre-activated glass bottom Petri dishes (1 wt % APTES/H2O
in EtOH, 1 h) overnight at 4  C. After a 1⇥ PBS wash, NIR imaging was carried out on an Olympus
BX53 microscope (Olympus K.K., Tokyo, Japan) using a 60⇥ oil-immersion objective and a Xenics®
Xeva-1.7-320 NIR camera (Xenics, Heverlee, Belgium). The frame-rate was set to 0.5 fps. After approx.
10 frames, 20 µL 100 nM norepinephrine solution was added to the adsorbed SWCNT-DNA. Dopamine
was added after 50 additional frames in the same volume and concentration to yield 40 µL containing
50 nM of each neurotransmitter.
Dose-response measurements of immobilized SWCNT-DNA sensors: One-hundred microliters
of a 1.1 µM SWCNT-(GT)10 solution in 1⇥ PBS was incubated on glass-bottom Petri dishes for one
hour at 4  C. After a 1⇥ PBS wash, NIR imaging was carried out on an Olympus BX53 microscope
using a 60⇥ oil-immersion objective and a Xenics® Xeva-1.7-320 NIR camera. The frame-rate was set
to 0.5 fps. Approx. every 30 frames, 5 µL of increasing dopamine concentrations (a = 1 nM, b = 10 nM,
c = 100 nM, d = 1 µM, e = 10 µM) were added to a 50 nM norepinephrine solution (in 1⇥ PBS, 500 µL)
on top of the adsorbed SWCNT-DNA.
3. Results
3.1. Preparation and Optical Properties
(6,5)-chirality enriched SWCNTs were dispersed using tip-ultrasonication with ten different
oligonucleotides in 1⇥ PBS (pH 7.4). The corresponding absorbance and NIR-fluorescence emission
spectra are shown for (GT)10 as an example in Figure 2.
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Figure 2. Absorbance and fluorescence spectra of DNA-dispersed single-walled carbon nanotubes
(SWCNT). (a) VIS-NIR absorbance spectra of (GT)10-dispersed SWCNT. (b) NIR-fluorescence emission
spectra of (GT)10-dispersed SWCNT after the addition of 0 M (black) and 100 nM dopamine (red).
(c) NIR-fluorescence emission spectra of (GT)10-dispersed SWCNT after the addition of 0 M (black) and
100 nM epinephrine (re ). (d) NIR-fluoresce ce emission s ectra of (GT)10-dispersed SWCNT after the
addition of 0 M (black) and 100 nM norepinephrine (red).
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The absorbance spectra (Figures 2a and A1) clearly show that it is possible to disperse
the otherwise insoluble carbon nanotubes with all tested DNA sequences. For the fluorescence
measurement with an excitation wavelength of 560 nm, SWCNT-DNA conjugates were adjusted in
concentration to 0.1 nM according to their absorbance at the S11 peak at around 991 nm [31].
Figure 2b–d shows the representative fluorescence spectra of (GT)10-dispersed SWCNT before
and after the addition of 100 nM dopamine, epinephrine, and norepinephrine. Between the three
neurotransmitters, which were selected due to their structural similarity to dopamine, there is a clear
difference in fluorescence intensity modulation at this concentration. Interestingly, most SWCNT-DNA
conjugates responded to catecholamines by an increase of fluorescence. However, the absolute changes
depend strongly on DNA sequence and structure of the analyte. This is in agreement with previous
studies and indicates that these SWCNT-DNA conjugates can serve as sensors for catecholamine
neurotransmitters [5,27]. However, the limits of detection and the dynamic range remained unclear,
which is important if there are multiple catecholamines present in a sample.
3.2. Dose-Response Curves for Dopamine, Epinephrine, and Norepinephrine
A good sensor should not only be sensitive for its respective analyte, but also show high selectivity
for its target and exclude biologically-relevant interfering molecules. To evaluate, whether the sensors
for dopamine built from SWCNTs and oligomeric DNA sequences are suitable for the desired kind
of discrimination between these neurotransmitters, we took the aforementioned pool of sensors and
collected dose-response curves for each of them against dopamine, epinephrine, and norepinephrine.
The resulting relative changes in fluorescence for each combination are depicted in Figure 3.
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Figure 3. Dose-response curves of different catecholamine SWCNT/DNA sensors. Relative
fluorescence change of the sensors upon addition of increasing concentrations (0, 100 pM, 1 nM,
10 nM, 100 nM, 1 µM, 10 µM, 100 µM) of dopamine (a), epinephrine (b), and norepinephrine (c). The
x-axis shows different DNA sequences used to functionalize the SWCNTs. Here, the (6,5)-SWCNTs
responses were evaluated. Errors are standard deviations (n = 3). (d) An example dose-response plot
for dopamine recognition of SWCNT-(GT)10. Errors are standard deviations (n = 3).
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The data shown in Figure 3 contains all the information to evaluate sensor performance. The
first and most obvious observation is that almost all SWCNT-DNA sensors react upon exposure
to dopamine, epinephrine, and norepinephrine with an increase in NIR fluorescence. A30, (GT)10
and (GT)20 show the largest relative fluorescence increase for dopamine and epinephrine, while
(GT)10-dispersed SWCNT only react minimally to norepinephrine. Interestingly, SWCNT-(AT)15 does
not show any change in fluorescence in case of dopamine and norepinephrine and only a small change
to epinephrine. However, for most analytical tasks it is important to consider relevant concentrations.
For example, the maximum concentration of 100 µM used in these assays is high and will most
likely not be reached (for long periods of time) in biological scenarios [34]. All sensors respond to
catecholamines with different magnitudes and they saturate at different concentrations. Therefore, it
should be possible to discriminate between different neurotransmitters at concentrations << 100 µM
(see Figure 3).
The heatmap in Figure 4 illustrates the relative NIR-fluorescence change of DNA-dispersed
(6,5)-SWCNTs upon exposure to 100 nM and 1 µM dopamine, epinephrine and norepinephrine.
Especially A30, (GT)10 and (AT)15 exhibit a different response to the three different neurotransmitters
at these concentrations. This presentation of the response data is different from Figure 3 because it sets
the focus on smaller concentrations, which are most likely more relevant in many analytical scenarios.
For example, the static concentration of catecholamine neurotransmitters in brain tissue is in the
order of 1–50 nM [35]. In contrast, concentrations of dopamine in vesicles reach values >100 mM [11].
When they are released, dopamine levels are very high for the first few milliseconds but decline very
quickly to the nM regime [30]. Therefore, the effective mean concentration that is seen by a sensor
during acquisition is typically in the range depicted in Figure 4 (1 nM–1 µM). Consequently, response
data in this concentration regime provide a more realistic picture than at higher concentrations, at
which most sensors already saturate. The results shown in Figure 4 indicate that for example at
catecholamine concentrations of 100 nM the SWCNT-(GT)10 sensor is able to distinguish between
dopamine and epinephrine/norepinephrine as the corresponding relative fluorescence intensity
changes are 0.97 (±0.14) vs. 0.33 (±0.02)/0.12 (±0.07).
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Figure 4. Sensitivity versus selectivity at low catecholamine concentrations. Relative fluorescence
change of sensors upon addition of 100 nM (a) and 1 µM (b) of dopamine, epinephrine, and
norepinephrine in the range from 0 (i.e., no change in fluorescence intensity) to 1.3 (equaling 130%
fluorescence increase). Here, the (6,5)-SWCNTs responses at 987 nm were evaluated.
As already shown by Salem et al., the chirality of the SWCNTs has an influence on SWCNT/DNA
sensors similar to those presented in this work [36]. This behavior can be expected because different
chiralities/diameters should cause different macromolecule adsorption (organic phases) and, therefore,
different sensor responses. The corresponding heatmaps for the (6,4)- and (8,4)-SWCNT species are
provided in Figure A2. Both chiralities also show increasing fluorescence at ⇡885 nm and ⇡1122 nm,
respectively. The relative fluorescence increase, however, differs quite significantly (Figure A2). We
attribute these large differences to a chirality dependence but the spectra consist of at least three
nanotube species (6,4), (6,5), and (8,4) and the absolute differences might, therefore, be convoluted.
Additionally, the experiments were performed for constant (6,5)-SWCNT concentrations (0.1 nM),
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adjusted via the (6,5)-S11 peak. The SWCNT concentration can have an influence on the absolute
fluorescence values/changes and different dispersion yields by different DNA-oligonucleotides could
affect it [5]. In the future, our studies could be extended to highly-purified (6,4) and (8,4) SWCNT
species to study chirality dependence in greater detail.
3.3. Dissociation Constants and Limits of Detection for Different Neurotransmitter-Sensors
The recognition of catecholamines by SWCNT-DNA sensors can be seen as a bimolecular reaction:
S + A ⌦ SA. (1)
Here, the sensor S reacts with an analyte A to form a sensor/analyte complex SA. To get an idea
of the dynamic range and the limits of detection for the different sensor-analyte combinations, the
dose-response curves (Figure 3) were fitted using Equation (2):
Y = ymin +
ymax   ymin
1 + 10(log (KD) X)⇥HillSlope
(2)
The obtained dissociation constants from this logistic fit are shown in Table 1 and in a heatmap
(Figure A3). In addition, Table 1 also contains the limits of detection extracted from each dose-response
curve for every sensor-analyte combination.
Table 1. Overview of the different dissociation constants (Kd) and limits of detection (LOD) values
obtained for each SWCNT-DNA sensor-neurotransmitter combination. Both Kd and LOD are in
nmol/L.
NT (GT)15 (GT)20 (GT)10 A30 C30 T30 (GA)15 (GC)15 (CT)15 (AT)15
Kd
D 395.2 * 42.3 9.2 28.4 499.2 * 237.2 627.8 * 0.7 * 25.8 9438
E 159.1 112.6 178.2 171.9 177.2 51.1 234.3 49.3 47.1 241.5
N 70.3 58 71.9 25 193.1 33.6 * 21.4 2.3 52.8 -*
LOD
D 6.4 * 0.6 0.1 3.6 2.7 * 1.2 * 507.2 28.5 * 4.4 3776.6
E 1.4 2.2 0.7 3.2 1.4 1.0 1.8 0.5 0.8 * 23.7
N 3.2 2.4 7.7 1.6 4.8 33.3 3.8 0.5 3.9 *
* No clear (sigmoidal) fit possible. Kd: Dissociation constant. LOD: Limit of detection definition used = 3⇥ standard
error at c = 0 nM. D: Dopamine. E: Epinephrine. N: Norepinephrine.
The results show that there are large differences even though all sensors respond to catecholamines.
The Kd-values vary from 2.3 nM to 9.4 µM and the limits of detection from 0.5 to 507.2 nM. This span
of six (four) orders of magnitude demonstrates the large influence of oligonucleotide sequence. Kd
values give an idea of where the middle of the dynamic range of the sensor is and consequently for
which analytical task it can be used.
Certain Kd values obtained for dopamine have larger confidence intervals due to poor
fitting/non-sigmoidal dose-response curves. Nevertheless, the dissociation constants for epinephrine
in general exceed those of dopamine and norepinephrine. In detail, especially SWCNT-(GT)10,
SWCNT-(A)30, and SWCNT-(AT)15 seem to be well suited for discrimination between the three
catecholamines, which are structurally very similar as they share the same catechol-moiety. By
using MD simulations it was previously shown that the two hydroxy groups of the catechol-moiety
interact with phosphate groups of the DNA backbone on SWCNT/DNA sensors [5]. Our results show
fluorescence increases for all three neurotransmitters but the magnitude and the onset of saturation
varies by orders of magnitude. This observation might be explained by differences between those
three neurotransmitters (e.g., primary vs. secondary amine, size, and charge).
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3.4. Detection of Dopamine with Single Carbon Nanotube Sensors in the Presence of Homologues
One very important aspect of a sensor is the need to detect the analyte of interest (e.g., dopamine)
in the presence of other relevant analytes, which can be very similar in structure. After having
determined the dissociation constants and limits of detection for different SWCNT-DNA sensors for
dopamine, epinephrine, and norepinephrine, the next step was to verify it in a realistic scenario with
nM concentrations of dopamine and a homologue. SWCNT-(GT)10 sensors were immobilized on
a glass surface by physisorption and the NIR response of single sensors to dopamine (50 nM) in a
background of norepinephrine (50 nM) was quantified. SWCNT-(GT)10 sensors were used because
the Kd-values and responses (Figures 3 and 4.) indicated that these sensors respond to dopamine, but
not to norepinephrine, at this concentration. The results including the control using the lower-affinity
sensor (GA)15 as a control are shown in Figure 5.
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Figure 5. Detection of dopamine in the presence of norepinephrine. NIR fluorescence images of
single (SWCNT)-DNA sensors. Here, 50 nM dopamine was added (t = 60 s) in the presence of
50 nM norepinephrine in phosphate-buffered saline. (a) Control experiment using SWCNT-(GA)15,
which showed a lower affinity/selectivity for dopamine (see Figures 3 and 4). (b–d) Three
SWCNT-(GT)10-traces showing a change in fluorescence intensity upon dopamine addition. Insets
show the fluorescence images of the single sensors at t = 0. Fluorescence counts were normalized. Scale
bar = 1 µm.
Single SWCNT-(GT)10 sensor particles responded to dopamine in the presence of norepinephrine,
which indicates that it is possible to discriminate those neurotransmitters, at least at 50 nM
concentrations. In contrast, it was not possible to monitor the addition of dopamine after 60 s using
neither the control sensor SWCNT-(GA)15 nor SWCNT-(AT)15 (see Figure A4) for which the results of
Figures 3 and 4 suggested a lower selectivity/affinity. The overall change in fluorescence intensity was
not as high as in the solution-based experiments (Figure 3), which can be attributed to a different level
of background and an impact of the surface on sensor responses. These NIR fluorescence microscopy
experiments provide a spatial resolution and are closer to applications of these sensors for imaging of
neurotransmitters in cell networks.
To further evaluate the detection of dopamine with a 50 nM background of norepinephrine,
another experiment similar to Figure 5 was carried out. However, in this case we gradually increased
the dopamine concentration from 1 nM to 10 µM while maintaining a constant 50 nM norepinephrine
background. Figure 6 shows the increasing fluorescence for single SWCNT-(GT)10 sensors, as well
as the calibration curve generated from n = 11 sensors. The arrows denote the addition of dopamine
(a = 1 nM, b = 10 nM, c = 100 nM, d = 1 µM, e = 10 µM).
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Figure 6. Dynamic detection of dopamine in the presence of norepinephrine. NIR fluorescence image
of a single (SWCNT)-DNA sensor. Here, 1 nM to 10 µM dopamine was added approx. each 60 s
(a = 1 nM, b = 10 nM, c = 100 nM, d = 1 µM, e = 10 µM) in the presence of 50 nM norepinephrine
in phosphate-buffered saline. (a) Example SWCNT-(GT)10-trace showing a change in fluorescence
intensity upon dopamine addition. Inset shows the NIR-fluorescence image of the single sensor
at t = 300 s. Fluorescence counts were normalized. Scale bar = 1 µm. (b) Dose-response curve
generated from the mean fluorescence changes of eleven different SWCNT-(GT)10 sensors between
each addition-point of dopamine. Errors are standard deviations (n = 11).
The effective Kd increased to 72.9 nM compared to the solution-based value of 9.2 nM without the
presence of 50 nM norepinephrine, while the limit of detection under these conditions changed from
0.1 nM to 4.9 nM. These results are very promising as they indicate that dopamine can be detected in
the presence of realistic concentrations of the homologous neurotransmitter norepinephrine.
4. Discussion
The properties of nanomaterials depend strongly on their immediate chemical environment. In
many cases this is an organic phase (corona), such as the DNA-oligonucleotides used in this work.
This organic phase is not only important for dispersion of the hydrophobic SWCNTs, but also for
interactions and recognition of other molecules. For sensors this is obviously clear and it is of general
relevance when nanoparticles interact with their environment for example during nanoparticle growth
or when studying or tailoring cell-nanoparticle interactions [37–41].
In this study we used ten different DNA-oligonucleotides to non-covalently modify (6,5)-enriched
SWCNTs. These SWCNT-DNA conjugates were evaluated in terms of recognition ability of the three
catecholamine neurotransmitters dopamine, epinephrine, and norepinephrine. They are important
neurotransmitters, but so far it is extremely difficult to distinguish them when they are released by
cells. As shown in Figure 3, almost all of the generated SWCNT-DNA conjugates showed increasing
NIR fluorescence with increasing catecholamine concentration (range between 100 pM and 100 µM).
One exception at this point is SWCNT-(AT)15, which did not show any response to dopamine or
norepinephrine, and only a small increase to epinephrine. This behavior could possibly arise due
to the self-complementarity, which leads to DNA-duplex formation in aqueous solution and on the
SWCNT surface lowering its flexibility and thus hindering analyte-recognition. Another result are
the special sensing capabilities of A30- and (GT)10-SWCNTs. Both of them exhibited a large relative
fluorescence intensity change upon exposure to dopamine in comparison to both epinephrine and
norepinephrine. In addition, as shown in Figure 4, they responded at much lower concentrations of
dopamine than that of (nor)epinephrine, which can also be deduced from the measured Kd values
summarized in Table 1. These two sequences might be very useful to discriminate between these
chemically very similar analytes. The NIR fluorescence microscopy experiments of the (GT)10-SWCNT
sensor showed, for single immobilized sensors, that low nM concentrations of dopamine are detected
in the presence of equimolar amounts of norepinephrine. This result shows how the evaluation of
dose-response curves (Kd and LOD values) helps to identify selective sensors and tune them for a
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specific application. In the future these insights may also be used in ratiometric sensing approaches
with single-chirality SWCNT samples that emit light at different wavelengths.
The ‘library’ of ten DNA sequences led to sensors with Kd differences of up to six orders of
magnitude. This is surprising because there was no rationale behind choosing those ten specific
sequences. It is very likely that larger libraries and a screening or high-throughput approach could
identify even more selective and sensitive sensors.
5. Conclusions
This study reveals the dose-response curves of several SWCNT/DNA sensors for the
neurotransmitters dopamine, epinephrine, and norepinephrine. We find large differences in terms
of dissociation constants and limits of detection for different DNA sequences and identify a sensor
that can discriminate between the structural homologues dopamine and norepinephrine. These
sensors can be used for biological studies that aim to distinguish these chemically very similar
neurotransmitters. Our results also show that varying the organic phase around carbon nanotubes
is a versatile approach to identify new sensors and to select the most selective and sensitive ones for
specific analytical applications.
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Figure A2. Chirality-dependence of the relative fluorescence change upon exposure to
neurotransmitters. Relative fluorescence change of the sensors upon addition of 100 nM of dopamine,
epinephrine and norepinephrine in the range from 0, i.e., no change in fluorescence intensity, to 1.2
equaling 120% fluorescence increase. Here, (6,4)-SWCNTs responses at 885 nm (a) and (8,4)-SWCNTs
responses at 1122 nm (b) were evaluated. Black color indicates off-scale fluorescence changes
presumably due to the small signal to noise ratios for the (6,4)-SWCNTs. (c) Representative fluorescence
spectrum (SWCNT-(GT)10 and dopamine) and assignment of the nanotube chiralities.Sensors 2017, 17, 1521  11 of 13 
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Figure A4. Control experiment for the detection of dopamine in the presence of norepinephrine. NIR 
fluorescence images of single (SWCNT)-DNA sensors. Here, 50 nM dopamine was added (t = 60 s) in 
the presence of 50 nM norepinephrine in phosphate-buffered saline. Control experiment using 
SWCNT-(AT)15, which showed a lower affinity/selectivity for dopamine (see Figures 3 and 4). Insets 
show the fluorescence image of the single sensor at t = 0. Fluorescence counts were normalized. Scale 
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4.1.2. Discussion
The detection of neurotransmitters such as dopamine is an important task to understand
our brain’s function also in the context of related diseases such as Parkinson’s or Hunting-
ton’s. In these diseases, malfunctions of dopamine signaling play a crucial role and it is
thus of high importance to develop new tools allowing for better scientific understanding.
FSCV is an electrochemical detection technique with low detection limit (up to 1 nM un-
der optimized conditions but decreased temporal resolution[167]) and can operate with
a temporal resolution of up to 10 ms.[168] However, due to the size of the electrodes
necessary for the measurements, the spatial resolution that can be obtained is not suf-
ficient to evaluate e.g. patterns of release events as the maximum density of electrodes
achieved until now was 4-6 on the area of one chromaffin cell.[169,170] Another technique
offering a drastically increased spatial resolution are genetically modified variants of re-
ceptors which usually take up or transport the respective neurotransmitter. After being
previously established for the sensing of GABA and glutamate, Patriarchi et al. pub-
lished another variant for the in vivo sensing of dopamine in 2018.[171] Here, the authors
made use of the conformational change the human dopamine receptor undergoes upon
binding of dopamine. Through genetic insertion of a GFP-variant into its intracellular
loop (and screening of different variants) they were able to couple this conformational
change to changes in the GFP fluorescence intensity. The two most promising variants
showed a high affinity for dopamine (Kd = 330-770 nM) with significantly higher values
for epinephrine and norepinephrine (12.7 µM and 19.9 µM , respectively). Following
characterization, the authors applied these variants not only in cellulo, but also in vivo
for dopamine monitoring in behaving mice. Only two weeks later, Sun et al.[172] pub-
lished a similar concept comprising also a conformationally sensitive GFP variant cloned
into a G protein-coupled receptor (GPCR) yielding even more affine dopamine sensors
(Kd = 10 nM), yet with smaller fluorescence increase compared to the approach from Pa-
triarchi et al. (90% vs. 230%  F/F0). Here, the genetically encoded sensor was applied
for dopamine imaging in mice, flies and zebrafish. While these two examples represent
impressive examples of what fluorescent fusion protein-based sensors are capable of,
they also have certain shortcomings. These include e.g. the fast bleaching of fluorescent
proteins and the (compared to the NIR) low tissue-penetration. In addition, they also
require extensive genetic engineering before they can be applied in the system of choice.
It is exactly these points, which SWCNT-based optical sensors aim to overcome. In con-
trast to the traditionally employed systems such as FSCV or microdialysis, they offer the
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clear advantage of drastically enhanced spatiotemporal resolution. And in comparison
to the GFP-based systems published after this study (see chapter 4.1.2), SWCNT-based
dopamine sensors offer a similar or higher affinity (Kd = 9.2 nM) and an even lower limit
of detection (LOD, 0.1 nM). As shown in Fig. 3 of the manuscript (see 4.1.2, p. 51), the
SWCNT-DNA based sensors respond to all three structurally similar neurotransmitters
with a fluorescence increase, yet with different affinities and magnitudes of fluorescence
change (highest for dopamine). This effect can also be observed for both genetically
encoded sensors with a similar difference in Kd values for dopamine, epinephrine and
norepinephrine.[171,172] In their cases the sensitivity and selectivity can be tuned via ge-
netic alteration of the GFP insertion site and the linker sequences, whereas SWCNT-DNA
based sensors can be easily modified using different DNA sequences, which proved to
yield different Kd and LOD values (see 4.1.2, p. 53, Tab. 1). Thus, one can conclude that
discrimination between these structurally very similar neurotransmitters is a challenge
for all the different techniques, but in each case higher affinities for dopamine were re-
ported allowing its detection also with a (nor)epinephrine background.
One clear advantage of SWCNT-based dopamine sensors is the non-bleaching nature of
their NIR-fluorescence allowing for larger tissue-penetration depths. In addition, the
synthetic nature of these sensors enables application in diverse systems without prior
genetic engineering. In contrast to the approaches by Patriarchi et al. and Sun et al.,
SWCNT-based dopamine sensors were up to now only applied in vitro and in cellulo,
yet in the latest study by Kruss et al.[97] they also enabled sensing not only at the cell
surface, but also between cells. Thus, this feature also allows for studying e.g. volume
transmission, which genetically encoded sensors based on membrane proteins can not
accomplish. However, genetically engineered systems offer the advantage of easier ap-
plication in in vivo settings as the genetic material can be delivered e.g. by viral delivery
vectors. For SWCNT-based sensors, it would either be necessary to implant them e.g. in
a hydrogel-sensor-patch or to inject them, which would in turn require a targeting mech-
anism to bring them to the desired site of action. It is especially this last point, which
will be further evaluated in the following chapter.
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4.2 Targeted delivery of nanosensors
After the previous chapter elucidated the sensitivity and selectivity of SWCNT-based sen-
sors for neurotransmitters, this chapter/project aims at the decoration of these nanosen-
sors with recognition units enabling targeting or even new sensing concepts. To this end,
antibody fragments termed nanobodies are attached to a DNA-oligonucleotide wrapping
a SWCNT. The nature of this oligonucleotide was chosen based on the study in chapter
4.1.2. While there are a few examples of antibody immobilization on SWCNTs, both
covalently[173] and non-covalently[159,163], the only study reporting SWCNT-nanobody
conjugation was published in 2018 by Filipiak et al., who used a anti-GFP nanobody
as a recognition unit on a FET for the label-free, electrical detection of GFP.[174] Here,
the authors used carboxylic acid-bearing pyrenes to coat the SWCNT surface and serve
as an attachment site for the nanobody’s lysine residues after EDC/NHS activation. This
process, however, leads to a large variety of mixed configurations. Thus, in this study, a
GFP-targeting nanobody comprising a single ectopic cysteine (at the C-terminus) is used
for attachment to maleimide-modified DNA-oligonucleotides. The aims of this combina-
tion of biomolecular units for this project are:
(a) The generation of colloidally stable SWCNT-DNA-Nanobody conjugates, which are
still showing NIR fluorescence and can thus be used for NIR microscopy.
(b) Controlling retained function of the nanobody after conjugation to the SWCNT-
DNA hybrid.
(c) The use of the SWCNT-DNA-Nanobody conjugate as a NIR labelling agent for in
vivo NIR fluorescence microscopy.
(d) To show that SWCNT-DNA hybrids are able to respond to the neurotransmitter
dopamine even after conjugation of the nanobody. Together with the targeting
capabilities of the nanobody, this would enable targeted delivery of dopamine sen-
sors.
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Abstract: Fluorescent nanomaterials such as single-walled
carbon nanotubes (SWCNTs) have many advantages in terms
of their photophysics, but it is difficult to target them to specific
locations in living systems. In contrast, the green fluorescent
protein (GFP) has been genetically fused to proteins in many
cells and organisms. Therefore, GFP can be seen not only as
a fluorophore but as a universal target/handle. Here, we report
the conjugation of GFP-binding nanobodies to DNA-wrapped
SWCNTs. This approach combines the targeting capabilities of
GFP-binding nanobodies and the nonbleaching near-infrared
fluorescence (850–1700 nm) of SWCNTs. These conjugates
allow us to track single Kinesin-5-GFP motor proteins in
developing embryos of Drosophila melanogaster. Addition-
ally, they are sensitive to the neurotransmitter dopamine and
can be used for targeted sensing of dopamine in the nm regime.
Single-walled carbon nanotubes (SWCNT) are a 1D mate-
rial and display unique optoelectronic properties such as near-
infrared (nIR) fluorescence (850–1700 nm).[1] This spectral
window is highly beneficial for biological and especially deep-
tissue imaging due to reduced phototoxicity, background
fluorescence, and scattering.[2] In addition, SWCNTs do not
bleach or blink such as many organic dyes or quantum dots.[3]
As a result, single-walled carbon nanotubes have already
found applications in diverse areas ranging from sensors to
photodynamic therapy and drug delivery.[4–10] Regardless of
their beneficial photophysical properties, biological imaging
typically requires targeting of the fluorophore to the desired
epitope. This step remains a challenge for all nanomaterial-
based approaches.
In this work, we use nanobodies as a recognition element
on the surface of SWCNTs. Nanobodies have several
advantages over their larger counterparts (antibodies). They
possess a comparable specificity for their antigens while being
only ⇡ 1/10 in size and molecular weight.[11–13] Since their
discovery (derived as the variable domain from naturally
evolved heavy-chain antibodies from, for example, camels),
nanobodies have been successfully employed both in label-
ing[14, 15] and therapeutic studies making use of their advanta-
geous smaller structure, which allows a different way of
antigen binding as well as robust expression in both bacterial
and eukaryotic hosts.[16, 17] Their small size is utilized fre-
quently in superresolution microscopy as it leads to a drasti-
cally decreased linkage error with respect to the bound
antigen.[11, 12,18] In addition, they were recently modified
semisynthetically with cyclic cell-penetrating peptides for
live cell immunostaining[19] as well as used for isotopic
labeling of biological samples imaged by secondary-ion
mass spectrometry (SIMS).[20]
In this study, we aimed to combine the photophysical
advantages of SWCNTs with the size and targeting capabil-
ities of nanobodies. To this end, we conjugated a GFP-binding
nanobody (GFP-binding protein, GBP, 4) to a DNA oligo-
nucleotide (2) -wrapped SWCNT (see Figure 1a). GFP is
a valuable target because a large number of transgenic
organisms and cells are available with GFP-tagged proteins.
Noncovalent functionalization is used in order not to alter or
destroy the nIR fluorescence of SWCNTs,[21–25] although
recently Setaro et al. also reported a covalent modification
strategy preserving the nIR fluorescence.[26] While there are
many different noncovalent functionalization concepts avail-
able,[21, 27, 28] DNA/SWCNTs have the additional advantage
that they can be used for the sensing of small molecules.[29]
Recently, Filipiak et al. used nanobodies to generate
SWCNT-based amperometric sensors/transistors for the
detection of GFP using EDC/NHS chemistry leading to
a mixture of orientations of the nanobody on the SWCNT
surface yet still enabling the detection of GFP in the
picomolar range.[30] In contrast, we employ a maleimide-
based coupling strategy allowing for site-specific and oriented
attachment of the GBP through a C-terminally introduced
cysteine. In this way, we are able to generate more defined
conjugates with the antigen-binding region pointing away
from the SWCNT surface. By using a GFP-binding nanobody
we generate a highly versatile platform, which can be directly
applied in many biological systems containing GFP-modified
variants of the protein of interest.
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To conjugate the GBP to the SWCNT, first the 3’-amine-
modified d(GT)20 oligonucleotides are reacted with the
bifunctional crosslinker sulfosuccinimidyl 4-(N-maleimido-
methyl)cyclohexane-1-carboxylate (Sulfo-SMCC) to gener-
ate thiol/cysteine-reactive DNA oligonucleotides (2). Next,
these modified DNA sequences are used to noncovalently
wrap the hydrophobic SWCNT surface via ultrasonication,
resulting in a colloidally stable aqueous solution of SWCNT-
DNA-Maleimide (3). After removal of excess DNA-Malei-
mide (2),⇡ 5 equivalents (with respect to the number of DNA
oligonucleotides present on the SWCNT surface[31–33]) of the
reduced GFP-binding nanobody are added to the solution of
3. The excess of GBP (4) was adjusted based on previous
optimization experiments (see Figures S1 and S2). Here, fine-
tuning of the experimental parameters is crucial to prevent
colloidal instability resulting from the conjugation of too
many nanobodies to the SWCNT surface. This colloidal
stability is a known and important, but still often neglected
factor in research on peptide- or protein-modified
SWCNTs.[24] Using the optimized GBP/SWCNT-(GT)20
ratio, the conjugates were still stable even after more than
six weeks of storage at 4 8C (see Figure S3). Figure 1b shows
the retained nIR fluorescence properties after conjugation of
the GFP-binding nanobody upon excitation at 561 nm
compared to the unconjugated sample. To prove the success-
ful conjugation of GBP (4) to the SWCNT, we employed
DNA- and protein-stained sodium dodecylsulfate polyacryl-
amide gel electrophoresis (SDS-PAGE) (Figure 1c). Both
Coomassie Brilliant Blue (protein) and GelRed (nucleic acid)
staining showed a band at ⇡ 28 kDa corresponding to the
formed d(GT)20-GBP conjugate eluted/detached from the
SWCNT during SDS-PAGE sample preparation (boiling at
95 8C in 1 î Laemmli sample buffer, see the Supporting
Information, SI).
To further confirm the conjugation directly on the
SWCNT, we used atomic force microscopy (AFM, Fig-
ure 1d). Heights increased by values fitting almost exactly
the additional height introduced by the conjugated GBP,
whereas SWCNTs not activated by SMCC showed heights
matching the diameter of (almost) naked SWCNTs
(⇡ 0.7 nm, see Figure 1e (blue) and Figure S4). Together
with an observed change in z-potential upon conjugation to
more negative values (see Figure S5, pIGBP = 5.45), these
results show that the conjugation worked successfully and the
nIR fluorescence is retained, making these conjugates suit-
able for imaging applications.
Next, we wanted to test whether the nanobody is still
functional when conjugated to the hydrophobic SWCNT
wrapped by a negatively charged oligonucleotide. For this
purpose, we developed an in vitro assay with conjugate 5
micropatterned on a glass surface by polydimethylsiloxane
(PDMS)-based microcontact printing (Figure 2a). After the
surface was blocked using bovine serum albumin (BSA),
a 1 mm eGFP solution was added and incubated on the surface
for one hour. Fluorescence images show colocalization of
GFP and SWCNT fluorescence as opposed to the control
SWCNT-DNA without GBP (Figure 2b, further controls in
Figure S6), indicating the preserved nanobody function and
the targeting capabilities of the conjugate.
SWCNTs are not only static fluorophores but they have
also been successfully used as building blocks in sensors to
detect small molecules, mRNA, sugars, and proteins.[2,34–40]
DNA/SWCNT conjugates in particular have previously
served as optical sensors for the spatiotemporal detection of
the neurotransmitter dopamine.[29,41, 42] Depending on the
sequence of the wrapping oligonucleotide, the nIR fluores-
cence increases between 50–400% upon dopamine binding
with Kd values between 1 nm and 1 mm.[7, 29] The (GT)20
Figure 1. Site-specific and oriented conjugation of a GFP-binding nanobody (GBP, 4) to DNA-oligonucleotide-wrapped single-walled carbon
nanotubes (SWCNT, 1). a) General conjugation scheme for linking a GFP-binding nanobody to DNA-wrapped SWCNTs via maleimide chemistry.
b) Near-infrared fluorescence spectra before and after conjugation show retained fluorescence features (cSWCNT = 35 nm, texp = 1 s). c) SDS-PAGE
analysis proves DNA–GBP conjugation. + : reaction mixture, ˇ: reaction mixture without SMCC, M: marker. d) Atomic force microscopy images
of GBP-conjugated SWCNTs. Scale bar = 500 nm. e) The height traces (black and gray) of two exemplary SWCNT-(GT)20-GBP conjugates (depicted
in (d) as slightly offset dashed lines labeled a and b) show an increase in comparison to the unmodified SWCNT-(GT)20 control.
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sequence used in this study for the conjugation of the GBP
previously showed fluorescence increases of up to 70% with
a Kd,dopamine of 42 nm.[7] Thus, we investigated next whether the
SWCNT-GBP conjugate (5) still responds to dopamine. The
fluorescence response remained unchanged (Figure 3a,b)
compared to SWCNT-(GT)20, showing an increase of
⇡ 61% upon addition of dopamine (100 mm). Encouraged
by this result, we tested whether it is also possible to target 5
to immobilized GFP and detect dopamine. Figure 3 c shows
the SWCNT-GBP conjugate bound to micropatterned GFP
structures and the average of five fluorescence traces of single
nanotubes (Figure 3d). We observed a fluorescence increase
of GFP-bound SWCNTs both for 100 nm and 1 mm concen-
trations of dopamine. The increase was greater than in
solution (Figure 3a,b) because in this case single sensors were
analyzed as opposed to an ensemble, which decreases back-
ground and prevents scattering, quenching, and reabsorption.
Therefore, it is possible to detect dopamine with carbon
nanotubes bound to GFP, which opens up great possibilities
for targeting GFP-fusion proteins of, for example, dopamine
transporters on neurons and with the ability to sense single-
neurotransmitter release events locally.
To further demonstrate the versatility of the SWCNT-
GBP platform and make use of the unique properties of
SWCNTs for deep-tissue imaging, we injected the nanotube–
nanobody conjugate (1 nm) into live Drosophila embryos
expressing the motor protein Kinesin-5 (Kin-5) as a GFP-
fusion protein (Figure 4a,b). These syncytial embryos have
not yet formed cell membranes between the nuclei, are
approximately 150 mm in height, and thus provide an ideal
scenario for high-contrast imaging at greater light penetration
depths than in classic cell culture. Kin-5 is an indispensable
motor protein for spindle formation and separation of the
chromosomes. It binds to antiparallel microtubule arrays and
exerts repulsive forces due to its (+)-end directed motor
activity. In addition, Kin-5 is also involved in microtubule
Figure 2. Functionality of nanobody–SWCNT conjugates. a) Schematic
of the assay that uses microcontact printing of SWCNT-GBP conju-
gates 5, BSA blocking, and GFP addition. b) nIR and GFP fluorescence
images show colocalization SWCNT-GBP and GFP. In contrast, the
SWCNT-DNA control shows no colocalization. Scale bars= 5 mm.
Figure 3. Targeted near-infrared fluorescent dopamine sensors. a) nIR
fluorescence response of GBP-modified SWCNT increases upon dop-
amine addition. b) Fluorescence changes after addition of the neuro-
transmitter dopamine show that the dopamine-sensing capability of
DNA-functionalized SWCNTs is retained in nanobody-conjugated
SWCNTs (cSWCNT = 10 nm, texp =2 s, mean and s.d., n = 3). c) SWCNT-
GBP conjugate 5 bound to surface-immobilized GFP. d) Fluorescence
response of immobilized single SWCNT-GBP sensors (mean and s.e.,
n =5) upon addition of the neurotransmitter dopamine at concentra-
tions of 100 nm and 1 mm. Scale bars =10 mm (c), =1 mm (d).
Figure 4. Injection of SWCNT-DNA-GBP conjugate 5 in Drosophila
embryos, near-infrared labeling, and in vivo tracking of the motor
protein Kinesin-5 (Kin-5). a) General scheme showing the injection of
conjugate 5 into live Drosophila embryos expressing GFP fusion
proteins of Kin-5 motors, which show a different morphology depend-
ing on the developmental stage (interphase/mitosis). b) Schematic of
a SWCNT-tagged Kin-5-GFP moving along a microtubule. c) GFP and
SWCNT channel images showing colocalization of Kin-5 and conjugate
5 at a mitotic spindle (scale bars =10 mm). d) Real-time tracking of the
directional movement of a single Kin-5 motor in the Drosophila embryo
compared to random movement of the SWCNT-(GT)20 control (e,
t =4 s, 5 frames per second). f) Mean-square displacement (MSD)
plots of several SWCNT-GBP conjugates show directed movement in
comparison to the control (SWCNT-DNA) and SWCNT-GBP conju-
gates bound to inactive (static) Kin-5-GFP (mean and s.e., n = 1–13
[SWCNT-GBP], n = 9 [SWCNT-GBP-bound], n =28 [SWCNT-DNA]).
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network dynamics in the interphase.[43] Therefore, Kin-5 is
present in the whole organism but enriched in spindles during
mitosis. Figure 4c shows colocalization of the (low signal/
noise) GFP signal and the SWCNT s nIR fluorescence in
a mitotic spindle, emphasizing their use as high-contrast
immunolabeling agents. The conjugate 5 is thus a highly
versatile tool for near-infrared experiments in Drosophila, as
there are numerous variants containing different GFP-fusion
proteins. In addition, the SWCNT fluorescence does not
bleach as for example GFP, which (see Figure S7) renders
them highly suitable candidates for long-term observation
and fast fluorescent tracking of almost any molecule of
interest.
In this study, we used our SWCNT-GBP platform to
acquire real-time tracks of Kin-5 motors in vivo. Earlier
studies already used SWCNT-Halo-tag variants or quantum
dot/nanobody conjugates for Kinesin tracking in COS7 cells
and were able to resolve tracks over several micrometers.[44,45]
Tracking of single motor proteins in vivo, however, is more
challenging due to active movement or diffusion/movement
in the z-direction. In addition, Kin-5 exists in multiple states
inside this living organism. First, Kin-5 molecules are diffus-
ing around in the whole organism. Second, another fraction of
Kin-5 is bound to microtubules in mitotic spindles but does
not move (inactive). And lastly, a third fraction is bound to
microtubules and active, which means they move along
microtubules carrying cargo. Figure 4 d shows the trajectory
of a single SWCNT-GBP conjugate bound to a moving Kin-5
protein over four seconds, while Figure 4e depicts a represen-
tative trace of a SWCNT-(GT)20 control in the same time
frame (see also movie M1, SI). Whereas only random move-
ment can be observed for the control, the SWCNT-GBP
conjugate s trace shows directional movement over several
micrometers with a mean velocity of ⇡ 1340 nmsˇ1. The
directionality of this movement represents a direct proof for
the successful binding of the SWCNT-GBP to Kin-5-GFP. To
our knowledge, this represents the first real-time tracking of
Kin-5 in Drosophila. Such directional tracks were analyzed
and yield a motor velocity of 613⌃ 328 nmsˇ1 (mean⌃ SD,
n = 14). This value is in the same order of magnitude as values
previously described for other members of the Kinesin family
in vitro (780⌃ 110 nm sˇ1 [Kin1 in COS7 cells],[46] 570⌃
20 nm sˇ1 [Kin in HeLa cells],[47] 300⌃ 210 nm sˇ1 [Kin1 in
COS7 cells][44]). The SWCNT-GBP conjugate does most likely
not affect the movement of Kin-5 because the additional
friction is small compared to the energy of ATP hydrolysis. To
further analyze the different types of movement observable in
the nIR SWCNT tracks, we calculated the mean-squared
displacement (MSD) for both conjugate 5 and the control
(Figure 4 f). These averaged MSDs show the different behav-
ior of the SWCNT probes depending on their binding status.
While DNA/SWCNTs were found to freely diffuse through
the syncytial organism, SWCNT-GBP conjugates were found
to be either bound to static Kin-5-GFP (red dashed line, as,
for example, in the spindle in Figure 4c) or active Kin-5-GFP
motors carrying out active movement and thus showing
superdiffusive behavior (blue line). Analysis of the diffusive
motion of SWCNTs has already been used to probe the
extracellular space in brain slices and our novel nanobody-
based targeting could add a new level of spatial control to
such approaches.[48]
In summary, we conjugated GFP-targeting nanobodies to
the surface of DNA-wrapped SWCNTs and showed that the
SWCNT s nIR fluorescence is preserved after protein con-
jugation. We also proved that the nanobody is still functional
after SWCNT conjugation and that these GBP-conjugated
SWCNT are able to detect the important neurotransmitter
dopamine, as previously observed with unconjugated
SWCNTs. Furthermore, we injected the SWCNT-GBP con-
jugate into living embryos of Drosophila melanogaster for
deep-tissue nIR labeling of the spindle apparatus as well as
single-molecule tracking of the motor protein Kinesin-5.
Taken together, these results demonstrate the robustness and
the broad applicability of these novel nanotube–nanobody
conjugates for in vitro and in vivo applications as well as
targeted sensing.
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1. Supplementary figures 
1.1. Figure S1  
 
Figure S1. DNA- and protein stained SDS-PAGE analysis of the conjugation of the GFP-binding nanobody (GBP, equivalents with respect to the number of DNA 
oligos on the SWCNT surface) to a (GT)15 wrapped single-walled carbon nanotube.  
1.2. Figure S2  
 
 
Figure S2. DNA- and protein stained SDS-PAGE showing precipitation at high equivalents of GBP (~50 eq. with respect to the number of DNA oligos on the SWCNT 
surface) during the conjugation. This emphasizes the importance of choosing the right ratio of GBP/SWCNT. 
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1.3. Figure S3 
 
Figure S3. (a) UV/vis/nIR absorbance spectra before and after the conjugation of the GFP-binding nanobody (GBP). (b) Comparison of maximal absorbance 
of the conjugate 5, the SWCNT-(GT)20 reaction control (no SMCC activation) and SWCNT-(GT)20 directly after the reaction/dialysis and after 6 weeks at 4 °C. 
For absorbance measurements, the top 75% of the solution after centrifugation were taken. This comparison shows, that all SWCNT variants display 
comparable colloidal stability.  
1.4. Figure S4 
  
 
Figure S4. Atomic Force Microscopy image showing the non-SMCC activated SWCNT-DNA control. The white dashed line indicates the height-trace taken 








SUPPORTING INFORMATION          
5 
 
1.5. Figure S5 
 
Figure S5. z-potential measurement showing the difference between the conjugate 5 (left), the reaction control (without SMCC activation of the GT20-NH2, middle) 
and SWCNT-GT20 (mean and s.e., n = 6). The shift to more negative values can be explained by the additional charges introduced by the negatively charged anti-




SUPPORTING INFORMATION          
6 
 
1.6. Figure S6 
  
Figure S6. Different in vitro assay controls. (a) Control assay with immobilized GFP and addition of the (GT)20-SWCNT control. Despite a certain degree of unspecific 
binding, no colocalization of GFP and nIR signal could be observed. (b) Control assay with immobilized SWCNT-GBP conjugate 5 and addition of the blue fluorescent 
protein Tag-BFP. This clearly shows, when compared to Fig. 2b, that the binding of SWCNT-GBP is specific to GFP. (c) Control assay with immobilized GFP and 
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1.7. Figure S7 
 
Figure S7. Intensity vs. time analysis of single-walled carbon nanotubes under continuous excitation using a 561 nm laser (Cobolt) at 500 mW. 
 
 
1.8. Supplementary movie M1 
Supplementary movie M1 showing a SWCNT-(GT)20-GBP conjugate bound to Kin5-GFP moving 
inside a drosophila embryo. Movie was acquired at 5 fps (exposure time = 200 ms). Start (green) and 
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2. General Information 
(6,5)-chirality enriched single-walled carbon nanotubes (SWCNT, Product No.: 773735), Sulfo-SMCC 
crosslinker and 3’-amino functionalized DNA oligonucleotides were acquired from Sigma Aldrich 
(Darmstadt, Germany). All reagents were of synthesis grade quality and were used as supplied. Unless 
otherwise stated, experiments and measurements were performed in phosphate buffered saline (PBS, 
8.2 mM Na2HPO4, 1.8 mM K2HPO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4). Protein concentrations were 
determined by UV-absorbance at 280 nm using a NanoDrop 2000 Spectrophotometer from Thermo 
Scientific. 
 
2.1. UV/vis/nIR absorbance spectroscopy and SWCNT concentration estimation 
200 µL of a solution containing individualized SWCNTs were submitted to UV/vis/nIR absorbance 
spectroscopy on a JASCO V-670 (Spectra Manager Software) using a 10 mm-path cuvette. Spectra 
were acquired using a scan speed of 1000 nm/min, a data interval of 0.5 nm and a UV/vis and nIR 
bandwidth of 2 nm and 4 nm, respectively.  
SWCNT concentration was estimated using the maximal absorbance at approx. 991 nm using the 
molar extinction coefficient determined by Schöppler et al.[1] 
2.2.  nIR fluorescence spectroscopy 
In a 96-well plate, 100 µL of the SWCNT-DNA-(GBP)-solutions were excited at 561 nm using a 300 W 
Xe-lamp guided through a monochromator (LOT, Germany) and their fluorescence spectra recorded 
in the range between 850 and 1250 nm using a Shamrock 193i spectrograph (Andor Technology Ltd., 
Belfast, Northern Ireland) coupled to an Olympus IX73 microscope and an exposure time of 1 s, a slit 
width of 500 µm and an Andor iDus InGaAs 491 array NIR detector. 
2.3.  SDS-PAGE with Coomassie-/GelRed-Stain 
The samples subjected to sodiumdodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
were mixed with the corresponding amount of 4x reducing Laemmli sample buffer to reach a final 1x 
concentration. SDS-PAGE was performed at 220 V/400 mA for 45 min in 1x Tris/Glycine/SDS-running 
buffer with 12% acrylamide gels using PageRuler Plus Prestained (life technologies) as a size marker. 
Staining of nucleic acids was carried out with the dye GelRed (Biotium Inc., USA, 3x solution in 30 % 
(v/v) ethanol, 10% (v/v) acetic acid) for 60 minutes after heating in the microwave and five subsequent 
washing steps using ddH2O. 
Staining of proteins was performed with a solution of Coomassie Brilliant Blue R-250 (0,25% (w/v) 
Coomassie Brilliant Blue R-250, 30 % (v/v) ethanol, 10% (v/v) acetic acid) for 15 minutes after heating 
in the microwave. Subsequent incubation with destaining solution (50% (v/v) ethanol, 10% (v/v) acetic 
acid, 40% (v/v) Millipore H2O) for 10 minutes after microwave-heating was repeated three times. The 
destained gel was captured using a c300 imaging system (Cambridge Bioscience) both for protein 
(vis) and nucleic acid detection (UV). 
2.4. Atomic Force Microscopy (AFM) 
20 µL of each of the SWCNT-DNA-(GBP) solutions were immobilized on freshly cleaved muscovite 
mica by spin-coating, ten minutes incubation, subsequent washing of the surface with MilliQ water 
and drying using a N2-stream. AFM images were acquired in tapping mode (scan rate = 0.5 Hz, 
512 lines) using an Asylum Research MFP-3D InfinityÒ instrument equipped with rectangular 
cantilevers (Opus, MikroMasch Europe, Al-coating, tetrahedral tip, nres = 300 kHz, k = 26 N·m-1).  
Analysis of the acquired images was performed via the open-source software Gwyddion. For all 
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images, the background/tilt was removed via a 2nd order polynomial fit. The surface plane was set to 
zero using three-point levelling.  
2.5.  nIR fluorescence microscopy 
nIR imaging was carried out under 561 nm-laser excitation (Cobolt Jive™ laser (Cobolt AB, Solna, 
Sweden, 500 mW) on an Olympus IX53 microscope equipped with a 100x oil-immersion objective 
(Olympus 100x UPLSAPO 100XS, NA=1.35). Detection of the near-infrared photoluminescence was 
carried using either a XenicsÒ Xeva-1.7-320 NIR camera (Xenics, Heverlee, Belgium) or an Andor 
Zyla 5.5 sCMOS camera (Andor Technology Ltd., Belfast, Northern Ireland). 
2.6. z-potential measurement 
z-potential measurements were carried out using a Zetasizer Nano S (Malvern Instruments, UK) in 
1x PBS at a SWCNT concentration of ~0.5 nM (pH 7.4). Analysis was performed using the 
corresponding Zetasizer software. 
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3. Experimental Procedures 
3.1. Single-walled carbon nanotube dispersion, conjugation to GBP and characterization 
3.1.1. SWCNT-GT20-GBP conjugation 
3.1.1.1 (GT)20-SMCC-Maleimide (2) 
3 mg Sulfo-SMCC (in 15 µL DMSO) and 28 µL 10x PBS buffer were added to 250 µL of a 
2 mg/mL DNA-oligonucleotide solution in ddH2O. The pH was adjusted to pH 7.4 via 
addition of 1 µL 1M NaOH and the solution agitated at 400 rpm/RT for 60 minutes. 
3.1.1.2 Dispersion of (6,5) enriched carbon nanotubes using DNA-maleimide (3) 
Based on a 2 mg/mL (6,5)-chirality-enriched SWCNT stock suspension in MilliQ™-grade 
H2O, ~ 250 µg SWCNTs were added to a 1.5 mL centrifuge tube, spun down at 16,100 g 
for 15 minutes and the supernatant discarded.  
In the next step, 290 µL of DNA-oligo-Maleimide solution 2 were added to the raw SWCNT 
material. The solution was tip sonicated for 15 minutes (Fisher Scientific™ Model 120 Sonic 
Dismembrator, 30% amplitude, 36 W, 4 °C) and subsequently centrifuged at 16100 g 
(30 min) to remove large bundles, aggregates or metal catalyst remaining from SWCNT 
synthesis. The supernatant was transferred to 100 kDa-MWCO centrifugal filters and 
washed 5x with 1xPBS. The remaining solution was resuspended in 500 µL 1xPBS using 
tip-sonication (36 W, 2 min, 4 °C) and again centrifuged (30 min, 16100 g). The SWCNT 
concentration in the supernatant was determined as described in 2.1. 
3.1.1.3 Conjugation of an anti-GFP nanobody to SWCNT-DNA-Maleimide (5) 
The SWCNT-DNA-Maleimide solutions 3 were diluted to a concentration of 10 nM using 
1xPBS and transferred to two different microcentrifuge tubes each (v = 250 µL).  
The anti-GFP nanobody bearing a single ectopic cysteine at the C-terminus (NanoTag 
Biotechnologies GmbH, Cat# N0301) was reduced on ice for 30 minutes using 5 mM TCEP 
and 5 mM EDTA and rebuffered subsequently to 1xPBS (5 mM EDTA, pH 7.4) using 
ZebaSpin Desalting columns (7 kDa MWCO). The protein concentration was estimated 
using A(280 nm) using the NanoDrop 2000.  
After addition of the reagents the pH was checked, and the reaction solution agitated at 
250 rpm for five minutes at RT and then incubated without shaking for 14 hours. 
 
The solution was transferred to 300.000 MWCO dialysis tubings and dialyzed against 
1xPBS (4x change of PBS) to remove unconjugated nanobody. 
3.2. In vitro binding assay  
Based on a previously created silicon master, patterned PDMS stamps were created. Next, a 1 nM 
SWCNT solution (either SWCNT-GBP conjugate 5 or the (GT)20/SWCNT control) was added to the 
stamp and incubated for 30 min at room temperature. After washing (1xPBS, 0.3% TritonX100, 3x) 
stamping was carried out via 30 min of incubation on a glass bottom petri dish. Excess SWCNT-
material on the surface was again removed via washing (1xPBS, 0.3% TritonX100, 3x). In the next 
step, the surface was passivated using a 5% w/v BSA solution and subsequently washed again with 78
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washing buffer (3x). Either purified green fluorescent protein (GFP form Aequorea Victoria) or Blue 
fluorescent protein (tagBFP from Entacmaea quadricolor) were then incubated on the surface at a 
concentration of 2 µM for one hour at ambient temperature in a buffer containing 1% w/v BSA. After 
washing (see above), imaging was carried out using a 100x objective on an Olympus IX53 
microscope. 
3.3. Drosophila embryo preparation and injection 
Drosophila embryos (0-30 min old) expressing Kinesin-5-GFP[2] were dechorionated with commercial 
klorix solution (hypochlorite) for 90 to 120 s, rinsed with water thoroughly, aligned on a piece of agar, 
transferred to a cover slip coated with glue, desiccated in open air for 15 min and covered with 
halocarbon oil (Voltalef 10S, Lehmann & Voss). SWCNT-GBP conjugate 5 was injected using a 
Microinjector FemtoJet® (Eppendorf) on an inverted microscope. After 30-120 min incubation, the 
image of nIR and GFP channels were acquired. Nanotube without conjugated GBP was used as a 
negative control. 
3.4. Dopamine sensing 
In order to detect the fluorescence increase upon addition of the neurotransmitter dopamine, 5 µL of 
the corresponding and freshly prepared dopamine•HCl solution (0, 100 µM, 1 mM) in 1xPBS were 
added to 50 µL of 5 and the corresponding control (both 10 nM, in 1xPBS) in a 96-well plate format 




3.5. Targeted dopamine sensing 
 
Based on a previously created silicon master, patterned PDMS stamps were created. Next, a 2 µM 
GFP solution was added to the stamp, incubated for 10 minutes and the stamp subsequently rinsed 
with 1x PBS. In the next step, the PDMS stamp was transferred to a glass bottom petri dish and 
incubated for 30 minutes. Excess GFP was removed by washing (1xPBS, 0.3% TritonX100, 3x). The 
GFP-patterned surface was passivated using a 5% w/v BSA solution and subsequently washed again 
with washing buffer (3x). To immobilize the SWCNT-GBP conjugate 5 on GFP, the surface was then 
incubated with a 1 nM solution of 5 for 1 h and subsequently washed again three times (washing 
buffer). Imaging was carried out using a 100x objective and dopamine•HCl was added after 30 




[1] F. Schöppler, C. Mann, T. C. Hain, F. M. Neubauer, G. Privitera, F. Bonaccorso, D. Chu, A. C. Ferrari, T. Hertel, J. Phys. Chem. C 2011, 115, 14682–
14686. 
[2] Z. Lv, J. Rosenbaum, T. Aspelmeier, J. Großhans, J. Cell Sci. 2018, 131, jcs210583. 
 
79
4. Results and Discussion
4.2.2. Discussion
The manuscript in chapter 4.2.1 describes the conjugation of a GFP-binding nanobody to
a DNA-wrapped carbon nanotube and the subsequent characterization, use for a proof-
of-concept targeted dopamine sensing experiment and utilization for the first tracking
of a motor protein inside a living organism. But how does this study compare to previ-
ous or later studies? The first report on a combination of antibodies and SWCNTs was
published in 2001 by Erlanger et al., who showed, that a previously raised anti-C60 an-
tibody can also bind SWCNTs via a binding cavity rich in hydrophobic amino acids.[159]
The authors verified successful antibody binding using AFM versus a control with an-
other IgG specific for the aldosterone receptor, that did not show binding to the nan-
otube. Further examples include the non-covalent immobilization of a prostate-specific
antigen (PSA) binding antibody using 1-pyrenebutanoic acid succinimidyl ester (and the
antibody’s lysine residues) by Li et al. in 2005[175] and several studies by the group of
Hongjie Dai in 2008/2009, where they immobilized the therapeutic antibody Herceptin
on SWCNTs wrapped by phospholipid-PEG using amine- or thiol-chemistries.[163,176–178]
In the last examples, the studies aimed mostly at using SWCNTs as targeted Raman-
or NIR-labels for Her2 positive beast cancer cells. However, besides functional studies
these early examples of bioconjugation to SWCNTs did not include any characteriza-
tion or control of successful bioconjugation. At best, the authors performed AFM/SEM
imaging of the final conjugate, but without including any negative controls. In 2011,
Venturelli et al. reported the covalent immobilization of an anti-MUC1 antibody on
MWCNTs and DWCNTs using both carboxylated tubes and the 1,3-dipolar cycloaddition
of azomethine ylides (see chapter 2.2.3.2) for the attachment of NHS- or maleimide-
anchors, which could subsequently be linked to the antibody.[173] Here and in two follow-
up studies by the same laboratories[179,180], the authors also made use of many differ-
ent characterization techniques such as thermogravimetric analysis (TGA), sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), transmission electron mi-
croscopy (TEM) and UV-absorbance spectroscopy. In addition, they confirmed retained
function of the antibody after conjugation using surface plasmon resonance (SPR). How-
ever, if carried out for SWCNTs, the use of these types of covalent functionalization
would destroy their NIR fluorescence and thus prevent their use in e.g. microscopy ap-
plications. In contrast, Williams et al. reported in two separate studies the conjugation
of an anti-HE4 antibody and an anti-uPA antibody to (TAT)6-DNA wrapped SWCNTs to
create sensors for the ovarian cancer biomarker HE4 (human epididymis protein 4)[96]
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and the metastatic prostate cancer biomarker uPA[181], respectively. Here, however, the
authors only carried out ⇣-potential measurements to assess the bioconjugation success.
In contrast to the studies described above, this work (see section 4.2.1) does not rely
on full-length antibodies, but makes use of the retained specificity and the decreased
size of nanobodies (see section 2.3.3).[125] Consequently, they offer the advantage of a
reduced distance between the antigen binding event and e.g. the signal generation in
SWCNT-based optical sensors. Furthermore, they were shown to be more stable e.g.
in the reducing intracellular environment opening up possibilities also for intracellular
sensing or targeted drug delivery. In this study at hand, a GFP-binding nanobody (GBP)
with a C-terminal ectopic cysteine was attached to a 3’-amine modified d(GT)20 oligonu-
cleotide, which was previously shown to cause a fluorescence increase in response to the
neurotransmitter dopamine, when wrapping a SWCNT. The conjugation of the GBP was
also carried out with the d(GT)10 oligonucleotide, which was shown to yield the most se-
lective and sensitive sensors for dopamine, however, its decreased length led to reduced
colloidal stability of the SWCNT-DNA after GBP conjugation. Also, it is important to note,
that the excess of GBP in the reaction mixture is crucial to prevent SWCNT aggregation,
which likely results from too many GBPs per nanotube. To control the success of the con-
jugation reaction, a combination of different methods was carried out including AFM,
⇣-potential measurements and SDS-PAGE. In addition, the retained functionality after
the conjugation was tested using an in vitro fluorescence colocalization assay. Taken
together, these methods of analysis and characterization clearly show successful conju-
gation and desired function of the SWCNT-d(GT)20-GBP conjugate.
Fig. 3 (p. 66) shows that the SWCNT-d(GT)20-GBP conjugate still responds to the neuro-
transmitter dopamine in solution, but also when bound to its surface-immobilized anti-
gen GFP. This proof-of-concept experiment exemplifies that targeting of SWCNT-based
optical sensors is possible and that they still show a sensor response even on the single-
nanotube level. This in turn opens up a lot of possibilities for using this technique to
target SWCNT-based dopamine sensors to e.g. dopaminergic neurons after injection in
an in vivo setting, so that they can act only at the desired sites.
In addition to targeted sensing, the conjugate was also used as an in vivo NIR-tag. Af-
ter injection into drosophila embryos, the SWCNT-d(GT)20-GBP conjugate did not only
enable high-contrast deep-tissue imaging of the spindle-apparatus in the NIR, but also
tracking of a Kinesin-5 motor protein inside this living organism. The proteins of the
kinesin family are, together with dynein and myosin, essential for transport of e.g. cargo
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and organelles inside our cells. Under consumption of ATP, they are able to move (with
their cargo) along microtubules (from - to +-end). SWCNTs were already used in an ear-
lier study by Fakhri et al. for the tracking of Kinesin motor proteins in cellulo.[182] Here,
the authors used the Halo-Tag platform (see section 2.4.1, Fig. 2.14) to attach DNA-
wrapped SWCNTs to Kinesin-1 in cultured COS-7 cells. By this means, they were able to
track single SWCNTs bound to a molecular motor over several seconds and retrieve bio-
physical parameters such as velocity or mean-square-displacement (MSD). Specifically
for their system, they reported a mean velocity of 300 ± 210 nm/s (mean ± SD), whereas
Courty et al. determined a mean velocity of 600 ± 10 nm/s in vitro and 570 ± 20 nm/s
in HeLa cells using quantum dot-streptavidin conjugates and biotin-labelled kinesin.[183]
These values are in the same range as other values previously determined for other in
vitro or in cellulo systems.[184–187] In contrast, this study comprises the injection of the
SWCNT-d(GT)20-GBP conjugate into living drosophila embryos and their use for tracking
of single kinesin-5 motor proteins inside this living organism. The determined mean ve-
locity of 610 ± 330 nm/s (mean ± SD) represents, to the best of the author’s knowledge,
the first value for kinesin movement speed in an in vivo setting and is in the same order of
magnitude as those values determined in vitro or in cellulo. This measurement represents
an important step in understanding molecular motors not only in vitro, but in their real,
native environment. Furthermore, it emphasizes the strengths of SWCNTs for bioimag-
ing, where the extremely low background (autofluorescence) and the non-bleaching (see
Fig. S7, p. 75) nature of the NIR-fluorescence enables deep-tissue tracking of single nan-
otubes for several seconds or minutes.
In summary, this study showed that it is possible to install small targeting units on SWC-
NTs with preserved sensing capabilities. This allows not only targeted sensing of e.g.
dopamine, but also NIR-immunofluorescence microscopy and tracking of molecular mo-
tors in live animals. The next step is now, to modify these conjugates further to tailor
their cell-penetration properties according to the specific needs of the application. If for
instance sensing outside the cell is desired, the SWCNT-conjugate should not be taken up
into the cell, whereas for intracellular drug delivery or sensing, derivatives are required,
that are able to cross cellular membranes. This fine-tuning of cellular localization prop-
erties will be studied and addressed in the following chapter.
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4.3 Peptide barrels as a novel functionalization platform
for SWCNTs
The biopolymer wrapping of SWCNTs can be used to tailor their properties generating
e.g. optical sensors. It can also carry an additional functional group (anchor group)
allowing attachment of further units such as fluorophores, drugs or recognition units
(see chapter 4.2.1). In the preceding chapters of this thesis, DNA oligonucleotides were
used to mask the hydrophobic carbon nanotube surface imparting aqueous solubility and
sensing capabilities through conformational changes upon analyte exposure. While the
DNA’s nucleobases bind and stack to the SWCNT’s surface, the phosphate backbone in-
teracts with the solvent leading to stable colloidal dispersion and preventing the SWCNTs
from reaggregation. The space of nucleobases is very limited consisting of adenine (A),
guanine (G), cytosine (C), thymine (T) and a few unnatural derivatives. These unnatural
derivatives can also be synthesized in a way enabling e.g. click chemistry to generate site-
specific DNA-protein hybrids.[188] With respect to SWCNT-based optical sensors, however,
it is especially the sequential arrangement of nucleobases determining the sensitivity and
selectivity of the respective sensor (see chapter 4.1). Here, it is of high desire to increase
the sequence space in order to be able to fine-tune the SWCNTs characteristics to the
application’s specific needs. Peptides and proteins offer a drastically increased degree
of flexibility consisting of 20 proteinogenic amino acids as building blocks with a vast
variety of also commercially available unnatural amino acids. Translated to a sequence
space this would mean e.g. for a pentamer 1024 (DNA) compared to 3.200.000 different
possibilities (peptide). However, compared to oligonucleotides, peptides and proteins
were only scarcely used for SWCNT dispersion, which is mainly due to the fact, that in
many cases they did not yield colloidally stable systems.[189]
In this chapter, a-helical coiled-coil peptide barrels (aHBs, see section 2.3.2) will be eval-
uated for the ability to encapsulate and thus debundle/disperse SWCNTs depending e.g.
on their pore size. If successful, this non-covalent wrapping could serve as a function-
alization platform, where outer residues of the barrel can be modified before or after
SWCNT-wrapping with functional units. As outlined in section 2.3.2, they can be de
novo designed to contain an inner pore of varying size depending on their amino acid
sequence. To study the effect of the peptide’s tertiary/quaternary structure on SWCNT
encapsulation, two different barrels will be compared containing on the one hand a 7.6 Å
pore (coiled-coil heptamer, CC-Hept) and on the other hand a control peptide forming
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an inner cavity of just 3.9 Å (see Fig. 1, p. 87). The resulting SWCNT@Barrel hybrids
should then be evaluated regarding their:
(a) SWCNT dispersion yield using NIR absorbance spectroscopy
(b) Structural and spatial arrangement of the barrels on a nanotube (using AFM)
(c) Their retained NIR fluorescence properties.
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4.3.1. Carbon Nanotubes Encapsulated in Coiled-coil Peptide Barrels
(Manuscript 3)
This chapter was published in the following journal:
Florian A. Mann, Jan Horlebein, Nils Frederik Meyer, Daniel Meyer, Franziska Thomas*
and Sebastian Kruss*
"Carbon Nanotubes Encapsulated in Coiled-Coil Peptide Barrels"
Chem. Eur. J. 2018, 24, 12241 - 12245
This article is available using at: DOI:10.1002/chem.201800993 * Corresponding
authors
Responsibility assignment: S.K., F.T. and F.A.M designed and conceived the project. F.A.M. and J.H.
performed SWCNT dispersion, absorbance/fluorescence spectroscopy/microscopy and AFM. N.F.M., J.H.
and F.A.M. carried out peptide synthesis and purification. J.H., F.T. and F.A.M. carried out CD measure-
ments. F.A.M. and J.H. did data analysis and D.M. built the NIR microscopy setup. F.A.M., F.T. and S.K
wrote the manuscript with input from J.H..
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Carbon Nanotubes Encapsulated in Coiled-Coil Peptide Barrels
Florian A. Mann,[a] Jan Horlebein,[a] Nils Frederik Meyer,[b] Daniel Meyer,[a]
Franziska Thomas,*[b, d] and Sebastian Kruss*[a, c]
Abstract: Specific functionalization of 1D nanomaterials
such as near infrared (nIR) fluorescent single-walled
carbon nanotubes (SWCNTs) is essential for colloidal stabil-
ity and tailoring of their interactions with the environ-
ment. Here, we show that de novo designed alpha-helical
coiled-coil peptide barrels (aHBs) with appropriate pores
encapsulate and solubilize SWCNTs. In contrast, barrels
without or with narrow pores showed a much smaller effi-
ciency. Absorption/fluorescence spectroscopy and atomic
force microscopy indicate that the SWCNTs are incorporat-
ed into the aHB’s pore. The resulting hybrid
SWCNT@aHBs display periodic surface coverage with a
40 nm pitch and remain fluorescent in the nIR. This ap-
proach presents a novel concept to encapsulate, discrimi-
nate and functionalize SWCNTs non-covalently with pep-
tides and holds great promise for future applications in
bioimaging or drug delivery.
1D Materials such as single-walled carbon nanotubes (SWCNT)
and their properties are of high fundamental interest and po-
tential building blocks for optoelectronic devices. Semicon-
ducting SWCNTs are fluorescent in the near-infrared (nIR)
region and show ultra-low photobleaching and blinking.[1–2]
These properties make them promising candidates for applica-
tions in biosensing, drug delivery and imaging.[3–7] The key
challenge is to tailor their surface and thus render them stable
in aqueous solution but also to control interactions with their
environment.[8] To preserve their nIR fluorescence, mainly non-
covalent functionalization schemes including amphiphilic (bio)-
polymers, modified polyethyleneglycols, proteins and especial-
ly single-stranded DNA (ssDNA) have been used.[9–16] Covalent
conjugation strategies of SWCNTs are highly promising but
they alter the nanotube’s conjugated sp2 system and thus their
excitonic fluorescence.[17–19] Therefore, these approaches are
less used if unchanged optoelectronic properties such as the
nIR fluorescence are important.
Peptides would be ideal to tailor the surface of SWCNTs due
to their chemical diversity. However, peptides have so far been
used much less than DNA for non-covalent functionaliza-
tion.[20–22] The major reason is that successful solubilization/dis-
persion/functionalization requires a fine balance between ad-
sorption to the SWCNT surface, aggregation and colloidal sta-
bility of SWCNT/peptide complexes. Therefore, not every pep-
tide sequence leads to colloidally stable SWCNTs. In contrast,
most ssDNA sequences lead to stable suspensions of DNA/
SWCNT complexes. As a consequence, the high potential of
peptide functionalization is not yet fully explored with only a
few exceptions.[23–27] In one example Dieckmann et al. used an
amphiphilic peptide (nano-1) to disperse SWCNTs.[23] Grigoryan
et al. used a different approach and computationally designed
peptides. They could preferentially bind to for example,
SWCNTs of (3,8) chirality and self-assembled into antiparallel
hexameric helical bundles upon adhesion. Interestingly, pep-
tide assembly and geometry of the SWCNTs were matched and
used as parameter to predict and achieve discrimination in
binding.[24]
In this work, we explore the potential of coiled-coil peptide
barrels to solubilize and functionalize SWCNTs (Figure 1).
Coiled coils are highly abundant amphiphilic helical peptides
and form very defined assemblies ranging from coiled-coil
dimers to heptamers or even dodecamers.[28, 29] The rules of
folding are largely uncovered, hence coiled-coil assemblies are
available by de novo design.[29] These insights render them
highly promising tools for functionalization of SWCNTs as one
could make use of a pool of well-studied and pre-assembled
peptidic barrels circumventing the need for optimization.
Recently, a computational approach towards the design of
coiled-coil pentamers to heptamers has been reported.[30]
These peptide assemblies are highly stable and mutable and
have successfully been applied in synthetic-biology applica-
tions or as building blocks in the synthesis of peptide nano-
tubes.[31–34] Furthermore, it was shown that the pore is accessi-
ble to hydrophobic molecules.[32, 35]
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We were especially interested in the coiled-coil heptamer
(CC-Hept), which forms a channel/pore of 0.76 nm in diame-
ter.[30] The size of this pore is in a similar range as diameters of
typical SWCNT species such as SWCNTs of (6,5)-chirality. There-
fore, we hypothesized that CC-Hept could efficiently encapsu-
late and solubilize SWCNTs. For this purpose, we chose a var-
iant of CC-Hept containing lysine residues at all f positions of
the coiled-coil register (CC-Hept-K = Barrel 1 = B1, Figure 1).
This modification should increase solubility and diminish pep-
tide-induced aggregation due to charge repulsion.[31] To distin-
guish if SWCNTs incorporate into the pore of CC-Hept-K or
physisorb, we selected the tetrameric CC-Tet-K peptide, a
lysine variant of de novo designed CC-Tet, as a control (Control
1 = C1, Figure 1[36]) This peptide has the same amino acid com-
position as CC-Hept-K, but should not be able to encapsulate
SWCNTs due to its much smaller inner cavity (⇡0.39 nm, de-
rived from crystallographic data[37]).
First, we quantified how efficient the peptides B1 and C1
(see S3 and S4 for characterization and circular dichroism spec-
troscopy) disperse SWCNTs. The S11 transitions of (6,5)-SWCNT
species at around 991 nm (Figure 2 a) show that B1 solubilized
(6,5)-SWCNT 4.5 î better than the control. The S11 transition of
(6,5)- SWCNT@B1 (994.0⌃1.1 nm) versus SWCNT@C1 (989.8⌃
1.3 nm) are redshifted. This shift might be associated with a
higher surface coverage of the C1 wrapping peptide and less
exposure to water.[38, 39]
As proven by CD-thermal denaturation experiments (Fig-
ure S4 D and S4 H) both peptides form very stable assemblies
in aqueous solution. We reasoned that this type of self-assem-
bly might reduce efficient solubilization of SWCNTs. Hence, we
synthesized C-terminally truncated versions of CC-Hept-K (CC-
Hept-K-LK, B2, see Figure 1) and CC-Tet-K (CC-Tet-K-K, C2) to
slightly destabilize the coiled coils in solution,[40, 41] which could
in turn improve their dispersion capabilities for diameter-
matching SWCNTs. This approach should improve SWCNT dis-
persion yield. As shown in Figure 2 b, truncation led to a dra-
matic increase in SWCNT dispersion. B2 was about 15 times
more efficient to disperse (6,5)-SWCNT compared to control
peptide C2. This increase in SWCNT concentration is also re-
flected in the corresponding nIR fluorescence spectra (excited
at 561 nm) in Figure 2 c.
Commonly used surfactants such as sodium cholate (SC)
solubilize all SWCNT chiralities including the major (6,5)-species
used in the samples shown in Figure 2. SC dispersed also sam-
ples with larger diameter SWCNTs (Figure S1a). In contrast, B2
could not efficiently solubilize larger diameter SWCNTs, indicat-
ing that the yield depends on SWNCT diameter. The large dif-
ference in dispersion yield between B1/C1 or B2/C2 is a first
indication that aHBs encapsulate SWCNTs if aHB pore diameter
and SWCNT diameter match.
To further support the hypothesis of barrel formation on the
SWCNT surface, we analyzed the samples via intermittent con-
tact mode atomic force microscopy (AFM). In the case of pep-
tide-barrel formation around the SWCNT, we would expect an
increase in height from ⇡0.7 nm ((6,5)-SWCNT diameter) to
⇡1.9 nm due to the size of the heptameric aHB (Scheme
Figure 3, based on peptide structural data obtained by X-ray
crystallography and analytical ultracentrifugation[30]). Figure 3 a
shows SWCNT@B2 and SWCNT@C2 physisorbed on freshly
cleaved muscovite mica. The comparison of the height topog-
raphy images in Figure 3 a and the two histograms (mean
height along SWCNT-axis) in Figure 3 b show a clear difference
in height. The measured mean heights for the nanotubes dis-
Figure 1. a-Helical coiled-coil peptide barrels (aHBs) encapsulate single-
walled carbon nanotubes (SWCNTs) and form stable SWCNT@aHBs hybrids.
Coiled-coil peptides (CC-Hept-K) that form heptameric barrels with pores (B1
and B2) encapsulate SWCNTs. In contrast, control peptides (CC-Tet-K) that
form tetrameric barrels with no (too small) pore (C1 and C2) do not solubi-
lize SWCNTs. Therefore, encapsulation is most efficient if barrel pore size and
SWCNT diameter match.
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persed by the peptide C2 peak at ⇡0.5 nm, whereas
SWCNT@B2 shows a broader height distribution ranging from
0.7 to 2.2 nm. We attribute the rather low measured height
(around 0.5 nm) for SWCNT@C2 to adsorption of peptide onto
the mica reducing the effective height difference. The large dif-
ferences in height between SWCNT@B2 and SWCNT@C2
imply that B2 self-assembles around the SWCNT and C2 ad-
sorbs randomly with much lower efficiency and overall affinity.
These results are in best agreement with a SWCNT incorporat-
ed into the pores of B2 barrels.
To further investigate the reason for the broad height distri-
bution, representative height profiles for SWCNT@B2 and
SWCNT@C2 were collected (Figure 3 c). Line-scans for
SWCNT@B2 show a repetitive pattern and height variations
between ⇡0.7 and 1.9 nm. This difference fits exceptionally
well to the additional height introduced by the heptameric
peptide B2 as previously estimated (see above). This result to-
gether with the drastic differences in SWCNT dispersion yield
compared to the control peptides C1 and C2 is a strong indi-
cation that diameter-matching SWCNTs are encapsulated by a-
helical coiled-coil peptide barrels.
We further investigated the repetitive pattern on
SWCNT@B2, which was not found for SWCNT@C2. Figure 4 a, b
show a height-trace along the axis of a single SWCNT. While
free CC-Hept-based aHB’s should have a length of ⇡4 nm in
aqueous solution, we found repeating peak–peak-distances of
43.6⌃6.7 nm via autocorrelation analysis (example in Fig-
ure 4 c, more autocorrelation plots [n = 8] in Figure S5).
There are two possible explanations for this periodicity. First,
the repeating height pattern could be due to supramolecular
assembly of the barrels along the SWCNT axis driven by the
helical read through (pitch length 28–48 nm[30]) or the instabili-
ty of barrel-stacking over long length scales. Second, processes
during drying of the sample could lead to the formation of re-
gions without peptide (dewetting). Even though the lateral res-
olution of the AFM could influence the measured pattern, it is
not likely that the periodicity is an artefact. Similar patterns
have been described for DNA functionalized SWCNTs with
pitch lengths of for example, 14⌃5 nm.[42, 43]
In summary, we introduced de novo designed aHBs as a
new functionalization and encapsulation platform for single-
walled carbon nanotubes. Spectroscopy and microscopy data
indicate that barrels are formed around the single-walled
carbon nanotubes. Importantly, the optical properties are re-
tained in SWCNTs@aHBs as demonstrated by nIR spectroscopy
(Figure 2 c) and microscopy (Figure 4 d). Coiled coils can be
functionalized via their f positions and their termini, which
leaves the overall coiled-coil assembly unaffected.[44, 45] The
Figure 3. Height profiles of peptide-barrel encapsulated single-walled
carbon nanotubes (SWCNT). a) Atomic force microscopy images of B2- and
C2-dispersed (6,5)-chirality enriched SWCNTs. The two samples show a clear
difference in height. b) Histogram of mean SWCNT heights for the
B2- (green) and C2-dispersed (red) SWCNTs. The mean height of SWCNT@B2
origins from a repeating height pattern of free and encapsulated SWCNTs
surface. c) Height traces (n = 5 each) along the axis of single SWCNT@B2 or
C2-dispersed SWCNT. The height of SWCNT@B2 (⇡1.9 nm) fits well to the
value of free (6,5)-SWCNT (⇡0.7 nm) and the height additionally introduced
by the heptameric a-helical barrel (⇡1.2 nm). Scale bars = 1 mm.
Figure 2. Dispersion efficiency depends on peptide barrel type. a) Absorbance spectra of the peptide-dispersed single-walled carbon nanotubes (SWCNTs)
show a clear tendency in dispersion yield (CC-Hept-K-LK(B2)>CC-Hept-K(B1) @ CC-Tet-K(C1) = CC-Tet-K-K(C2)). b) Dispersion yield as quantified by the absorb-
ance of the (6,5) S11 peak. Error bars are standard errors of the mean (SEM). n = 3. c) Fluorescence spectra of CC-Tet-K- and CC-Hept-K-dispersed SWCNTs.
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outer surface of aHBs is therefore promising as functionaliza-
tion platform while the SWCNTs are colloidally stabilized. This
approach could be used to tailor the organic phase around
SWCNTs to for example, control molecular interactions, confor-
mational kinetics and photophysical processes.[39, 46–49] In con-
trast to other functionalization approaches for SWCNTs,
de novo designed aHBs could be easily tailored for certain
carbon nanotube diameters.[30] This approach opens up a ple-
thora of possibilities to attach additional entities, such as fluo-
rophores and pharmacophores, or recognition units for exam-
ple, antibodies or nanobodies to the outer surface of the func-
tionalized SWCNT.
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Figure S1, Comparison of dispersion ability of larger diameter single-walled carbon nanotube (SWCNT) 
samples by sodium cholate (SC) and the helical peptide CC-Hept-K-LK (B2). (a) Absorbance spectra of SC- 
and B2-dispersed SWCNTs. (b) Comparison of the absorbance maxima of different larger diameter carbon nano-
tube species dispersed by SC and B2. n=2. 
 
 
Figure S2, Line profile of a long SWCNT@B2 adsorbed to mica surface. (a) SWCNT@B2 adsorbed to musco-




along the SWCNT@B2 axis shown in a). Start and end points are indicated in a) by the white arrows. Note that the 
schematic is not to scale and the number of barrels corresponding to one peak are not to scale. (c) Autocorrelation 
of the trace shown in b).  
 
 
Characterization of coiled-coil peptides 
 
Sequences of the coiled-coil peptides applied in this work 
 
Table S1. Sequences of the coiled-coil peptides applied in this project.  
  Sequence and heptad registera 
    g abcdefg abcdefg abcdefg abcdefg ab 
B2 CC-Hept-K (L28_K29del) G     EIAKA LKEIAKA LKEIAKA LKEIAKA    G 
B1 CC-Hept-K G     EIAKA LKEIAKA LKEIAKA LKEIAKA LK G 
C2 CC-Tet-K (K29del) G E LAAIKKE LAAIKKE LAAIKKE LAAIK      G 
C1 CC-Tet-K G E LAAIKKE LAAIKKE LAAIKKE LAAIKK     G 





Figure S3, MALDI/TOF mass spectra and HPLC traces of coiled-coil peptides. (A-B: CC-Hept-K (L28_K29del) 
calc. [M+H+]: 2948.6, C-D: CC-Hept-K calc. [M+H+]: 3190.0, E-F: CC-Tet-K (K29del) calc. [M+H+]: 3061.7, G-H: 





Figure S4, CD spectra and CD thermal denaturation profiles of A-B) CC-Hept-K (L28_K29del), C-D) CC-Hept-
K, E-F) CC-Tet-K (K29del), G-H) CC-Tet-K. Data are presented as an average over three independent measure-











Figure S6, Comparison of the S11 absorbance maxima of (6,5)-SWCNT@B2 before and after the addition 
of 6 M guanidine hydrochloride. When peptide is removed from the SWCNT surface the SWCNT are not water-
soluble anymore and tend to aggregate. After a centrifugation step the absorption spectra were taken to compare 





2. Supplementary Methods 
 
2.1 General Information 
Fmoc-protected amino acids were purchased from GL Biochem LTD (Shanghai, China). DIC and OxymaPure 
were purchased from Iris Biotech GmbH (Marktredwitz, Germany). (6,5)-chirality enriched single-walled car-
bon nanotubes (SWCNT, Sigma Aldrich, Product No.: 773735) and H-Rink Amide-Chemmatrix® resin were 
acquired from Sigma Aldrich (Darmstadt, Germany). Larger diameter SWCNTs were purchased from 
PlasmaChem GmbH (LOT: SCNP-M135). DMF used for peptide synthesis was supplied by Fisher Scientific 
(Schwerte, Germany) and was of peptide grade quality. Acetonitrile used for HPLC was supplied by Fisher 
Scientific (Schwerte, Germany) with HPLC grade quality. Water used for HPLC and reactions was obtained 
by purifying distilled water with the purification device SIMPLICITY from MILLIPORE. All other reagents were 
supplied by Sigma Aldrich (Taufkirchen, Germany), Thermo Fisher Scientific (Langenselbold, Germany), VWR 
International (Darmstadt, Germany) and Carl Roth (Karlsruhe, Germany). All reagents were of synthesis grade 
quality and were used as supplied. Unless otherwise stated, biophysical measurements were performed in 
phosphate buffered saline (PBS, 8.2 mM Na2HPO4, 1.8 mM K2HPO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4). 
Peptide concentrations were determined by UV-absorbance at 214 nm using a NanoDrop 2000 Spectropho-
tometer from Thermo Scientific. Extinction coefficients at 214 nm were calculated according to Kuipers et al.1 
2.2 Solid-phase peptide synthesis 
De novo designed peptide amides were synthesized on a H-Rink Amide-Chemmatrix® resin on a 0.1 mmol 
scale on a Liberty Blue CEM microwave-assisted peptide synthesizer. The synthesis was conducted via a 
standard Fmoc/tBu-protocol using DIC and OxymaPure as coupling reagents and a solution of piperidine in 
DMF (1:4) for Fmoc-removal. N-Acetylation of the peptides was carried out by equilibrating the peptide resin with 
5 mL of acetic acid anhydride / pyridine (1:9) for 5 min at room temperature. Acidic cleavage from the resin was 
achieved by a treatment with a mixture of trifluoroacetic acid (TFA) / triisopropylsilane / water (90:5:5, 3 h). 
The resin was extracted with additional TFA (5 mL), and the combined extracts were concentrated to a third 
of the initial volume under a flow of nitrogen. The crude peptide was then precipitated in cold diethylether 
(40 mL) and isolated by centrifugation and decantation of the supernatant. The precipitate was washed twice 
with ice-cold diethylether and subsequently dissolved in 5 mL of a 1:1 mixture of acetonitrile and water and 
then freeze-dried to give a fine white solid. 
2.3 Peptide purification 
Peptides were purified by semi-preparative reversed-phase HPLC using a JASCO chromatography system 
(pumps PU-2080 Plus, degasser DG-2080-53, detector MD-2010 Plus) at flow rates of 3 ml/min, and a Nu-
cleodur 100-5-C18 ec, (250 mm by 10 mm, 5 μm) reversed-phase column. Linear gradients of water and 
acetonitrile (buffer A: water, 0.1 % TFA, buffer B: acetonitrile, 0.1 % TFA) of 30-80 % buffer B over 30 min for 
coiled-coil heptamers and 30-60 % buffer B over 30 min for coiled-coil tetramers were used for purification. 
During purification the column was run at a controlled temperature of 60 °C. Chromatograms were recorded 
at 220 nm. 
2.4 Peptide characterization 
Peptides were characterized by mass spectrometry on a Bruker Autoflex Speed MALDI-TOF mass spectrom-
eter operating in positive-ion reflector mode. (matrix: α-cyano-4-hydroxycinnamic acid (CHCA), external cali-
bration). Analytical HPLC measurements were performed using a JASCO chromatography system (pumps 
PU-2085 Plus, detector MD-2010 Plus, autosampler AS-2055 Plus) and a Nucleodur 100-5-C18 (5 µm, 4.6 x 
250 mm) reversed-phase column at a flow rate of 1 ml/min. For peptide characterization a linear gradient of 
water and acetonitrile (buffer A: water, 0.1 % TFA, buffer B: acetonitrile, 0.1 % TFA) run from 30-80 % buffer 




Chromatograms were monitored at 220 nm wavelengths. The column was run at a controlled temperature of 
60 °C. 
2.5 Circular dichroism (CD) spectroscopy 
CD spectra and CD thermal-denaturation curves were recorded using a JASCO J-1500 which was equipped 
with a JASCO PTC510 temperature measuring unit. CD spectra were measured at 50 µM peptide concentra-
tion in PBS at 20 °C in 1 mm quartz cuvettes from Starna at 50 nm / min scanning speed. CD thermal-
denaturation experiments were performed by heating from 2 to 98 °C at a heat rate of 60 °C / h. The CD signal 
at 222 nm was recorded at 0.1 °C intervals (1 nm interval, 1 nm bandwidth, 16 s response time). The midpoints 
of the thermal denaturation curves (Tm) were determined from the second derivative of the variable tempera-
ture slope.  
2.6 Dispersion of carbon nanotubes using alpha-helical peptides 
Based on a 2 mg/mL (6,5)-chirality-enriched SWCNT stock suspension in MilliQ™-grade H2O, ~ 62.5 µg 
SWCNTs were added to a 1.5 mL centrifuge tube, spun down at 16,100 g for 30 minutes and the supernatant 
discarded.  
In the next step, 250 µL of a 2 mg/mL "-helical peptide solution (B1, B2, C1 or C2 in 1x PBS) were added to 
the raw SWCNT material. The solution was vortexed, tip sonicated for 5 minutes (Fisher Scientific™ Model 
120 Sonic Dismembrator, 20% amplitude) and subsequently centrifuged at 16,100 g (2 x 30 min) to remove 
large bundles, aggregates or metal catalyst remaining from SWCNT synthesis. The supernatant was used for 
further experiments. 
 
2.7 UV/vis/nIR absorbance spectroscopy and SWCNT concentration estimation 
200 µL of the supernatant containing individualized SWCNTs was submitted to UV/vis/nIR absorbance spec-
troscopy on a JASCO V-670 (Spectra Manager Software) using a 10 mm-path cuvette. Spectra were acquired 
using a scan speed of 1000 nm/min, a data interval of 0.5 nm and a UV/vis and nIR bandwidth of 2 nm and 
4 nm, respectively.  
SWCNT concentration was estimated using the maximal absorbance at approx. 991 nm using the molar ex-
tinction coefficient.2 
 
2.8 nIR fluorescence spectroscopy 
In a 96-well plate, 100 µL of the SWCNT-"HB solutions were excited at 561 nm using a Cobolt Jive™ laser 
(Cobolt AB, Solna, Sweden, 100 mW) and their fluorescence spectra in the range between 850 and 1300 nm 
recorded using a Shamrock 193i spectrograph (Andor Technology Ltd., Belfast, Northern Ireland) coupled to 
an Olympus BX53 microscope and an exposure time of 1 s, a slit width of 500 µm and an Andor iDus InGaAs 
491 array NIR detector. 
 
2.9 nIR fluorescence microscopy of immobilized SWCNT@barrels 
20 µL of a 6.6 nM SWCNT@B2 solution were incubated on a glass-bottom petri dish for one hour at 4 °C. 
After a 1x PBS wash, nIR imaging was carried out on an Olympus BX53 microscope equipped with a laser 
(see above) using a 60× oil-immersion objective and a XenicsÒ Xeva-1.7-320 NIR camera (Xenics, Heverlee, 
Belgium). 
 
2.10 Atomic Force Microscopy (AFM) of immobilized SWCNT-"HB 
20 µL of each of the SWCNT-"HB solutions were immobilized on freshly cleaved muscovite mica via ten 
minutes incubation and subsequent washing of the surface with MilliQ water. AFM images were acquired in 
tapping mode using an Asylum Research MFP-3D InfinityÒ instrument equipped with Olympus AC-160-TS 
cantilevers.  
Analysis of the acquired images was performed via the open-source software Gwyddion. For all images, the 










1. Kuipers, B. J.; Gruppen, H., Prediction of molar extinction coefficients of proteins and peptides using 
UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-
performance liquid chromatography-mass spectrometry analysis. J. Agric. Food. Chem. 2007, 55 (14), 5445-
51. 
2. Schöppler, F.; Mann, C.; Hain, T. C.; Neubauer, F. M.; Privitera, G.; Bonaccorso, F.; Chu, D.; Ferrari, 




4.3. Peptide barrels as a novel functionalization platform for SWCNTs
4.3.2. Do peptide barrels allow SWCNT chirality enrichment?
The manuscript in section 4.3.1 shows, that it is possible to use aHBs for the dispersion of
SWCNTs. Their predefined pore diameter should - in principle - also allow for enrichment
of certain SWCNT chiralities/diameters. The AFM experiment shown in Fig. 3 (p. 88)
also suggests, that there is a difference even when comparing the two aHBs with their
different pore diameters. Whereas the B2-barrel (d = 7.6 Å) shows alternating heights
corresponding to peptide barrels wrapping (6,5)-SWCNTs (d = 7.6 Å), the control sample
with the barrel C2 shows ’naked’ tubes with a mean diameter of 5 Å. These could,
amongst others, correspond e.g. to the smaller metallic (5,2)-SWCNTs with a diameter
of 5 Å, which would not be detectable in the absorbance spectra due to their metallic
nature. In this case, however, the C2 peptide would have been desorbed under the
Figure 4.1.: Fitted NIR absorbance spectra of different SWCNT samples. a) NIR-
absorbance spectrum of (GT)20-DNA dispersed SWCNTs and the corresponding fit. b)
NIR-absorbance spectrum of a SWCNT/SDBS sample and the corresponding fit. c) NIR-
absorbance spectrum of SWCNT@B2 and the corresponding fit. d) Comparison of the
relative peak areas of the three different samples for four SWCNT-chiralities.
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same washing procedure applied also to the SWCNT@B2 sample indicating a weaker
C2-SWCNT-binding. Fig. 4.1 shows the background subtracted (e b ) NIR absorbance
spectra of carbon nanotubes dispersed using (GT)20-DNA, the B2 aHB and the surfactant
SDBS fitted with nine Lorentzians corresponding to different SWCNT-chiralities. The
barrel B2 does not exclusively disperse a single SWCNT-chirality, but does show a trend
towards encapsulating smaller SWCNT diameters compared to the SWCNT/(GT)20 and
SWCNT/SDBS sample (e.g. for (6,5)-SWCNTs: 48% ((GT)20), 62% (B2), 37% (SDBS)).
From the combination of AFM and NIR absorbance spectroscopy one can conclude, that
the peptide barrels can ’breathe’ and adjust to encapsulate different chiralities, yet still
preferentially binds those with exactly fitting diameters.
While these AFM studies are not representative for the whole sample and NIR absorbance
spectroscopy does only show the semiconducting SWCNTs, as a next step also Raman-
spectroscopy should be employed to get a better understanding of all involved chiralities
characterized by their radial breathing modes (RBM). In future studies, one could also
combine the preferential binding with enrichment techniques such as aqueous-two-phase
(ATP) separation[190] to use aHBs for single-chirality isolation.
4.3.3. Discussion
Up to now, peptides were - despite their great versatility - only rarely utilized for the mod-
ification of carbon nanotubes. For comparison, a PubMed search with the terms "carbon
nanotube AND peptide" in the title/abstract yielded 121 results compared to 492 results
for "carbon nanotube AND DNA". In general, the reported studies can be categorized
into three distinct approaches.
First, the use of phage-displayed peptide libraries to find peptide sequences with a high
affinity for carbon nanotubes, which led to the peptides containing conserved hydropho-
bic/aromatic residues found by Wang et al.[191] and Su et al.[192]. In a follow-up study,
Su et al. found especially the amino acid tryptophan crucial for effective nanotube
binding.[193] Second, peptides were also conjugated covalently to SWCNTs leading to de-
stroyed NIR fluorescence. This approach includes mainly examples, where the SWCNTs
were used e.g. as delivery vehicles for bioactive peptides to cross cellular membranes[80]
or as shielding agents preventing the generation of immune responses against the conju-
gated peptide.[194] Third, researchers made use of special peptide characteristics such as
amphiphilicity, reversible cyclization or the formation of a-helices on SWCNTs for the dis-
persion of carbon nanotubes. The first study using peptides to coat SWCNTs was carried
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out by Dieckmann et al. in 2003, who used a peptide sequence they termed nano-1. This
peptide was then shown to ab able to fold into an a-helix in the presence of SWCNTs lead-
ing to their dispersion.[120,195] In 2005, Arnold et al. used an anionic peptide amphiphile
(containing an alkyl-tail for SWCNT-binding) termed PA3 for SWCNT dispersion[196],
while Ortiz-Acevedo et al. showed the possibility of using reversible cyclic peptides for
reversible SWCNT dispersion (upon disulfide formation/cleavage).[121] In 2011, Grygo-
rian et al. further expanded on the idea of Dieckmann et al. with a computational design
approach addressing a variety of different parameters such as residues interacting with
the SWCNT, the pitch angles of different SWCNT chiralities and the feasibility of pep-
tide design and stability. Using these parameters, they found two sequences, which form
a-helical coiled-coil hexamers with parameters matching the geometry of (3,8)-SWCNTs
and were also able to show that they can enrich, yet not exclusively bind this chirality.
Furthermore, they also used cysteine-residues introduced close to the N-terminus for the
templated attachment of gold nanoparticles.[122]
In contrast to these examples of peptides encapsulating carbon nanotubes, this work
makes use of previously characterized, de novo designed a-helical coiled-coil barrels.
While the work of Grygorian et al. is a truly impressive example of what computational
peptide design can yield, it is a clear advantage to be able to rationally ’choose from a
catalogue’ of aHBs with different diameters[114] rendering the whole procedure a very
straightforward process. The fact, that aHBs self-assemble in aqueous solution and are
very well characterized themselves in terms of sequence-structure relationships is crucial
for this attempt to gain also further use in other applications. Figure 2 (p. 88) shows the
difference in dispersion yield for the four peptides chosen - two with a larger (B1/B2,
d = 7.6 Å) and two control peptides with a very narrow pore (C1/C2, d = 3.9 Å). While
the two peptides containing the larger pore were able to disperse SWCNTs, the C1/C2
peptide were not successful. But also the C-terminal truncation of B1 leading to B2 led
to a significant increase in dispersion yield, which could be attributed to a reduced sta-
bility of the aHBs on their own leading to increased assembly on the nanotube and thus
enhanced dispersion. While it is important to note that the pore diameters estimated
from the X-Ray structures of the barrels themselves are not fixed values, but can rather
’breathe’, Fig. 3 (p. 88) as well as section 4.3.2 show a trend towards smaller SWC-
NTs being enriched with the smaller pore peptides (C1/C2) compared to B1/B2. This
is especially apparent in the AFM images shown in Fig. 3. Whereas this could also be
attributed to larger adsorptive forces of the C2-peptide on mica, it is more likely that
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the smaller measured heights (approx. 0.5 nm) are due to a more stable dispersion of
smaller SWCNT species. The smallest free-standing SWCNT reported to date has a di-
ameter of 0.43 nm.[7] However, in the absorbance as well as fluorescence spectra with
excess peptide present in the solution, this difference is not as apparent as in the AFM
images. This could also be due to the tubes in the AFM image being mainly smaller di-
ameter, metallic tubes which are not visible in the optical signature of the sample. These
assumptions will be subject of further study including techniques such as Raman spec-
troscopy.
The next important step is now to further increase the colloidal stability of the SWCNT@
Barrel hybrids to the point, where no excess peptide in solution is necessary anymore.
This in turn would enable functionalization of outwards-facing residues (e.g. f-positions,
compare Fig. 2.12) with fluorophores or targeting-units. It is, however, important to
note, that this was also not accomplished in all other approaches mentioned above em-
phasizing the need for novel techniques for stabilization. In preliminary experiments
Jan Horlebein (in his B.Sc. thesis) achieved together with the author of this thesis a
slight stabilization of the hybrid structures towards removal of excess peptide by utiliz-
ing so-called peptide nanotubes (PNTs) instead of single aHBs. These structures based
on aHBs with ’sticky ends’ were recently described by the Woolfson lab[118,119] to form
tubular structures of several micrometers in length and could thus also possibly lead to
a more densely covered SWCNT surface and thus increased colloidal stability. In addi-
tion, also carbodiimide-initiated cross-linking or native chemical ligation could be used
to covalently link adjacent barrels to one another fixing the structures and preventing
disassembly upon removal of excess peptide. While these approaches will be subject of
further study to generate a stable peptidic platform for carbon nanotube functionaliza-
tion, the work described in the following section will employ sp3 defects for the covalent




-defects as versatile anchors for the generation of covalent SWCNT-bioconjugates
4.4 sp3-defects as versatile anchors for the generation
of covalent SWCNT-bioconjugates
Carbon nanotubes possess a large variety of unique properties that make them inter-
esting for diverse applications ranging from chip production and quantum computers
over biosensing to drug delivery. In order to carry out their desired function especially
in the latter two areas, they have to be chemically modified to create e.g. specificity.
Next to non-covalent wrapping, which was addressed in the preceding chapters, cova-
lent modifications offer increased stability, which can be crucial in demanding applica-
tions such as drug delivery. If the attached drug is e.g. replaced by a protein before
it can reach the desired target site, this would lead to more off-site effects and conse-
quently a worse therapeutic outcome. Thus, the generation of stably linked conjugates
is of high desire. With respect to covalent SWCNT-peptide or SWCNT-protein conju-
gates, there were already a few different strategies reported. The laboratories of Prato,
Bianco and Kostarelos utilized the 1,3-dipolar cycloaddition of azomethine ylides for the
attachment of previously synthesized and purified peptides to guide the peptides into
cells or shield them from eliciting an immune response.[79,194,197] The same reaction was
also made use of by Spinato et al. for the attachment of the Cetuximab antibody for
targeting of epidermal growth factor receptor (EGFR) expressing cells.[180] Another type
of chemistry for covalent SWCNT modification is the carbodiimide-activation of -COOH
groups formed via oxidative treatment followed by a nucleophilic attack of a protein’s
or peptide’s amine. This approach was first used by Huang et al. for the covalent at-
tachment of bovine serum albumine (BSA) in 2002[56] and followed Jiang et al. with
MWCNT-BSA and MWCNT-ferritin conjugates[198] and Yu et al., who created covalently
linked SWCNT-anti-HSA antibody conjugates.[199] However, all approaches mentioned
have a destroyed NIR fluorescence in common and could thus not be used for optical
sensing, photodynamic therapy or theranostics. Recently, Setaro et al. reported the cova-
lent derivatization of SWCNTs with preserved NIR emission features, which they used to
create photo-switchable and AuNP-functionalized SWCNTs.[53] In 2020, Chio et al. used
the same [2+1]-cycloaddition for the attachment of small molecules such as biotin or
glycine.[200] These two studies show, that it is indeed possible to create covalently func-
tionalized, yet still NIR-fluorescent carbon nanotubes. The authors of these two studies
did, however, not achieve functionalization with larger biomolecules.
Another type of covalent SWCNT modification is the radical arylation using aryl diazo-
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nium salts[14,40], which was recently shown to induce a brightening of prior dark excitonic
states leading to further red-shifted emission.[39] At this point it is crucial to achieve the
right defect density as too high defect densities would again lead to diminished NIR flu-
orescence (see section 2.2.2.3). It is now the aim of this work to introduce two novel
aryldiazonium salts containing anchor groups allowing for subsequent attachment of flu-
orophores, peptides and even whole proteins, while preserving the NIR fluorescence. In
order to achieve this goal, the following points are addressed:
(a) Synthesis of a maleimide-containing diazonium salt as well as a phenylalanine di-
azonium salt
(b) Optimize and prove successful defect introduction using the new diazonium salts
(c) Use the maleimide-defects for protein attachment and show retained protein func-
tion
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Abstract: Single-walled carbon nanotubes (SWCNT) are a 1D 
nanomaterial that shows fluorescence in the near-infrared (NIR, 
> 800 nm). In the past, covalent chemistry was less explored to 
functionalize SWCNTs as it impairs NIR emission. However, certain 
sp3 defects (quantum defects) in the carbon lattice have emerged that 
preserve NIR fluorescence and even introduce a new, red-shifted 
emission peak. Here, we report on quantum defects, introduced using 
light-driven diazonium chemistry, that serve as anchor points for 
peptides and proteins. We show that maleimide anchors allow 
conjugation of cysteine-containing proteins such as a GFP-binding 
nanobody. In addition, a Fmoc protected phenylalanine defect serves 
as a starting point for conjugation of visible fluorophores to create 
multicolor SWCNTs and in situ peptide synthesis directly on the 
nanotube. Therefore, these quantum defects are a versatile platform 
to tailor both the nanotube’s photophysical properties as well as their 
surface chemistry.  
Since their discovery[1]  single-walled carbon nanotubes 
(SWCNT) attracted a lot of attention not only because of their 
unique chemical structure, but also because of their outstanding 
photophysical properties such as non-bleaching/blinking near-
infrared (NIR) fluorescence.[2-4] This NIR-fluorescence is 
beneficial especially for bioimaging as the emission wavelength 
of SWCNTs falls into the so-called tissue-transparency window 
where the absorption of water, hemoglobin and lipids reaches a 
combined minimum and scattering is reduced compared to visible 
light.[5] Consequently, SWCNTs already found application in 
diverse settings ranging from in vivo NIR imaging[6-8] over drug 
delivery vehicles[9,10] to NIR optical sensors.[11-20] In order to carry 
out their desired function in these important applications, the pure 
carbon tube has to be modified with e.g. the cargo to be carried 
or a recognition unit imparting specificity for the analyte to be 
detected. Furthermore, carbon nanotubes are not water-soluble 
preventing applications in aqueous systems unless the 
hydrophobic surface is coated with an amphiphilic surfactant.[12] 
In the last 20 years, both covalent and non-covalent 
functionalization were employed for the decoration of SWCNTs 
with functional units. Non-covalent functionalization as for 
example adsorption of DNA is by far the most frequently applied 
approach owing to its ease-of-use and mild conditions.[21-23] 
Furthermore, conformational changes of the coating molecule can 
directly translate into changes of the NIR fluorescence, which is 
interesting for sensing.[16,24] On the other hand, covalent 
functionalization leads to more stable conjugates, but destroys 
the SWCNT’s extended π-network and thus also the NIR-
fluorescence.[2,25] In 2017, Setaro et al. reported preserved 
fluorescence by using a [2+1]-cycloaddition with electron-poor 
aromatic nitrenes, which they also used for the attachment of gold 
nanoparticles and spiropyranes.[26] Very recently, Godin et al. 
used spyropyran-switchable SWCNTs for NIR super-resolution 
microscopy[27] while Chio et al. used the same nitrene [2+1]-
cycloaddition for the attachment of small molecules such as 
biotin.[28] 
However, sp3 defects can not only diminish the NIR-fluorescence, 
but were also found to modulate it depending on the nature and 
density of the defects. In 2010, Ghosh et al. reported on a NIR 
emission peak red-shifted by approx. 130 nm (termed E11*) upon 
introduction of oxygen defects.[29] Later, Piao et al. observed a 
similar peak shift and enhanced fluorescence quantum yield upon 
introduction of aryl defects using diazonium salts (quantum 
defects).[30] This technique also enabled tuning of the defect-
fluorescence both in terms of intensity and emission wavelength 
via different substituents on the aryl/alkyl-defect.[31-34] 
 
Figure 1. Defects as a generic handle to functionalize single-walled carbon 
nanotubes (SWCNT*). Differently substituted aryl-defects are introduced into 
the nanotube’s sidewall and used to conjugate biomolecules such as 
nanobodies (1) or for the direct growth of peptide chains on the SWCNT* (2). 
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Figure 2. Light-driven introduction of maleimide-carrying quantum defects into SWCNTs. a) Schematic of the photo-induced defect introduction based on 
aqueous diazonium chemistry. Size of the structures is not to scale. b) NIR-fluorescence spectra of SWCNT*/SDBS samples after the photoinduced defect reaction 
(15 min illumination) with different concentrations of MalPh-Dz. c) NIR fluorescence excitation-emission map after introduction of the covalent MalPh defects, 
removal of excess 2 and resuspension in 1% SDBS (a control 2D-spectrum can be found in Fig. S3).  
In the last years, a number of different oxygen and aryl-defects 
were reported, that are now very promising tools for the 
generation of brighter/modified SWCNTs[31,35,36], pH-[37] or 
saccharide[38] sensors, short fluorescent SWCNTs for super-
resolution microscopy[39] or single-photon sources for quantum 
computing.[40,41] Furthermore, this new defect-induced 
fluorescence feature moves the emission even further into the bio-
transparency window leading to even better tissue penetration 
properties.[42,43] 
In this work, we expand the use of quantum defects from 
modulation of the SWCNT’s photophysical properties towards 
using them as modular anchors for the attachment of peptides 
and proteins (Fig. 1). To this end, we employed a (N-
maleimido)phenyl diazonium salt (MalPh-Dz, 2), which – after 
defect introduction – can be targeted by thiol-containing 
molecules such as proteins, while at the same time generating a 
further red-shifted E11* emission feature (defect-carrying SWCNTs 
are thus referred to as SWCNT* from now on).  
We started our investigations by optimizing the narrow window of 
reaction conditions[44] between sodium dodecylbenzenesulfonate 
(SDBS) dispersed SWCNTs 1 and 4-(N-maleimido)phenyl-
diazonium tetrafluoroborate (MalPh-Dz, 2) allowing for the NIR-
fluorescence to be altered, yet not diminished (Fig. 2a). For a fast 
and efficient screening of conditions (reaction time and reactant 
concentration, see Fig. S1), we made use of a 96-well green LED 
array for SWCNT excitation driving the radical arylation reaction. 
The best results were achieved when a 10 nM SWCNT 
(ccarbon » 530 µM) solution (dispersed in 1% SDBS/H2O) was 
mixed with 2 (100 µM) and irradiated for 15 minutes. Higher 
MalPh-Dz concentrations would lead to too many defects and 
diminish NIR fluorescence.[30] 
 
Figure 3. One-pot introduction of quantum defects and nanobody conjugation to SWCNT*. a) Schematic of the one-pot defect reaction and bioconjugation to 
GFP-binding nanobodies (GBP). b) NIR-fluorescence spectra comparing the SWCNT*-GBP conjugate 5 and its negative control where no MalPh-Dz was added 
showing the successful introduction of quantum defects despite the simultaneous addition of the anti-GFP nanobody. c) Atomic Force microscopy (AFM) image of 
a SWCNT after defect/conjugation reaction to GBP. Scale bar = 200 nm. The arrows point at locations of increased height indicating the conjugation of the nanobody. 
The reaction conditions (low defect density, reactant concentration) were chosen to immobilize only a few GBPs per tube. d) Measured heights of SWCNT*s only 
non-covalently wrapped by phospholipid-polyethyleneglycol-5000 (PL-PEG5000), isolated GBP nanobodies and SWCNT*-GBP showing the increased height after 
nanobody-conjugation (mean ± SD, n ³ 16). e) Pattern of green-fluorescent protein (GFP) on a glass surface incubated with SWCNT*-GBP. The colocalization 
shows retained functionality of the nanobody even after covalent conjugation to the SWCNT. Scale bars = 5 µm.  
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The success of the defect reaction was monitored by NIR-
fluorescence spectroscopy (Fig. 2b) and the SWCNT’s structural 
integrity and colloidal stability was controlled using VIS-NIR 
absorbance spectroscopy (Fig. S2). The fluorescence spectra 
and the excitation/emission map (see Fig. 2c) clearly show a 
growing E11* peak at approx. 1135 nm with increasing 
concentration of 2 (control 2D-spectrum with a non-modified 
SWCNT/SDBS sample can be found in Fig. S3). The increased 
E11*/E11 ratio of the 2D versus the 1D NIR-fluorescence spectrum 
could be attributed to prolonged exposure to MalPh-Dz 2 before 
spin filtration and measurement of the 2D-spectrum or due to 
preferential redispersion of MalPh-SWCNT*. 
After successful introduction of (N-Maleimido)phenyl quantum 
defects (MalPh defects), we tested whether biomolecules can be 
conjugated to this anchor. As a first example, we chose a 
nanobody against green-fluorescent protein (GFP). Nanobodies 
are the isolated antigen-binding region of heavy-chain antibodies 
found e.g. in Camelidae and are only 10% of the size of 
conventional antibodies.[45,46] This renders them very useful as 
binders for diverse applications such as super-resolution 
microscopy[47-49], live-cell immunostaining after modification with 
cell-penetrating peptides[50] or isotopic labeling of biological 
samples for secondary-ion mass spectrometry (SIMS) imaging.[51] 
Nanobodies binding GFP (GFP-binding protein, GBP) in 
particular can be used as a platform technology due to the 
widespread availability of GFP-fusion proteins or even whole 
genetically modified organisms expressing GFP-fusion proteins 
giving the possibility to target a whole variety of proteins with just 
one single conjugate. Similar to our previous (non-covalent) 
work[13], we used a GBP with a single ectopic C-terminal cysteine 
for oriented conjugation to the MalPh-SWCNT* 3 leaving the 
antigen-binding region pointing away from the SWCNT*’s surface.  
With the fast hydrolysis kinetics of N-aryl maleimides[52] in mind, 
we evaluated both the sequential defect introduction followed by 
nanobody conjugation as well as a one-step approach combining 
all three reaction partners at once (Fig. 3a). For the sequential 
reaction, the excess diazonium salt 2 was removed using 300 kDa 
molecular weight cut-off (MWCO) spin filters followed by 
resuspension of the now naked MalPh-SWCNT* 3 in 1x 
phosphate-buffered saline (PBS, pH 7.4) and reaction with 500 eq. 
(~25 eq. with respect to introduced maleimides) of the nanobody 
4 (16 h at room temperature). In the one-step approach, the same 
excess of GBP was added directly during the defect-introduction 
(30 minutes instead of 15 minutes for the sequential reaction) and 
left reacting for 16 h at room temperature as well. After defect-
introduction/bioconjugation, the excess nanobody was removed 
using 300kDa-MWCO-spin-filtration and the SWCNT*-GBP 
conjugate 5 resuspended in 1xPBS using 1,2-distearoyl-sn-
glycero-3-phosphoethanolamine-N-[methoxy(polyethylene 
glycol)-5000] (ammonium salt, PL-PEG5000). As shown in Fig. 
S4, the redispersion step was efficient only for the conjugate 5 
synthesized via the one-step approach yielding a highly 
concentrated solution (OD = 1.8). Consequently, we proceeded 
with the resuspended conjugate 5 resulting from the one-step 
procedure in the following.  
Fig. 3b shows the NIR-fluorescence spectra of the conjugate 5 as 
well as the negative control, where no diazonium salt 2 was added, 
both resuspended using PL-PEG5000. A comparison of both 
spectra shows successful introduction of sp3 quantum defects and 
E11* emission. To further evaluate, whether these defects also 
contain the covalently attached nanobody, we employed atomic 
force microscopy (AFM). Here, the one-step-synthesized sample 
clearly shows nanobodies attached to the SWCNT* (see Fig. 3c, 
control without 2 in Fig. S5) with the additional height introduced 
by the GBP fitting both the value measured by AFM 
(d = 4.3±0.9 nm) as well as the diameter obtained from the crystal 
structure (PDB: 3G9A, d = 3.4-4.3 nm, see Fig. S6). In a few 
cases, also larger heights of SWCNT*-GBP conjugates (approx. 
7 nm) were measured, which could be explained by the possible 
side reaction of the diazonium salt 2 with the GBP’s aromatic 
residues leading to dimer formation. Taken together, these results 
indicate successful conjugation of the nanobody to maleimide-
bearing quantum defects, which in turn are still able to modulate 
the SWCNT*’s NIR-fluorescence yielding emission at 1143 nm.  
As a next step, we verified that the nanobody is still able to bind 
GFP even after covalent conjugation to the SWCNT. Therefore, 
we immobilized GFP (patterned using polydimethylsiloxane 
(PDMS)-based micro-contact printing) on a poly-L-lysine (PLL) 
coated glass surface followed by blocking (with bovine serum 
albumin [BSA])/washing steps and incubation with the conjugate 
5.  
 
Figure 4. Fmoc-Phenylalanine quantum defects and multi-color single-
walled carbon nanotubes (SWCNTs). A) Strategy for defect introduction and 
subsequent Fmoc-deprotection followed by 5(6)-carboxyfluorescein (CF)-
conjugation. B) NIR-fluorescence spectra of SWCNTs treated with different 
concentrations of Fmoc-Phe-Dz showing increased E11*/E11 ratios at higher 
diazonium salt concentrations. C) Excitation-emission map of Fmoc-Phe-
SWCNT* showing the E11*-fluorescence amongst other minor SWCNT species 
and E11-fluorescence. d) SWCNT*-Phe-CF immobilized on a glass slide 
showing colocalization of the NIR (>900 nm) and the CF-channel (500-550 nm), 
whereas the control without sp3-defects does not show a CF-signal, indicating 
successful conjugation.  Scale bars = 5 µm. 
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The observed colocalization of the GFP- and the NIR-channel 
indicates retained function of the GBP even after covalent 
conjugation to the SWCNT* (Fig. 3e, control without the MalPh 
defect on the right and without GBP in Fig. S7). This is, to the best 
of our knowledge, the first covalent conjugation of a functional 
(immuno)protein to a SWCNT under preserved/enhanced NIR-
fluorescence.  
After having successfully established MalPh quantum defects as 
an anchor for the attachment of (immuno)proteins, we wanted to 
challenge this defect-based approach even further with the aim of 
synthesizing peptide chains directly on the SWCNT’s sidewall. 
While there are a few reports on the use of coiled-coil or cyclic 
peptides for SWCNT dispersion[53-55] or the non-covalent 
immobilization of RGD-motifs[56], covalent immobilization of 
peptides is less explored. Pantarotto et al. and Bianco et al. 
utilized the 1,3-dipolar cycloaddition of azomethine ylides for the 
covalent modification of SWCNTs and for subsequent attachment 
of previously synthesized, short peptides.[57,58] However, this 
approach destroys the SWCNT’s optical properties and rules out 
NIR fluorescence imaging  applications.  
To use quantum defects as a starting point for peptide growth, we 
synthesized a diazonium salt containing a 
fluorenylmethoxycarbonyl (Fmoc)-protected L-Phenylalanine 
(Fmoc-Phe-Dz, 6) in a one-step procedure. Next, we again 
optimized the conditions for defect introduction (Fmoc-Phe 
defects) and evaluated the success using 1D/2D-NIR-
fluorescence spectroscopy (Fig. 4b/c, control 2D-spectrum in Fig. 
S8). We carried out the Fmoc-deprotection using 
20% piperidine/DMF in a 1 mL syringe reactor equipped with a 
standard 20 µm pore-size frit. After washing, we coupled the 
fluorophore 5(6)-carboxyfluorescein (CF) to assess addressability 
of the unprotected amine. Fig. 4d shows colocalization of the NIR- 
and the CF-channel after immobilization on glass and washing 
steps using 1xPBS with 0.1% Triton-X-100 as opposed to the 
negative controls (without 6 [Fig. 4d] or without Fmoc-
deprotection [Fig. S9]). This result shows that the unprotected 
amine is still addressable and the conjugation of 
carboxyfluorescein led to the generation of covalently linked multi-
color SWCNT*. 
Encouraged by these promising results, we wanted to test next, 
whether it is also possible to synthesize a whole peptide 
sequence on the Fmoc-Phe-SWCNT* 7. Here, we decided for a 
positively charged hexaarginine peptide to also evaluate its 
impact on the SWCNT*’s solubility in aqueous environments (Fig. 
5a). To evaluate the success of the SWCNT*-Peptide synthesis, 
neither the Kaiser test for free amines nor UV-measurements after 
Fmoc cleavage could be used due to their insufficient sensitivities 
on the small scale of these experiments (nSWCNT = 100 pmol in 
1 mL solution). Thus, we decided to couple 5(6)-CF to the N-
terminus before global deprotection of the arginine’s side chains 
using a deprotection cocktail (75% trifluoroacetic acid [TFA], 15% 
dichloromethane [DCM], 5% ddH2O, 5% triisopropylsilane [TIS]). 
This was followed by tip-sonication in 1xPBS (3 min, 30% amp, 
4°C) and centrifugation (16100g, 30min) to remove insoluble 
SWCNTs. Fig. 5b shows colocalization of the NIR- and the CF-
channel on the single-nanotube level indicating successful 
synthesis of SWCNT*-F-R6-CF in contrast to the control (without 
6, see Fig. S10) and retained optoelectronic properties after TFA 
deprotection. In fact, the negative control did not contain any 
SWCNTs indicating increased solubility in aqueous environments 
by covalent peptide functionalization. However, due to the small 
number of defects (approx. 1 defect per 20 nm tube[30]) the 
SWCNT*-F-R6-CF (8) did not display high solubility in water and 
therefore additional wrapping was used to increase the 
concentration and colloidal stability. In future studies, this aspect 
could be further evaluated with higher defect densities and/or 
longer peptide sequences.  
 
Figure 5. In situ peptide synthesis and modulation of E11*-peak intensities. A) Strategy for the generation of covalent and fluorescent SWCNT-F-R6-CF 
conjugates based on Fmoc/OtBu-solid phase peptide synthesis (SPPS) followed by N-terminal 5(6)-carboxyfluorescein (CF) coupling and Pbf-deprotection of the 
arginine’s side chains. B) SWCNT-R6-CF spin-coated on a glass coverslip showing colocalization of the near-infrared (NIR) and the CF-channel indicating successful 
peptide-synthesis and N-terminal CF-coupling directly on the SWCNT’s sidewall (scale bars = 10 µm). c) 96-well peptide synthesis for the generation of a SWCNT-
peptide pool following the same Fmoc/OtBu-SPPS protocol as shown in a), yet here in a 96 well-plate with filters (0.2 µm pore size). d)  Normalized NIR-PL spectra 
before and after synthesis of two selected peptide sequences showing the modulation of the defect-induced fluorescence. The red-shift from the protected to the 
unprotected sample could be attributed to the different surfactant (SWCNT*-F-Fmoc: SDBS, SWCNT*-Peptide: DOC). e) The SWCNT’s fluorescence properties (in 
particular the E11*/E11 ratio) depends on peptide sequence on the sidewall (mean ± SD, n=3). f) E11*/E11 ratio increases with the number of hydrophobic residues 
(mean and individual values, n=6,2,4). 
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As a next step we upscaled SWCNT*-based peptide synthesis 
and synthesized multiple SWCNT-peptide conjugates at the same 
time in a 96-well format (equipped with 0.2 µm pore size filters, 
Fig. 5c). Again, the synthesis followed the same protocol as above, 
yet with smaller reaction volumes. Using this technique, we 
synthesized twelve different peptide sequences directly on NIR-
fluorescent carbon nanotubes. After side-chain deprotection 
using the same deprotection cocktail as for SWCNT*-F-R6-CF, 
the carbon nanotubes were redispersed in an aqueous 1% DOC 
solution via tip-sonication. While DOC leads to slightly red-shifted 
emission compared to SDBS-dispersed SWCNT*-F-Fmoc/SDBS 
(7)[59,60], both Fig. 5d and e show the impact of peptide sequence 
on the NIR-fluorescence. For some sequences the original E11 
peak was almost twice as intense as the E11* peak - other 
sequences showed exactly the opposite behavior with the E11* 
signal being 2.5-fold stronger than the signal arising from the E11 
transition (VIS/NIR absorbance and NIR fluorescence spectra in 
Fig. S11). A closer evaluation of the sequence-dependence of this 
fluorescence modulation shows that the E11*/E11 ratio decreases 
with an increasing number of hydrophobic residues in the peptide 
sequence attached to the defect responsible for exciton trapping 
(Fig. 5f). A similar effect was already observed by Kwon et al., 
who found changing E11* emission wavelengths and E11*/E11 ratios 
for differently substituted (fluoro)alkyl/aryl sp3-defects.[32] This 
interesting impact on the SWCNT’s photophysics could be 
attributed to the peptides folding differently on the SWCNT and 
changing the charge landscape through which the exciton 
diffuses or where it gets trapped, thus leading to enhanced E11*- 
fluorescence for less hydrophobic sequences. Different folding of 
peptides is known from non-covalent SWCNT/Peptide hybrids.[61] 
Furthermore, a comparison of the sequences 9-12 consisting of 
identical amino acids shows that not only the nature of the 
attached amino acids, but also their sequential arrangement is of 
high importance for the SWCNT*’s NIR-fluorescence properties. 
These results demonstrate the possibilities of employing Fmoc-
protected phenylalanine defects for the growth of peptidic chains 
directly on the nanotube’s sidewall and indicate, that this method 
can not only be used for modulation of the SWCNT’s fluorescence, 
but also to tailor their surface properties. This in turn could enable 
SWCNTs with enhanced cellular uptake/retention[62,63], tailored 
molecular recognition motifs or novel and more stable optical 
sensors operating in the NIR. Furthermore, the coupling of a 
second optically active molecule (fluorophore) via a peptide 
sequence to a SWCNT could serve as general design principle 
for molecular recognition and signal transduction. Similar to 
Förster resonance energy transfer (FRET), conformational 
changes upon binding to a target structure could affect the 
SWCNT’s NIR fluorescence and enable novel fluorescent probes 
and labels. 
In summary, we introduced two new sp3 quantum defects in 
SWCNTs, which serve as anchors for the attachment of 
biomolecules. The versatility of this new functionalization platform 
was demonstrated by conjugation of a GFP-binding nanobody as 
an example for a protein and the synthesis of peptides directly on 
the carbon nanotube surface. This new technique for covalent 
decoration of SWCNTs with biomolecules opens up great 
possibilities for applications in (bio)photonics, biosensing or 
biomedicine.     
 
Acknowledgements 
We thank the VW foundation and the State of Lower Saxony 
(life@nano) for funding. We thank Andreas Janshoff and Claudia 
Steinem for their support. 
Keywords: nanotube • quantum defect • bioconjugation • 
nanobody • peptide  
[1] S. Iijima, Nature 1991, 354, 56–58. 
[2] S. Kruss, A. J. Hilmer, J. Zhang, N. F. Reuel, Bin Mu, M. S. Strano, 
Adv. Drug Deliv. Rev. 2013, 65, 1933–1950. 
[3] M. J. O'Connell, S. M. Bachilo, C. B. Huffman, V. C. Moore, M. S. 
Strano, E. H. Haroz, K. L. Rialon, P. J. Boul, W. H. Noon, C. Kittrell, 
et al., Science 2002, 297, 593–596. 
[4] S. M. Bachilo, M. S. Strano, C. Kittrell, R. H. Hauge, R. E. Smalley, 
R. B. Weisman, Science 2002, 298, 2361–2366. 
[5] C. Farrera, F. Torres Andón, N. Feliu, ACS Nano 2017, 11, 10637–
10643. 
[6] K. Welsher, Z. Liu, S. P. Sherlock, J. T. Robinson, Z. Chen, D. 
Daranciang, H. Dai, Nat. Nanotechnol. 2009, 4, 773–780. 
[7] Z. Liu, S. M. Tabakman, Z. Chen, H. Dai, Nat. Protoc. 2009, 4, 
1372–1381. 
[8] T. V. Galassi, P. V. Jena, J. Shah, G. Ao, E. Molitor, Y. Bram, A. 
Frankel, J. Park, J. Jessurun, D. S. Ory, et al., Sci. Transl. Med. 
2018, 10, eaar2680. 
[9] G. Pastorin, Pharm. Res. 2009, 26, 746–769. 
[10] H. Huang, Q. Yuan, J. S. Shah, R. D. K. Misra, Adv. Drug Deliv. 
Rev. 2011, 63, 1332–1339. 
[11] P. W. Barone, R. S. Parker, M. S. Strano, Anal. Chem. 2005, 77, 
7556–7562. 
[12] A. J. Gillen, A. A. Boghossian, Front. Chem. 2019, 7, 13793–13. 
[13] F. A. Mann, Z. Lv, J. Grosshans, F. Opazo, S. Kruss, Angew. 
Chem. Int. Ed. 2019, 58, 11469–11473. 
[14] F. A. Mann, N. Herrmann, D. Meyer, S. Kruss, Sensors (Basel) 
2017, 17, 1521. 
[15] M. Dinarvand, E. Neubert, D. Meyer, G. Selvaggio, F. A. Mann, L. 
Erpenbeck, S. Kruss, Nano Lett. 2019, 19, 6604–6611. 
[16] S. Kruss, D. P. Salem, L. Vuković, B. Lima, E. Vander Ende, E. S. 
Boyden, M. S. Strano, Proc. Natl. Acad. Sci. 2017, 114, 1789–
1794. 
[17] S. Kruss, M. P. Landry, E. Vander Ende, B. M. A. Lima, N. F. Reuel, 
J. Zhang, J. Nelson, B. Mu, A. Hilmer, M. Strano, J. Am. Chem. 
Soc. 2014, 136, 713–724. 
[18] H. Wu, R. Nißler, V. Morris, N. Herrmann, P. Hu, S.-J. Jeon, S. 
Kruss, J. P. Giraldo, Nano Lett. 2020, acs.nanolett.9b05159–28. 
[19] G. Bisker, J. Dong, H. D. Park, N. M. Iverson, J. Ahn, J. T. Nelson, 
M. P. Landry, S. Kruss, M. S. Strano, Nat. Commun. 2016, 7, 
10241. 
[20] R. M. Williams, C. Lee, T. V. Galassi, J. D. Harvey, R. Leicher, M. 
Sirenko, M. A. Dorso, J. Shah, N. Olvera, F. Dao, et al., Sci. Adv. 
2018, 4. 
[21] M. Zheng, A. Jagota, M. S. Strano, A. P. Santos, P. Barone, S. G. 
Chou, B. A. Diner, M. S. Dresselhaus, R. S. Mclean, G. B. Onoa, 
et al., Science 2003, 302, 1545–1548. 
[22] R. Nißler, F. A. Mann, P. Chaturvedi, J. Horlebein, D. Meyer, L. 
Vuković, S. Kruss, J. Phys. Chem. C 2019, 123, 4837–4847. 
[23] A. J. Gillen, J. Kupis-Rozmysłowicz, C. Gigli, N. Schuergers, A. A. 
Boghossian, J. Phys. Chem. Lett. 2018, 9, 4336–4343. 
[24] E. Polo, S. Kruss, J. Phys. Chem. C 2016, 120, 3061–3070. 
[25] A. Hirsch, Angew. Chem. Int. Ed. Engl. 2002, 41, 1853–9. 
[26] A. Setaro, M. Adeli, M. Glaeske, D. Przyrembel, T. Bisswanger, G. 
Gordeev, F. Maschietto, A. Faghani, B. Paulus, M. Weinelt, et al., 
Nat. Commun. 2017, 8, 838–7. 
[27] A. G. Godin, A. Setaro, M. Gandil, R. Haag, M. Adeli, S. Reich, L. 
Cognet, Sci. Adv. 2019, 5, eaax1166. 
[28] L. Chio, R. L. Pinals, A. Murali, N. S. Goh, M. P. Landry, Adv. 
Funct. Mater. 2020, 1910556–8. 
[29] S. Ghosh, S. M. Bachilo, R. A. Simonette, K. M. Beckingham, R. 
B. Weisman, Science 2010, 330, 1656–1659. 
[30] Y. M. Piao, B. Meany, L. R. Powell, N. Valley, H. Kwon, G. C. 
Schatz, Y. H. Wang, Nat. Chem. 2013, 5, 840–845. 
[31] F. J. Berger, J. Lüttgens, T. Nowack, T. Kutsch, S. Lindenthal, L. 
Kistner, C. C. Müller, L. M. Bongartz, V. A. Lumsargis, Y. Zakharko, 
et al., ACS Nano 2019, 13, 9259–9269. 
[32] H. Kwon, M. Furmanchuk, M. Kim, B. Meany, Y. Guo, G. C. Schatz, 
Y. Wang, J. Am. Chem. Soc. 2016, 138, 6878–6885. 
[33] Y. Miyauchi, M. Iwamura, S. Mouri, T. Kawazoe, M. Ohtsu, K. 
Matsuda, Nat. Photonics 2013, 7, 715–719. 
[34] M. Kim, X. Wu, G. Ao, X. He, H. Kwon, N. F. Hartmann, M. Zheng, 
S. K. Doom, Y. Wang, Chem 2018, 4, 2180–2191. 112
COMMUNICATION          
6 
 
[35] C. F. Chiu, W. A. Saidi, V. E. Kagan, A. Star, J. Am. Chem. Soc. 
2017, 139, 4859–4865. 
[36] P. Clement, P. Trinchera, K. Cervantes Salguero, Q. Ye, C. R. 
Jones, M. Palma, ChemPlusChem 2019, 84, 1235–1238. 
[37] H. Kwon, M. Kim, B. Meany, Y. Piao, L. R. Powell, Y. Wang, J. 
Phys. Chem. C 2015, 119, 3733–3739. 
[38] T. Shiraki, H. Onitsuka, T. Shiraishi, N. Nakashima, Chem. 
Commun. 2016, 52, 12972–12975. 
[39] N. Danné, M. Kim, A. G. Godin, H. Kwon, Z. Gao, X. Wu, N. F. 
Hartmann, S. K. Doorn, B. Lounis, Y. Wang, et al., ACS Nano 
2018, 12, 6059–6065. 
[40] X. He, H. Htoon, S. K. Doorn, W. H. P. Pernice, F. Pyatkov, R. 
Krupke, A. Jeantet, Y. Chassagneux, C. Voisin, Nat. Mater. 2018, 
17, 663–670. 
[41] X. He, N. F. Hartmann, X. Ma, Y. Kim, R. Ihly, J. L. Blackburn, W. 
Gao, J. Kono, Y. Yomogida, A. Hirano, et al., Nat. Photonics 2017, 
11, 577–. 
[42] A. K. Mandal, X. Wu, J. S. Ferreira, M. Kim, L. R. Powell, H. Kwon, 
L. Groc, Y. Wang, L. Cognet, bioRxiv 2019, 636860. 
[43] C.-W. Lin, S. M. Bachilo, Y. Zheng, U. Tsedev, S. Huang, R. B. 
Weisman, A. M. Belcher, Nat. Commun. 2019, 1–9. 
[44] A. H. Brozena, M. Kim, L. R. Powell, Y. Wang, Nat. Rev. Chem. 
2019, 3, 375–392. 
[45] J. Helma, M. C. Cardoso, S. Muyldermans, H. Leonhardt, J. Cell 
Biol. 2015, 209, 633–644. 
[46] C. Hamers-Casterman, T. Atarhouch, S. Muyldermans, G. 
Robinson, C. Hammers, E. B. Songa, N. Bendahman, R. 
Hammers, Nature 1993, 363, 446–448. 
[47] J. Ries, C. Kaplan, E. Platonova, H. Eghlidi, H. Ewers, Nat. 
Methods 2012, 9, 582–584. 
[48] M. Mikhaylova, B. M. C. Cloin, K. Finan, R. Van Den Berg, J. 
Teeuw, M. M. Kijanka, M. Sokolowski, E. A. Katrukha, M. Maidorn, 
F. Opazo, et al., Nat. Commun. 2015, 6, 1–7. 
[49] S. Sograte-Idrissi, N. Oleksiievets, S. Isbaner, M. Eggert-Martinez, 
J. Enderlein, R. Tsukanov, F. Opazo, Cells 2019, 8, 48–13. 
[50] H. D. Herce, D. Schumacher, A. F. L. Schneider, A. K. Ludwig, F. 
A. Mann, M. Fillies, M.-A. Kasper, S. Reinke, E. Krause, H. 
Leonhardt, et al., Nat. Chem. 2017, 9, 762–771. 
[51] S. Kabatas, P. Agüi-Gonzalez, K. A. Saal, S. Jähne, F. Opazo, S. 
O. Rizzoli, N. T. N. Phan, Angew. Chem. Int. Ed. 2019, 58, 3438–
3443. 
[52] J. M. J. M. Ravasco, H. Faustino, A. Trindade, P. M. P. Gois, 
Chem. Eur. J. 2018, 25, 43–59. 
[53] G. Grigoryan, Y. H. Kim, R. Acharya, K. Axelrod, R. M. Jain, L. 
Willis, M. Drndic, J. M. Kikkawa, W. F. DeGrado, Science 2011, 
332, 1071–1076. 
[54] F. A. Mann, J. Horlebein, N. F. Meyer, D. Meyer, F. Thomas, S. 
Kruss, Chem. Eur. J. 2018, 24, 12241–12245. 
[55] G. R. Dieckmann, A. B. Dalton, P. A. Johnson, J. Razal, J. Chen, 
G. M. Giordano, E. Muñoz, I. H. Musselman, R. H. Baughman, R. 
K. Draper, J. Am. Chem. Soc. 2003, 125, 1770–1777. 
[56] E. Polo, T. T. Nitka, E. Neubert, L. Erpenbeck, L. Vuković, S. 
Kruss, ACS Appl. Mater. Interfaces 2018, 10, 17693–17703. 
[57] A. Bianco, K. Kostarelos, C. D. Partidos, M. Prato, Chem. 
Commun. 2005, 14, 571–7. 
[58] D. Pantarotto, C. D. Partidos, R. Graff, J. Hoebeke, J.-P. Briand, 
M. Prato, A. Bianco, J. Am. Chem. Soc. 2003, 125, 6160–6164. 
[59] R. Haggenmueller, S. S. Rahatekar, J. A. Fagan, J. Chun, M. L. 
Becker, R. R. Naik, T. Krauss, L. Carlson, J. F. Kadla, P. C. 
Trulove, et al., Langmuir 2008, 24, 5070–5078. 
[60] T. Shiraki, Y. Niidome, F. Toshimitsu, T. Shiraishi, T. Shiga, B. Yu, 
T. Fujigaya, Chem. Commun. 2019, 55, 3662–3665. 
[61] D. A. Heller, G. W. Pratt, J. Zhang, N. Nair, A. J. Hansborough, A. 
A. Boghossian, N. F. Reuel, P. W. Barone, M. S. Strano, Proc. Natl. 
Acad. Sci. 2011, 108, 8544–8549. 
[62] M. Gravely, M. M. Safaee, D. Roxbury, Nano Lett. 2019, DOI 
10.1021/acs.nanolett.9b02267. 
[63] D. Meyer, S. Telele, A. Zelená, A. J. Gillen, A. Antonucci, E. 
Neubert, R. Nißler, F. A. Mann, L. Erpenbeck, A. A. Boghossian, 
et al., Nanoscale 2020, 2, 751. 
  
113




Entry for the Table of Contents 
 
 
Quantum defects as multifunctional handles for the covalent decoration of carbon nanotubes. Here, we incorporate two new 
quantum defects into single-walled carbon nanotubes (SWCNT) carrying anchor groups for functionalization with biomolecules. We 
demonstrate the potential and versatility of this approach by the conjugation of a GFP-binding nanobody as well as the growth of 
(fluorescent) peptide chains directly on the nanotube’s carbon lattice. 
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Abstract: Single-walled carbon nanotubes (SWCNT) are a 1D nanomaterial that shows fluorescence in the near-infrared (NIR, > 800 nm). In 
the past, covalent chemistry was less explored to functionalize SWCNTs as it impairs NIR emission. However, certain sp3 defects (quantum 
defects) in the carbon lattice have emerged that preserve NIR fluorescence and even introduce a new, red-shifted emission peak. Here, we 
report on quantum defects, introduced using light-driven diazonium chemistry, that serve as anchor points for peptides and proteins. We show 
that maleimide anchors allow conjugation of cysteine-containing proteins such as a GFP-binding nanobody. In addition, a Fmoc protected 
phenylalanine defect serves as a starting point for conjugation of visible fluorophores to create multicolor SWCNTs and in situ peptide synthesis 
directly on the nanotube. Therefore, these quantum defects are a versatile platform to tailor both the nanotube’s photophysical properties as 
well as their surface chemistry. 
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1. Experimental Procedures 
1.1. General Information 
NMR spectra were recorded with a BrukerTM Avance III HD 300 device	(Bruker Corp., USA), equipped with a 5 mm probe. For a 
measurement, approx. 15 mg of substance were dissolved in approx. 600 μL of the deuterated solvent stated and transferred to 
a standard glass NMR tube (d = 5 mm). The chemical shifts are reported in ppm relative to the residual solvent peak(s). Analysis 
was performed within MestReNovaTM 10.  
 
ESI-TOF-MS measurements of diazonium salts were performed on a BrukerTM micrOTOF ESI-TOF-MS using the non-deuterated 
form of the solvent also used for NMR measurements.  
 
VIS-fluorescence spectra were acquired between 500 and 600 nm using an excitation wavelength of 490 nm on a FluoroMax-4 
spectrofluorometer (Horiba Scientific, Japan).  
 
Reagents and solvents were, unless stated otherwise, of synthesis grade quality and used without further purification. Fmoc-
protected amino acids were purchased either from IRIS Biotech (Germany) or Novabiochem (Germany).  
 
(6,5)-chirality enriched single-walled carbon nanotubes (SWCNTs, Product No.: 773735) were acquired from Sigma Aldrich 
(Darmstadt, Germany). 
 
SWCNT/SDBS stock solutions were generated by tip sonication of a SWCNT/SDBS (1%) suspension for 15 minutes (Fisher 
Scientific™ Model 120 Sonic Dismembrator, 30% amplitude, 36 W) followed by centrifugation (2x, 16100g). Only the supernatant 
(top 80%) was used for further studies. 
 
Experiments and measurements were, unless otherwise stated, performed in phosphate buffered saline (PBS, 8.2 mM 
Na2HPO4, 1.8 mM K2HPO4, 137 mM NaCl, 2.7 mM KCl, pH 7.4). 
 
Protein concentrations were determined via absorbance measurements at 280 nm with a NanoDrop 2000TM spectrophotometer 
(ThermoFisher Scientific Inc., USA) using the extinction coefficient of the respective protein at 280 nm. The mean value of at least 
three independent measurements was taken for concentration calculation.  
 
VIS/NIR absorbance spectroscopy was conducted  on a JASCO V-670 (Spectra Manager Software) using a 10 mm-path cuvette. 
Spectra were acquired using a scan speed of 1000 nm·min-1, a data interval of 0.5 nm and a UV/vis and nIR bandwidth of 2 nm 
and 4 nm, respectively.  
SWCNT concentration was estimated using the maximal absorbance at approx. 990 nm using the molar extinction coefficient 
determined by Schöppler et al.[1] 
 
NIR fluorescence spectroscopy was conducted in glass-bottom 96-well plates via excitation at 561 nm using a gem-561 laser 
(LaserQuantumTM, Germany) at 100 mW excitation power and fluorescence spectra were recorded in the range between 850 and 
1250 nm using a Shamrock 193i spectrograph (Andor Technology Ltd., Belfast, Northern Ireland) coupled to an Olympus IX73 
microscope and an exposure time of 1 s, a slit width of 500 µm and an Andor iDus InGaAs 491 array NIR detector 
 
2D-excitation-emission maps were recorded in glass-bottom 96-well plates via excitation between 400 and 800 nm using a 
300 W Xe-lamp guided through a monochromator (LOT, Germany) and detection between 850 and 1250 nm using a Shamrock 
193i spectrograph (Andor Technology Ltd., Belfast, Northern Ireland) coupled to an Olympus IX73 microscope and an exposure 
time of 5 s, a slit width of 500 µm and an Andor iDus InGaAs 491 array NIR detector. 
 
Atomic Force Microscopy (AFM) was conducted in intermittent-contact mode (scan rate = 0.5 Hz, 512 lines) using an Asylum 
Research MFP-3D InfinityÒ instrument equipped with rectangular cantilevers (Opus, MikroMasch Europe, Al-coating, tetrahedral 
tip, nres = 300 kHz, k = 26 N·m-1). Freshly cleaved muscovite mica was incubated with a poly-L-lysine (PLL, 0.1 mg·mL-1, 10 min) 
solution. After washing with MilliQ water, the coated mica was incubated with 10 µL of the sample solution for another 10 minutes 
followed by repeated washing of the surface with MilliQ water and drying using a N2-stream before sample measurement. 
Analysis of the acquired images was performed via the open-source software Gwyddion. 
 
VIS-NIR-fluorescence microscopy was carried out under 561 nm-laser excitation (Cobolt Jive laser, Cobolt AB, Solna, Sweden, 
Pmax. = 500 mW) on an Olympus IX53 microscope equipped with a 100x oil-immersion objective (Olympus 100x UPLSAPO 100XS, 
NA = 1.35). Detection of the near-infrared photoluminescence was carried using a Xenics Cheetah-640-TE3 NIR camera (Xenics, 117
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Heverlee, Belgium), while the VIS-fluorescence was detected with an Andor Zyla 5.5 sCMOS camera (Andor Technology Ltd., 
Belfast, Northern Ireland).  
 
 
1.2. Chemical synthesis 
1.2.1. 4-(N-maleimido)phenyldiazonium tetrafluoroborate (2) 
4-(N-Maleimido)phenyldiazonium tetrafluoroborate was synthesized using an optimized procedure based on the general 
procedure given in [2]. In a glass snap-cap vial, 4-(N-aminophenyl)maleimide (95.1 mg, 505 μmol, 1.0 eq.) was dissolved in 
ethanol (500 μL). Tetrafluoroboronic acid (50% aqueous solution, 125 μL, 175 mg, 996 μmol, 2.0 eq.) was added and the resulting 
red suspension was cooled to 0 °C in an ice/water bath. Under magnetic stirring, tert-butyl nitrite (135 μL, 117 mg, 1.13 mmol, 
2.2 eq.) was added dropwise via syringe. The resulting greyish suspension was stirred for 1 h at room temperature. Diethyl ether 
(1 mL) was added and the resulting grey suspension was transferred to a polypropylene vial and centrifuged (2 min at 16100 g). 
The yellow supernatant was decanted off and the remaining solid was suspended in diethyl ether (1 mL). The centrifugation-
decantation-suspension washing cycle was repeated three times before the resulting solid was dried under reduced pressure at 
room temperature to yield a slightly yellow solid.  
While standard precautions were taken during synthesis and handling of the herein presented diazonium salts, no decomposition 
was observed even over several weeks. 
 
1H-NMR (300 MHz, CD3CN): d (ppm) = 8.54-8.60 (m, 2H, H2,6), 8.09-8.15 (m, 2H, H3,5), 7.08 (s, 2H, Hmaleimide). 
 
11B-NMR (96 MHz, CD3CN): d (ppm) = −1.16 (s). 
 
19F-NMR (282 MHz, CD3CN): d (ppm) = −151.48 (s), −151.54 (s) (two signals due to the two NMR-active boron isotopomers). 
 
13C-NMR (75 MHz, CD3CN): d (ppm) = 169.4, 144.8, 136.5, 134.7, 127.4, 111.2. 
 
The NMR data is in good agreement with literature data. [3] 
 
HRMS (ESI (pos.) [m/z]): calculated (C10H6N3O2 [M+]): 200.0455, found: 200.0448; calculated (C10H6NO2 [M-N2]+): 172.0393, 
found: 172.0389; (C11H10NO3 [M-N2+MeOH]+): 204.0645, found: 204.0655. 
 Fmoc-L-4-diazonium-phenylalanine tetrafluoroborate (6) 
 
Fmoc-L-4-diazonium-phenylalanine tetrafluoroborate was synthesized using an optimized procedure based on the general 
procedure given in [2]. Fmoc-L-4-aminophenylalanine (0.2 g, 0.497 mmol) was dissolved in 500 µL ethanol in a 5 mL glass 
scintillation vial. Next, approx. 125 µL HBF4 (50% aqueous, ) were added dropwise. The solution was placed in an ice bath and 
stirred constantly while 135 µL tBu-ONO (2 eq., 1.1 mmol, 117 mg) were added dropwise over the course of 30 min. Next, the 
solution was stirred for two hours at rt. After the reaction was completed, a white/slightly yellow precipitate was observed and 
transferred to a 2 mL Eppendorf tube using 1 mL diethyl ether. The precipitate was centrifuged at 16100g for five minutes and the 













2 eq. tBuONO, HBF4 (50% aq.)
(EtOH)
0°C      RT, 2h
118
SUPPORTING INFORMATION          
5 
 
While standard precautions were taken during synthesis and handling of the herein presented diazonium salts, no decomposition 
was observed even over several weeks. 
 
1H-NMR (300 MHz, CD3CN): d (ppm) = 8.35 (d, J = 8.5 Hz, 2H), 7.84 (d, J = 7.5 Hz, 2H), 7.76 (d, J = 8.4 Hz, 2H), 7.61 (dd, 
J = 7.5, 4.6 Hz, 2H), 7.43 (t, J = 7.5 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 6.13 (d, J = 8.7 Hz, 1H), 4.53 (s, 1H), 4.30 (d, J = 6.2 Hz, 
2H), 4.18 (t, J = 6.8 Hz, 1H), 3.50 – 3.41 (m, 1H), 3.27 – 3.16 (m, 1H). 
 
11B-NMR (96 MHz, CD3CN): d (ppm) = −1.15 (s). 
 
19F-NMR (282 MHz, CD3CN): d (ppm) = −151.47 (s), −151.53 (s) (two signals due to the two NMR-active boron isotopomers). 
 
HRMS (ESI (pos.) [m/z]): calculated (C24H21NO4 [M-N2]+): 386.1392, found: 386.1387. 
 
1.3. Carbon nanotube reactions 
1.3.1. Synthesis of SWCNT*-Ph-Mal (3) 
A (6,5)-chirality enriched SWCNT solution (1, 180 μL of a 10 nmol L−1 solution in 1% SDBS) was mixed with an aqueous 
solution of 4-(N-maleimido)phenyldiazonium tetrafluoroborate (2, 20 μL, 1 mmol L−1)  and irradiated in a 96-well plate using a 
LumidoxTM (Analytical Sales & Services, Inc., Flanders, NJ, USA) 96 green LED array with an LED current of 25 mA. After 
reaction control using nIR fluorescence spectroscopy, the reaction mixtures were transferred to spin filters (VivaspinTM 500, 
MWCO = 100 kDa, v = 500 μL, Sartorius, Göttingen, Germany) and centrifuged (12000 g, RT, final volume = approx. 50 μL). 
The SWCNT* precipitated on the filter’s membrane were washed with water (5× 450 μL), each time followed by a 
centrifugation step, and finally resuspended in a solution of the chosen surfactant (either 1% SDBS or 2 mg/mL 1,2-distearoyl-
sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-5000] (ammonium salt) [PL-PEG5000])  by scraping off 
the filter and repeated pipetting. For redispersion, those suspensions were tip-sonicated (30% amplitude, 36 W, 5 min, 0 °C), 
centrifuged (16100g, 30 min) and the supernatant used for further studies. 
1.3.2. Synthesis of SWCNT*-Ph-GBP (5) 
1.3.2.1. Sequential reaction 
A (6,5)-chirality enriched SWCNT solution (1, 180 μL of a 10 nmol L−1 solution in 1% SDBS) was mixed with an 
aqueous solution of 4-(N-maleimido)phenyldiazonium tetrafluoroborate (2, 20 μL, 1 mmol L−1) and 6.4 µL of a 156 µM 
GBP-Nanobody (4, previously reduced on ice using TCEP [5 mM] for 30 minutes) solution in a 96-well plate. The 
mixed solution was irradiated using a LumidoxTM (Analytical Sales & Services, Inc., Flanders, NJ, USA) 96 green LED 
array with an LED current of 25 mA for 15 minutes followed by removal of the excess MalPh-Dz 2 using spin-filtration 
(300 kDa MWCO) and subsequent resuspension of the MalPh-SWCNT* 3 in 1x phosphate-buffered saline (PBS, pH 
7.4). 500 eq. (~25 eq. with respect to introduced maleimides) of the nanobody 4 were added and the solution left 
shaking gently for 16 hours at room temperature. To remove excess unreacted nanobody, 300 kDa-MWCO spin 
filtration was carried out (5x washing with 1x PBS) followed by redispersion using PL-PEG5000 (2 mg·mL-1).  
1.3.2.2. One-step reaction 
A (6,5)-chirality enriched SWCNT solution (1, 180 μL of a 10 nmol L−1 solution in 1% SDBS) was mixed with an aqueous 
solution of 4-(N-maleimido)phenyldiazonium tetrafluoroborate (2, 20 μL, 1 mmol L−1) and 6.4 µL of a 156 µM GBP-
Nanobody (4, previously reduced on ice using TCEP [5 mM] for 30 minutes) solution in a 96-well plate. The mixed 
solution was irradiated using a LumidoxTM (Analytical Sales & Services, Inc., Flanders, NJ, USA) 96 green LED array 
with an LED current of 25 mA for 30 minutes and subsequently transferred to a microcentrifuge tube and left shaking 
gently for 15 hours at room temperature. To remove excess unreacted nanobody, 300 kDa-MWCO spin filtration was 
carried out (5x washing with 1x PBS) followed by redispersion using PL-PEG5000 (2 mg·mL-1).  
1.3.3. Synthesis of SWCNT*-Phe-Fmoc (7) 
To generate a SWCNT-SDBS dispersion (1% SDBS), 500 µL of an aqueous 2% SDBS solution were added to 500 µL of a 
2 mg/mL SWCNT/water suspension. This solution was tip-sonicated for 15 minutes (Fisher Scientific™ Model 120 Sonic 
Dismembrator, 30% amplitude, 36 W) followed by centrifugation (2x, 16100g) and only the supernatant (top 80%) used for 
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further studies. In the next step, the supernatant was diluted using 1%SDBS to yield a 10 nM solution (1, see SWCNT 
concentration determination, section 1.1). In a 96well-plate, 180 µL of this solution were added to 15 wells followed by the 
addition of different concentrations of Fmoc-Phe-N2+BF4- (6, 0 nM-100 µM). After careful mixing via repeating pipetting, the 
solutions were irradiated using a green 96-LED-array irradiator (LumidoxTM, Analytical Sales & Services, Inc., Flanders, NJ, 
USA) at 25 mA for 15 minutes to yield solutions of 7. The solutions were analyzed by nIR fluorescence spectroscopy for the 
degree of defect-introduction. The excess diazonium salt 6 was removed via repeated 300kDa-cut-off spin filtration (5x 600 µL 
ddH2O washing) and the remaining SWCNT* were resuspended in 500 µL ddH2O. In the last step, supernatant and pellet 
were then separated by centrifugation (16100g, 15 minutes) and the pellet containing SWCNT*-Phe-Fmoc 7 was used for 
downstream experiments. 
1.3.4. Synthesis of SWCNT*-Phe-5(6)-CF (10) 
The solutions of three wells from the Fmoc-Phe defect introduction process (v = 600 µL, approx. 5.4 pmol SWCNT*-Phe-
Fmoc 7) were added to a frit (20 µm pore size)-equipped syringe reactor (v = 2 mL), mixed with 1 mL EtOH for SWCNT 
precipitation and subsequent washing and removal of residual SDBS surfactant and excess Fmoc-Phe-Dz (5x 1 mL dH2O, 
3x DMF, 3x DCM, 3x DMF). Deprotection of the Fmoc-group was achieved via incubation with 200 µL of 20% 
piperidine/dimethylformamide (DMF, 2x 15 min). Excess reagents were removed by repeated washing with 
DMF/dichloromethane (DCM)/DMF (3x 1 mL).  Subsequent amide coupling to 5(6)-carboxyfluorescein (CF) was carried out 
in the dark for 30 minutes at room temperature after the addition of 1.88 mg 5(6)-CF (5 µmol), 1.9 mg HATU (5 µmol) and 
1.74 µL N,N-Diisopropylethylamine (DIPEA, 10 µmol) in 50 µL DMF. Excess reagents were removed by repeated washing 
with DMF/DCM/DMF (3x 1 mL). The crude product 10 was scraped off the frit using 50 µL DMF, transferred to a 1.5 mL 
microcentrifuge tube and centrifuged at 16100 g (15 min). The pellet was resuspended in 100 µL of a 1% SDBS solution and 
ultrasonicated (3 min, RT, 30% amplitude) followed by centrifugation (15 min, 16100g) and separation of pellet and 
supernatant. The latter was used for fluorescence microscopy and spectroscopy applications.  
1.3.3 Synthesis of SWCNT*-Phe-R6-CF (11) 
The solutions of 20 wells from the Fmoc-Phe defect introduction process (v = 4 mL, approx. 36 pmol SWCNT*-Phe-Fmoc 7) 
were pooled, mixed with 6 mL EtOH for SWCNT precipitation in a glass vial and the suspension subsequently transferred to 
a frit (20 µm pore size)-equipped syringe reactor (v = 2 mL). Residual SDBS surfactant and excess Fmoc-Phe-Dz were 
removed via washing (5x 1 mL dH2O, 3x DMF, 3x DCM, 3x DMF). Deprotection of the Fmoc-group was achieved via 
incubation with 200 µL of 20% piperidine/DMF (2x 15 min). Fmoc-based solid-phase peptide synthesis (SPPS) couplings to 
Fmoc-Arg(Pbf)-OH (11.7 mg, 18 µmol) and 5(6)-CF (6.8 mg, 18 µmol) were carried out for 30 minutes at room temperature 
with 6.8 mg 1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU, 
18 µmol) and 6.3 µL DIPEA (36 µmol)  in 100 µL DMF. Excess reagents were removed by repeated washing with 
DMF/DCM/DMF (3x 1 mL). After 5(6)-CF coupling and washing, the side-chain protecting groups ((2,2,4,6,7-
pentamethyldihydrobenzofuran-5-sulfonyl), Pbf) were cleaved upon gentle shaking with the cleavage cocktail (75% TFA/20% 
DCM/2.5% H2O/2.5% TIS, vtotal = 500 µL) for one hour. Subsequently, the crude product 5 was washed again with DMF and 
10x DCM and then scraped off the frit using 100 µL H2O, transferred to a 1.5 mL microcentrifuge tube and stored in the dark 
at 4°C. For fluorescence microscopy and spectroscopy applications, the product 11 in 100 µL H2O was submitted to 
ultrasonication (5 min, 30% amp, 4°C) followed by separation of supernatant and pellet by centrifugation (16100g, 30 min). 
The supernatant was used for fluorescence microscopy and spectroscopy applications. 
1.3.4 96-well synthesis of SWCNT*-Peptides 
Approx. 30 pmol SWCNT*-Phe-Fmoc (c = 10 nM, V = 3 mL) were added to and filtered through individual wells of a 96-well 
plate equipped with 0.2 µm pore size filters (Chromafil Multi 96 plate with PTFE filters, Macherey-Nagel, Germany). The 
samples were washed (with 5x H2O, 3x DMF, 3x DCM, 3x DMF)) followed by standard Fmoc/OtBu SPPS (2x15min Fmoc 
deprotection [20% Piperidine/DMF], 30min amino acid coupling [13.5 µmol amino acid/HATU, 27 µmol DIPEA]) and final 
deprotection of side-chain protecting groups using the deprotection cocktail (375 µL TFA, 100 µL DCM, 12.5 µL TIS, 12.5 µL 
H2O, 60 min). All steps were carried out under mild agitation of the 96-well plate on a shaker (150 rpm). After final deprotection, 
the SWCNT samples were again washed (using 3xDCM, 3xDMF, 10xDCM) and then resuspended using 600 µL H2O and 
transferred to 1.5 mL centrifuge tubes. Next, the samples were spun down (16100g, 30 min), resuspended in 200 µL 1% 
sodium deoxycholate (DOC) solution and submitted to tip-sonication (5 min, 4°C, 30% amplitude). After centrifugation, the 
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The following Fmoc-protected amino acids were used: 
 
Fmoc-Asn(Trt)-OH Fmoc-Gly-OH Fmoc-Tyr(tBu)-OH Fmoc-Asp(OtBu)-OH 
Fmoc-His(Trt)-OH Fmoc-Gln(Trt)-OH Fmoc-Ser(tBu)-OH Fmoc-Glu(OtBu)-OH 
Fmoc-Leu-OH Fmoc-Lys(Boc)-OH Fmoc-Val-OH Fmoc-Phe-OH 
Fmoc-Ile-OH Fmoc-Ala-OH Fmoc-Thr(tBu)-OH  
 
1.4 In vitro GFP-binding assay 
Based on a previously created silicon master, patterned PDMS stamps were created. Next, a 2 µM GFP solution was added to 
the stamp, incubated for 10 minutes and the stamp subsequently rinsed with 1x PBS. In the next step, the PDMS stamp was 
transferred to a glass-bottom 96well-plate (previously coated with poly-L-lysine [0.1 mg mL-1, 10 min] and incubated for 30 minutes 
followed by washing (1xPBS, 0.3% TritonX100, 3x). In the next step, the GFP-modified surface was passivated using a 
5% w/v BSA solution (15 min) and subsequently washed again (1xPBS, 0.3% TritonX100, 3x). Finally, the conjugate 5 and its 
corresponding controls were added to the wells and incubated for 30 minutes, followed again by washing (1xPBS, 0.3% TritonX100, 
3x) and addition of 200 µL of 1x PBS before imaging.   
1.5 VIS/NIR fluorescence microscopy of SWCNT*-F-CF, SWCNT*-F-R6-CF and the 
corresponding controls 
Each 5 µL of the respective solutions were immobilized on a glass-coverslip via spin-coating (RT, 1000 rpm). Mounted on a glass-
cover-slide, CF/nIR imaging was carried out on an Olympus IX53 microscope with a 100x oil-immersion objective (Olympus 
100x UPLSAPO 100XS, NA=1.35) using 561 nm excitation by a Cobolt Jive™ laser (Cobolt AB, Solna, Sweden, 200 mW). CF 
fluorophores were excited by a xCite 120Q lamp (Excelitas Technologies, USA) using the lowest intensity/iris step. Detection of 
the near-infrared photoluminescence was carried using a XenicsÒ Cheetah SWIR camera (Xenics, Heverlee, Belgium, tint = 1 s), 
whereas CF fluorescence was observed by an Andor Zyla 5.5 sCMOS camera (Andor Technology Ltd., Belfast, Northern Ireland, 
tint = 0.1 s). Image overlay was conducted using a custom Python script.  
 
1.6 VIS-fluorescence spectroscopy of SWCNT*-F-CF  








2. Results and Discussion 
 
Figure S1. Evolution of the E11* emission peak over time when irradiated with a green 96-LED-array and different concentrations of MalPh diazonium salt 2 (n = 3, 
mean ± SD). The defect introduction was carried out in triplicates for each MalPh-Dz concentration in a 96-well plate following the procedure described in section 
1.3.1. At the indicated time points (2, 5, 10, 15, 30 minutes) 30 µL aliquots were taken for NIR fluorescence measurement (see section 1.1).  
 
 
Figure S2. VIS/NIR absorbance spectroscopy of SDBS-dispersed SWCNTs before and after introduction of MalPh quantum defects [0, 10 and 100 µM MalPh-Dz 
2 concentration].  










































Figure S3. Excitation-emission map (2D spectrum) of SDBS-dispersed SWCNTs before introduction of MalPh quantum defects showing a major emission peak at 
approx. 1000 nm. 
 
Figure S4. VIS/NIR absorbance spectroscopy of SWCNT*-GBP and the SWCNT/GBP control (comparing the sequential and the one-pot reaction) after removal of 
excess GBP using spin-filtration and redispersion in PL-PEG5000 of both positive and negative control of the GBP conjugation to SWCNTs. In contrast to the one-
pot reaction (grey lines), redispersion of the samples originating from the sequential reactions did not lead to well-dispersed samples. The samples were prepared 
according to the procedures described in section 1.3.2 (for both controls without the addition of the MalPh diazonium salt and consequently without sp3 defects).  
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Figure S5. A) Representative atomic force microscopy image of a control SWCNT after following the same reaction steps as for conjugate 5 (one-step reaction, 
details see section 1.3.2.2) yet without the addition of MalPh-Dz 2 showing no conjugation of the nanobody. B) Measured heights of SWCNTs from the same control 
sample (mean ± SD, n = 24). 
 
Figure S6. X-ray structure of a GFP-Minimizer nanobody (PDB: 3G9A) and distance measurements. 
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Figure S7. Control VIS/NIR fluorescence experiment with a microcontact-printed GFP-pattern incubated with MalPh-SWCNT* following the same procedure as 
described in section 1.4. The absence of colocalization in this experiment shows the importance of the nanobody for GFP-binding and rules out binding as a result 
from possibly unoccupied und unhydrolyzed MalPh groups on the SWCNT surface, that could be captured by GFP’s thiols. Scale bars = 5 µm. The three columns 
are technical replicates.  
 
Figure S8. Excitation-emission map (2D spectrum) of a SWCNT/SDBS sample illuminated with green light for 15 minutes following the same procedure as for the 
synthesis of 7 (see section 1.3.3), but without the addition of Fmoc-Phe diazonium salt 6. 
 
 
Figure S9. VIS/NIR fluorescence microscopy control experiment showing SWCNT*-F-Fmoc, that were treated using the same procedure as for the synthesis of 10 
(see section 1.3.4) including the 5(6)-carboxyfluorescein coupling reaction, but without the Fmoc deprotection using 20% piperidine/DMF. After washing (see 1.3.4), 
they were immobilized on a glass surface and imaged. While they still show NIR fluorescence, no 5(6)-CF fluorescence can be observed and consequently no 








Figure S10. VIS/NIR fluorescence microscopy control experiment showing the SWCNT-R6-CF control (without the addition of diazonium salt 6 and thus without F-
Fmoc defects) after centrifugation and spin-coating on a glass coverslip showing neither carbon nanotube NIR-fluorescence nor CF fluorescence (scale 
bars = 10 µm). 
 
Figure S11. VIS/NIR absorbance and NIR fluorescence spectra of the SWCNT*-Peptides after redispersion using sodium deoxycholate (DOC). The absorbance 
intensity and thus also the absolute SWCNT concentrations are subject to variation due to small deviations in the tip-sonication process required for redispersion. 
For fluorescence measurements, the solutions were brought to the same SWCNT concentrations based on their absorbance at approx. 1000 nm (see section 1.1 
for concentration determination).  
 
 
























































Figure S11. Absorbance spectra of a SWCNT/SDBS sample treated using green light for 15 minutes with (grey) and without the addition of diazonium salt 6 (black) 
measured in the supernatant after centrifugation (30 min, 16100g). Mean ± SD (N = 3). 
 
Figure S12. Fluorescence spectroscopy of positive and negative control samples for the conjugation of 5(6)-CF to SWCNT*-F-NH2. The control was generated 
following the same procedure as for the synthesis of 10 (see section 1.3.4), yet without prior F-Fmoc defect introduction. Despite some degree of background 
fluorescence also in the control sample, which might arise from non-covalent adsorption to the hydrophobic SWCNT surface, the positive sample having the F-
defect shows a significantly higher CF-fluorescence. Mean ± SD (N = 3). 
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Figure S13. Absolute NIR fluorescence spectra of SWCNTs before and after introduction of MalPh defects with different concentrations of MalPh-Dz (15 minutes 
illumination time) showing the decrease of the E11 with increasing MalPh-Dz concentration. 
 
 
Figure S14. Excitation-emission map (2D spectrum) of a MalPh-SWCNT* sample after spin-filtration and redispersion using PL-PEG5000 following the process 
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5. NMR spectra of diazonium salts 2 and 6 
5.1. 4-(N-maleimido)phenyldiazonium tetrafluoroborate (2) 
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-defects as versatile anchors for the generation of covalent SWCNT-bioconjugates
4.4.2. Discussion
The covalent decoration of carbon nanotubes with preserved NIR fluorescence is a goal
that was thought to be impossible to reach for a long time since the discovery of carbon
nanotubes in 1991.[9] In 2017, however, Setaro et al. made use of a [2+1] cycloaddition
of electron-poor aromatic nitrenes to the ⇡-conjugated carbon network.[53] After a rehy-
bridization step, the SWCNT’s ⇡-conjugation is thought to be reestablished preserving the
optoelectronic properties. Setaro et al. used this technique to create AuNP-functionalized
and spiropyran-switchable SWCNTs. The latter were also applied later by Godin et al.
as photoswitchable nanotubes in NIR super-resolution microscopy.[201] In 2020, Chio et
al. used the same [2+1] cycloaddition for the attachment of a -(PEG)2-biotin as well as
an amine, a thiol and the amino acids glycine.[200] They then wrapped these modified
SWCNTs with different surfactants corresponding to previously created SWCNT-based
optical sensors such as (GT)15/(GT)6 DNA oligos (for dopamine[5,202]), DPPE-PEG5000
(for fibrinogen[50]) and a C16-PEG2000-ceramide phospholipid (for insulin[203]) and eval-
uated changes in the sensor response induced by the covalent modifications. The authors
observed a decrease in sensor performance for the dopamine sensors after covalent mod-
ification and retained performance in case of the phospholipid-based fibrinogen and in-
sulin sensors. Furthermore, they also used the attached biotin for neutravidin-binding,
which they verified by retention on neutravidin-modified beads as well as using AFM.
These examples are a large step forward in the field of SWCNT functionalization, how-
ever, they did not accomplish covalent attachment of fluorophores or biomolecules yet.
In this work, two novel quantum defects are used for the covalent attachment of 5(6)-
carboxyfluorescein (5(6)-CF), peptides and a protein. This technique has a few important
advantages:
1. The modularity of the approach allows installation of anchors and their subsequent
modification with any molecule of choice.
2. The red-shifted emission allows for deeper tissue penetration using 990 nm instead
of 560 nm excitation.
3. The 96-well setup for both defect introduction as well as peptide synthesis makes
large-scale parallel processing possible
Building on top of these points, this work utilizes the strengths of this modular tech-
nique for the attachment of GFP-binding nanobodies. Fig. 3 (p. 109) shows the nanobod-
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ies covalently attached to SWCNTs in AFM and their retained GFP-binding ability in
a fluorescence colocalization assay. This represents the first covalent conjugation of a
nanobody to SWCNTs and the first covalent conjugation of a protein in general to SWC-
NTs with preserved optoelectronic properties. The Fmoc-protected phenylalanine defect
was used for the attachment of 5(6)-CF generating multi-color SWCNTs showing fluo-
rescence not only at 990 nm, but also at 517 nm and at 1135 nm. Combining three
emission wavelengths in just one molecule/material can open up many possibilities in
e.g. microscopy or multiplexed sensing. Furthermore, this defect can also serve as a
starting point for peptide growth directly on the nanotube’s sidewall. In this case, the
nanotube can be compared to the resin used commonly in SPPS, yet with a drastically
reduced size and thus increased accessible surface area. This feature was used not only
for the attachment of a positively charged R6 peptide, but also for the growth 0.2 µm
filters (see Fig. 5c, p. 111). This, again also represent the first time, where carbon nan-
otubes were used as a template for peptide synthesis and also the first NIR fluorescent
SWCNT-Peptide conjugates. In addition, the modification with these peptides composed
of different amino acids also modulates the SWCNT’s NIR fluorescence and here espe-
cially the E11*/E11 ratio. A comparison of the different peptides and their amino acid
building blocks indicates, that more hydrophobic residues yield a decreased E11*/E11 ra-
tio, which could be due to different folding of the peptides on the nanotube’s surface and
consequently an altered electronic landscape surrounding the trapped exciton. Effects
of differently substituted diazonium salts or differently folded peptides on the SWCNT’s
fluorescence were also observed before by other authors.[41,204]
The two new functional quantum defects could in the future be used e.g. to create tar-
geted NIR fluorophores for in vivo applications, which could be especially interesting
when combined with the approach reported lately by Danné et al., who used C6F13-
defects to brighten ultrashort SWCNTs below 100 nm in length.[43] If these ultrashort
tubes could now be covalently functionalized in a way enabling targeting e.g. using an-
tibodies, their decreased size would allow labelling of sites, that would not be accessible
to longer SWCNTs (e.g. intracellular compartments). Furthermore, the covalent attach-
ment of recognition units could also lead to new, more stable optical sensors, that can
be developed using the parallel processing showed in Fig. 5c (p. 111). Taken together,
these results show, that it is not only possible to use these two novel quantum defects for
the modification of the SWCNT’s chemical and surface properties, but also to tailor their
NIR emission.
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Figure 5.1.: Overview on different parts of the thesis. A) Competitive detection of
the neurotransmitter dopamine after screening of a nanosensor pool. B) Generation
of nanotube-nanobody conjugates for targeted delivery of dopamine sensors and NIR-
immunolabeling. C) Encapsulation of SWCNT using a-helical peptide barrels to gen-
erate a functionalization platform. D) Use of quantum defects for covalent SWCNT-
Nanobioconjugates.
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Aging societies lead to an increased need for improved diagnosis and therapy options for
more and more diseases. Nanoparticle-based systems have been proven to be effective in
both diagnosis and therapy settings, but still face several problems regarding especially
sensitivity, selectivity, stability or spatiotemporal resolution. Especially these character-
istics of nanoparticle-based systems should be tackled within this thesis to find solutions
with the focus on NIR-fluorescent SWCNTs.
In order to improve SWCNT-based systems, this thesis spans over different areas from
generation and tuning of biosensors (Fig. 5.1 A) over targeting using small antibodies
(Fig. 5.1 B) to different novel methodologies, that can now be applied as platform tech-
nologies for the fast and straightforward development of new nanosized devices (Fig.
5.1 C/D). This chapter provides an overview over the achievements of this thesis and an
outlook on the next steps of research for more advanced SWCNT-based diagnosis and
therapy systems.
5.1 Competitive detection of the neurotransmitter
dopamine
In this work, ten different short, single-stranded DNA sequences were screened for
their ability to wrap SWCNTs in a way allowing the detection of the neurotransmitter
dopamine. As a first step, the ten different SWCNT/DNA hybrids generated via tip-
sonication were characterized using NIR absorbance showing the same features, but
different dispersion capabilities of the different oligonucleotides leading to different
SWCNT concentrations. After concentration adjustment, the NIR fluorescence of the
different samples was measured before and after addition of different concentrations
of the neurotransmitter dopamine and its structural analogues epinephrine and nore-
pinephrine. Already in this limited set of different SWCNT/DNA hybrids differences
were observed in the response towards these structurally similar molecules, which only
differ in one additional hydroxy or methyl group and are also not resolvable by other
established techniques (see section 4.1.2). These differences also manifested in the dis-
sociation constants determined from calibration curves as well as in the limits of de-
tection. While e.g. (GT)10 showed a large fluorescence increase upon dopamine addi-
tion (100 nM), (GA)15 did not respond at this concentration. This was also observed
in NIR fluorescence microscopy and the SWCNT/(GT)10 hybrid even allowed detection
of dopamine in the presence of equimolar amounts of norepinephrine. Taken together,
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these results show, that it is possible to achieve discrimination between structurally simi-
lar neurotransmitters already using a small set of different oligonucleotides. This can be
and is already very useful for (ongoing) studies in the Kruss lab with cultured mouse neu-
rons, that can be stimulated for dopamine release. To achieve even better discrimination,
a next step would be to increase the size of the oligonucleotide pool incorporating differ-
ent nucleotide compositions and oligonucleotide lengths. By this, it should be possible
to further enhance sensitivity and selectivity. Combined with the ease of use, especially
when compared with genetically encoded sensors, this SWCNT/DNA based technique
can find widespread use also in in vivo settings.
Figure 5.2.: Competitive detection of dopamine. a) SWCNT/DNA nanosensor pool.
b) Difference between the different SWCNT/DNA hybrids with respect to their fluores-
cence change upon addition of the neurotransmitters dopamine, epinephrine and nore-
pinephrine (100 nM). c) NIR microscopy of a single SWCNT/(GT)10 sensor and its re-
sponse towards different concentrations of dopamine [for details see section 4.1.1]
5.2 Targeting of nanosensors using nanobodies
In this part, GFP-binding nanobodies were attached to a (GT)20 DNA-oligonucleotide
wrapping a SWCNT in order to impart selective binding of its antigen. GFP is a proof-of-
concept, but very versatile antigen as it widely used as a fusion protein in transgenic or-
ganisms for fluorescence detection. The decoration of SWCNTs with the GBP now allows
targeting of these fusion proteins and co-staining in the NIR with enhanced signal-noise-
ratio.
In order to achieve conjugation, a 3’-amine modified (GT)20 oligonucleotide was used
for SWCNT dispersion, which was modified in the next step using the heterobifunctional
linker Sulfo-SMCC allowing for oriented attachment of the ectopic cysteine’s thiol of
the nanobody. After characterization and reaction control using UV/vis/NIR absorbance
spectroscopy, NIR fluorescence spectroscopy, SDS-PAGE, AFM and z-potential measure-
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ments, the SWCNT/(GT)20-GBP conjugate was tested for retained function in a vis/NIR
microscopy colocalization assay. Next, the conjugate was evaluated regarding its ca-
pability to detect dopamine even in this GFP-bound state. The observed retained fluo-
rescence increase upon addition of 100 nM or 1 µM dopamine paves the way for the
use of these targeted sensors also for the targeting of other locations e.g. in in vivo
applications using GFP-fusion proteins or nanobodies directed against other functional
targets such as dopamine transporters. With these promising in vitro results in hand,
the Nanotube-Nanobody conjugate was applied next to drosophila embryos expressing
Kinesin-5 as a GFP-fusion protein via microinjection. Here, the protein was bound by the
SWCNT/(GT)20-GBP conjugate enabling NIR-immunostaining for imaging of the spindle
apparatus as well as tracking of single molecular motors inside this living organism. The
latter also allowed estimation of Kinesin-5’s velocity and its MSD for the first time in vivo.
Figure 5.3.: Targeted dopamine sensors. a) Conjugation of a GFP-binding nanobody
to a DNA-wrapped SWCNT. b) Targeting of micro-printed GFP structures by the
SWCNT/DNA-Nanobody and subsequent detection of dopamine. c) Tracking of a Ki-
nesin motor protein in vivo. d) In vivo NIR immunostaining of the spindle apparatus.
Both the in vitro and in vivo applications show the potential of this approach. However,
in order to carry out e.g. intracellular NIR immunofluorescence microscopy, the SWCNTs
have to be shortened to approx. 50 nm in length. First studies on short SWCNTs conju-
gated to GBP have already been carried out, but have to be deepened in the future. Here,
combination with quantum defects to create localized defect emission could be helpful
to achieve PLQY suitable for microscopy applications. Furthermore, also other nanobod-
ies against different, more relevant targets such as IgG will be conjugated in the future
and evaluated regarding their capability to optically detect this antigen binding event.
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First studies interrogating the vis/NIR fluorescence upon GFP-binding were inconclusive,
however, they could be repeated using different nanobody/antigen pairs. A combination
of short SWCNTs and nanobodies targeting e.g. cell surface receptors or intracellular
targets could also pave the way for drug delivery applications. Lastly, for challenging
applications it might be necessary to switch from this hybrid non-covalent/covalent con-
jugation approach to a solely covalent one in order to achieve an increased stability (see
quantum defect conjugation).
5.3 Peptide barrels encapsulate SWCNTs
Next to DNA-oligonucleotides, which are widely used for SWCNT dispersion, peptides
are an interesting class of biomolecules largely unexplored for this purpose in the past,
although it theoretically offers a higher structural flexibility. In this work, a-helical coiled-
coil peptide barrels (aHBs) were tested for their capability to encapsulate SWCNTs. For
comparison, two peptide sequences with the same amino acid composition, but differ-
ent quaternary structures (i.e. pore size) were evaluated for their SWCNT dispersion
yield. NIR absorbance spectroscopy showed, that the peptide containing a 0.76 nm pore
was able to bring substantially more SWCNTs into aqueous solution than the control
tetrameric barrel with a smaller pore underlining the importance of the preformed 3D-
structure. Additional experiments also showed a slight enrichment of diameter-matching
chiralities. The fact, that no exclusive encapsulation of e.g. (6,5)-SWCNTs was observed,
can be attributed to ’breathing’ of the peptide barrels, which are able to adjust to larger
or smaller SWCNT diameters to a certain extent. In future experiments, this chirality
enrichment could be further advanced by carrying out repetitive cycles or combination
with the aqueous two-phase extraction (ATPE).[205] Further structural analysis was car-
ried out using intermittent-contact mode AFM indicating a mode of SWCNT/Peptide
binding, where the SWCNT is ’inserted’ into the heptameric aHB’s pore. Additionally,
heights regularly alternating between ’naked’ (6,5)-SWCNTs and peptide-encapsulated
(6,5)-SWCNTs were measured. This assembly could be attributed to either be driven
by the helical pitch of the coiled-coil barrel or to be a result of the drying process dur-
ing sample preparation (’dewetting’). These results show that it is possible to use aHBs
with defined and known pore sizes for the straightforward encapsulation of SWCNTs and
their dispersion in aqueous environments. Furthermore, the outwards-facing residues of
these barrels (f-position, see section 2.3.2) can be used for the attachment of further
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functional units and thus serve as a two-step functionalization platform consisting of
first, SWCNT encapsulation and second, covalent attachment of e.g. a fluorophore to a
f-position residue.
Figure 5.4.: Peptide barrel encapsulated SWCNTs. a) Barrels with a pore encapsulate
matching SWCNTs whereas barrels without the pore do not disperse the same SWC-
NTs. b) Dispersion efficiency of different peptide barrels evaluated using UV/vis/NIR
absorbance spectroscopy. c) AFM imaging of a barrel-encapsulated SWCNT showing pe-
riodic height differences.
However, for efficient conjugation reactions it is crucial to achieve colloidal stability
high enough to render excess peptide in solution unnecessary. In order to achieve this
goal, different strategies could be employed. First, the aHBs can be chemically altered
generating e.g. oppositely charged ends leading to peptide nanotube (PNT) formation.
This in turn could yield an increased SWCNT surface coverage and thus higher colloidal
stability. While this attempt was already tested in first experiments, that also pointed
towards increased, yet not sufficiently high colloidal stability, another strategy could be
the synthesis of the coiled-coil monomers as C-terminal thioesters with N-terminal cys-
teines allowing for native-chemical ligation (NCL) to assemble PNTs selectively on the
SWCNTs.
Furthermore, the alternating height pattern created by aHB encapsulation could be an
interesting subject of further study. Here, it should be evaluated next, whether these
structures can also be observed, when the AFM experiments are not carried out in air,
but in a buffered solution. In addition, the structures generated with the repetitive height
patterns could serve as an interesting tool for basic SWCNT photoluminescence investi-
gations using tip-enhanced near-field optical microscopy.[206] Studies like these could
reveal differences in photoluminescence arising from different SWCNT-regions covered
or not covered by the aHB.
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5.4 Quantum defects as anchors for covalent
SWCNT-bioconjugates
Since their discovery in 1991, carbon nanotubes have been subject to a large variety of at-
tempts to alter their chemical nature and tailor them for specific applications. While the
majority of studies employed non-covalent functionalization, also different approaches
for covalent functionalization were reported, however, almost all of them resulted in di-
minished NIR fluorescence. In order to make use of the superior stability of covalent
conjugation yet still profit from the beneficial NIR emission, this project aimed at the use
of previously reported aryl defects as anchors for covalent decoration of SWCNTs while
maintaining their optoelectronic properties.
In a first step, two different diazonium salts containing on the one hand a phenyl-
maleimide and on the other hand a Fmoc-protected phenylalanine were synthesized
in a one-step procedure. These phenyl diazonium salts were then used to incorporate
sp3-defects into the SWCNT’s sidewall, that were previously described to create lumi-
nescent exciton traps (so-called quantum defects). After confirming successful defect
introduction by NIR fluorescence spectroscopy, the maleimide defects were used for the
attachment of a GFP-binding nanobody. Similar to the work described in section 4.2.1
the success of conjugation was tested using AFM and an in vitro binding assay relying on
colocalization of GFP and NIR fluorescence. The protected phenylalanine defect on the
other hand was used for the attachment of 5(6)-carboxyfluorescein yielding covalently
linked three-color SWCNTs emitting light at 517 nm, 991 nm and 1135 nm. Further-
more, the Fmoc-protected phenylalanine residue can also serve as a starting point for
peptide synthesis directly on the SWCNT’s sidewall. This was tested and shown with
a hydrophilic and fluorescently modified R6 peptide as well as with twelve other pep-
tide sequences, that were synthesized in parallel in a 96-well format. These different
peptide sequences also showed the importance of the amino acid’s hydrophobicity and
their sequential arrangement for the modulation of the SWCNT’s fluorescence. All in
all, the results of this study show, that it is possible to use quantum defects for the co-
valent functionalization of SWCNTs while maintaining their optoelectronic properties.
In addition to showing the feasibility of this approach, this also led to the first covalent
and still NIR fluorescent SWCNT-fluorophore, SWCNT-peptide and SWCNT-protein con-
jugate described in the literature. With these tools in hand, demanding applications in
biosensing or in vivo fluorescent tracing can become reality. If this technique is combined
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e.g. with shorter SWCNTs, which were recently brightened up again through quantum
defect incorporation, small yet powerful molecular devices are generated with possible
applications in diagnostics or guided therapy. Furthermore, the high-throughput nature
of this approach makes screening of e.g. different linker lengths or different peptides a
very straightforward process leading to the fast generation of new biosensors, selective
NIR imaging agents or fluorescent drug delivery vehicles.
Figure 5.5.: Quantum defects for covalent SWCNT functionalization. a) Quantum de-
fects can serve as anchors for the attachment of peptides or proteins to NIR-fluorescent
SWCNTs. b) Red-shift of the SWCNT’s fluorescence after defect introduction. c) Cova-
lent SWCNT-Nanobody conjugates binding GFP as analyzed with Vis/NIR fluorescence





In summary, this work has not only contributed to the improved characterization of op-
tical sensors for neurotransmitters, but also introduced new concepts for their function-
alization.
Initially, SWCNT-DNA based sensors were characterized in detail regarding the DNA
sequence-sensor relationship, thus enabling the competitive detection of the neurotrans-
mitter dopamine in the presence of structurally similar analytes. Furthermore, these
sensors were linked to nanobodies, which give the sensors targeting capabilities. As a
consequence, it is now possible to place SWCNT-based optical sensors in the location
where they should carry out their task. In the future, this may be used in in vivo analysis,
for example, when the communication of neuronal cells by means of neurotransmitters
is to be investigated in more detail.
In addition to these further developments on advanced NIR optical sensors, new basic
concepts for the general functionalization of carbon nanotubes were developed. It was
shown that pore-containing aHBs can encapsulate carbon nanotubes and thus stabilize
them in aqueous solution. Due to the high variability of peptide structures, this could
in the future not only represent another method for the purification of different nan-
otube chiralities, but also enable the versatile attachment of functional units to the outer
surface of the peptide shell. Last but not least, so-called quantum defects have been
chemically modified so that they can serve as anchor groups for the covalent attachment
of functional biomolecules. Through this stable and modular combination, it is now pos-
sible to tune carbon nanotubes simultaneously with respect to their photophysics and
functionality. In the future this could be used, for example, to generate stable NIR fluo-
rescent probes that combine both diagnosis and therapy in one molecular device allowing
operation in challenging environments such as e.g. the cytoplasm.
To sum up, the approaches for covalent and non-covalent functionalization of carbon
nanotubes presented in this work not only provide new possibilities for tailoring their
photophysics and surface chemistry, but also enable the production of targeted sensors
and new tools for NIR fluorescence microscopy.
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6.1 General Information
6.1.1. Reagents and solvents
(6,5)-chirality enriched single-walled carbon nanotubes (SWCNT, Sigma Aldrich, Prod-
uct No.: 773735) and H-Rink Amide-Chemmatrix R  resin were acquired from Sigma
Aldrich (Darmstadt, Germany). Larger diameter SWCNTs were purchased from Plas-
maChem GmbH (LOT: SCNP-M135). Fmoc-protected amino acids were purchased from
GL Biochem LTD (Shanghai, China). DIC and OxymaPure were purchased from Iris
Biotech GmbH (Marktredwitz, Germany). DMF used for peptide synthesis was supplied
by Fisher Scientific (Schwerte, Germany) and was of peptide grade quality. Acetoni-
trile used for HPLC was supplied by Fisher Scientific (Schwerte, Germany) with HPLC
grade quality. All other reagents were supplied by Sigma Aldrich (Taufkirchen, Ger-
many), Thermo Fisher Scientific (Langenselbold, Germany), VWR International (Darm-
stadt, Germany) and Carl Roth (Karlsruhe, Germany). All reagents were of synthesis
grade quality and were used as supplied.
6.1.2. UV/vis/nIR absorbance spectroscopy
SWCNT-containing solutions were submitted to UV/vis/nIR absorbance spectroscopy on
a JASCO V-670 (Spectra Manager Software) using a 10 mm-path cuvette. Spectra were
acquired using a scan speed of 1000 nm/min, a data interval of 0.5 nm and a UV/vis and
nIR bandwidth of 2 nm and 4 nm, respectively.
The SWCNT concentration was determined using the maximal absorbance at approx.
990 nm using the molar extinction coefficient determined by Schöppler et al.[207]
6.1.3. nIR fluorescence spectroscopy
In a 96-well plate, 50-100 µL of the SWCNT-containing solution were excited at 561 nm
using a 300 W Xe-lamp guided through a monochromator (LOT, Germany) and their
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fluorescence spectra recorded in the range between 850 and 1250 nm using a Sham-
rock 193i spectrograph (Andor Technology Ltd., Belfast, Northern Ireland) coupled to an
Olympus IX73 microscope and an exposure time of 1 s, a slit width of 500 µm and an
Andor iDus InGaAs 491 array NIR detector.
6.1.4. Atomic Force Microscopy (AFM)
20 µL of the SWCNT-containing dispersions were immobilized on freshly cleaved mus-
covite mica via ten minutes incubation and subsequent washing of the surface with MilliQ
water. AFM images were acquired in intermittent contact mode using an Asylum Re-
search MFP-3D Infinity R  instrument equipped with Olympus AC-160-TS cantilevers.
Analysis of the acquired images was performed via the open-source software Gwyddion.
For all images, the background/tilt was removed via a 2nd order polynomial fit. The
surface plane was set to zero using three-point leveling.
6.1.5. nIR fluorescence microscopy
nIR imaging was carried out under 561 nm-laser excitation (Cobolt Jive R  laser, Cobolt
AB, Solna, Sweden, Pmax. = 500 mW) on an Olympus IX53 microscope equipped with a
100x oil-immersion objective (Olympus 100x UPLSAPO 100XS, NA = 1.35). Detection
of the near-infrared photoluminescence was carried using either a Xenics Xeva R -1.7-320
or a Xenics Cheetah R -640-TE3 NIR camera (Xenics, Heverlee, Belgium) or an Andor Zyla
5.5 sCMOS camera (Andor Technology Ltd., Belfast, Northern Ireland).
The optical setup for simultaneous vis/nIR imaging was planned and built together
with Dr. Sebastian Kruss and Dr. Claudia Geisler as part of this thesis enabling simulta-
























































































































































































































































































































   























































































































































































































































   









   
   
   
   






















   
   
   
   









   
   
   
   







   





























   









   
   
   
   






















   
   
   
   









   
   
   
   







   





























































































6. Materials and Methods
6.1.6. SDS-PAGE with Coomassie-/GelRed-Stain
The samples subjected to sodiumdodecylsulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) were mixed with the corresponding amount of 4x reducing Laemmli sample buffer
to reach a final 1x concentration. SDS-PAGE was performed at 220 V/400 mA for 45 min-
utes in running buffer with 12% acrylamide gels using PageRuler Plus Prestained (life
technologies) as a size marker. Staining of nucleic acids was carried out with the dye
GelRed (Biotium Inc., USA) for 60 minutes after heating in the microwave and five sub-
sequent washing steps using dH2O. Staining of proteins was performed with a solution
of Coomassie Brilliant Blue R-250 (Staining solution) for 15 minutes after heating in
the microwave. Subsequent incubation with destaining solution for 10 minutes after
microwave-heating was repeated three times. The destained gel was captured using a
c300 imaging system (Cambridge Bioscience) both for protein (vis) and nucleic acid de-
tection (UV).
Table 6.1.: Staining solution
EtOH 300 mL
MeCOOH 100 mL
Coomassie Brilliant Blue R-250 2.5 g
dH2O ad 1000 mL
Table 6.2.: Destaining solution
EtOH 500 mL
MeCOOH 100 mL
dH2O ad 1000 mL
Table 6.3.: Stacking buffer
Tris-base 4.84 g
dH2O ad 80 mL (pH 6.8 with HCl)
Table 6.4.: Resolving buffer
Tris-base 14.53 g
dH2O ad 80 mL (pH 8.8 with HCl)
Table 6.5.: 4x SDS sample buffer
0.5 M Tris-HCl, pH 6.8 5 mL
SDS 800 mg
Glycerol 4 mL
Bromophenol blue 2 mg
dH2O ad 10 mL
Table 6.6.: 4x red. SDS sample buffer








dH2O ad 2500 mL
Table 6.8.: 3x GelRed staining solution
EtOH 15 mL
MeCOOH 5 mL
GelRed (10000x) 12 µL
dH2O ad 50 mL
Table 6.9.: Gel composition
Stacking gel Resolving gel
4% 7.5% 12% 15%
dH2O 2993 µL 4845 µL 3345 µL 2345 µL
30% Acrylamide/Bisacrylamide 667 µL 2500 µL 4000 µL 5000 µL
Stacking buffer 1260 µL - - -
Resolving buffer - 2500 µL 2500 µL 2500 µL
10% SDS 50 µL 100 µL 100 µL 100 µL
10% APS 25 µL 50 µL 50 µL 50 µL
TEMED 5 µL 5 µL 5 µL 5 µL
Total volume 5000 µL 10000 µL 10000 µL 10000 µL
6.1.7. ⇣-potential measurement
⇣-potential measurements were carried out using a Zetasizer Nano S (Malvern Instru-
ments, UK) in 1x PBS at a SWCNT concentration of 0.5 nM (pH 7.4). Analysis was
performed using the corresponding Zetasizer software.
6.1.8. Circular dichroism (CD) spectroscopy
CD spectra and CD thermal-denaturation curves were recorded using a JASCO J-1500
which was equipped with a JASCO PTC510 temperature measuring unit. CD spectra
were measured at 50 µM peptide concentration in PBS at 20  C in 1 mm quartz cuvettes
(Starna Scientific Ltd., UK) at 50 nm/min scanning speed. CD thermal-denaturation ex-
periments were performed by heating from 2 to 98  C at a heat rate of 60  C/h. The
CD signal at 222 nm was recorded at 0.1  C intervals (1 nm interval, 1 nm bandwidth,
16 s response time). The midpoints of the thermal denaturation curves (Tm) were de-
termined from the second derivative of the variable temperature slope.
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6.1.9. Solid-phase peptide synthesis
Peptide amides were synthesized on a H-Rink Amide-Chemmatrix R  resin on a 0.1 mmol
scale on a Liberty Blue R  CEM microwave-assisted peptide synthesizer. The synthesis
was conducted via a standard Fmoc/tBu-protocol using DIC and OxymaPure as coupling
reagents and a solution of piperidine in DMF (1:4) for Fmoc-removal. N-Acetylation of
the peptides was carried out by equilibrating the peptide resin with 5 mL of acetic acid
anhydride/pyridine (1:9) for 5 min at room temperature. Acidic cleavage from the resin
was achieved by a treatment with a mixture of trifluoroacetic acid (TFA)/triisopropylsilane
(TIS)/water (90:5:5, 3 h). The resin was extracted with additional TFA (5 mL), and the
combined extracts were concentrated to a third of the initial volume under nitrogen flow.
The crude peptide was then precipitated in cold diethylether (40 mL) and isolated by cen-
trifugation and decantation of the supernatant. The precipitate was washed twice with
ice-cold diethylether and subsequently dissolved in 5 mL of a 1:1 mixture of acetonitrile
and water and then freeze-dried to give a fine white solid.
6.1.10. Semi-preparative high-performance liquid chromatography (HPLC)
Peptides were purified by semi-preparative reversed-phase HPLC using a JASCO chro-
matography system (pumps PU-2080 Plus, degasser DG-2080-53, detector MD-2010
Plus) at flow rates of 3 mL/min, and a Nucleodur 100-5-C18 ec (250 mm by 10 mm,
5 µm) reversed-phase column. Linear gradients of water and acetonitrile (buffer A: wa-
ter, 0.1% TFA, buffer B: acetonitrile, 0.1% TFA) of 30-80% buffer B over 30 min for
coiled-coil heptamers and 30-60% buffer B over 30 min for coiled-coil tetramers were
used for purification. During purification the column was run at a controlled tempera-
ture of 60  C. Chromatograms were recorded at 220 nm.
6.1.11. Analytical HPLC
Analytical HPLC measurements were performed using a JASCO chromatography system
(pumps PU-2085 Plus, detector MD-2010 Plus, autosampler AS-2055 Plus) and a Nucle-
odur 100-5-C18 (5 µm, 4.6 x 250 mm) reversed-phase column at a flow rate of 1 ml/min.
For peptide characterization a linear gradient of water and acetonitrile (buffer A: water,
0.1% TFA, buffer B: acetonitrile, 0.1% TFA) run from 30-80% buffer B over 20 min for
coiled-coil heptamers and 30-60% buffer B over 20 min for coiled-coil tetramers was
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used. Chromatograms were monitored at 220 nm wavelengths. The column was run at
a controlled temperature of 60  C.
6.1.12. Matrix-assisted laser desorption/ionization - time of flight mass
spectrometry (MALDI-TOF-MS)
Peptides were characterized by mass spectrometry on a Bruker Autoflex Speed R  MALDI-
TOF mass spectrometer operating in positive-ion reflector mode. (matrix: a-cyano-4-
hydroxycinnamic acid (CHCA), external calibration).
6.1.13. Nuclear magnetic resonance (NMR)
NMR spectroscopy was performed on a Bruker AvanceTMIII HD 300 device (Bruker Corp.,
USA), equipped with a 5 mm probe. For a measurement, approx. 15 mg of substance
were dissolved in approx. 600 µL of the deuterated solvent stated and transferred to a
standard glass NMR tube (d = 5 mm). The chemical shifts are reported in ppm relative
to the residual solvent peak(s). Analysis was performed within the MestReNova R  10
program.
6.1.14. Electrospray ionization time of flight mass spectrometry (ESI-TOF-MS)
Mass spectrometry measurements of diazonium salts were performed on a BrukerTMmicr-
OTOF ESI-TOF-MS using the non-deuterated form of the solvent also used for NMR mea-
surements.
6.1.15. Protein concentration determination
Protein concentration was determined via absorbance measurements at 280 nm with
a NanoDrop 2000TMspectrophotometer (ThermoFisher Scientific Inc., USA) using the
extinction coefficient of the respective protein at 280 nm. The mean value of at least
three independent measurements was taken for concentration calculation.
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6.2 Introduction of Fmoc-Phe-quantum defects
6.2.1. Synthesis of Fmoc-L-4-diazonium-phenylalanine tetrafluoroborate
Fmoc-L-4-diazonium-phenylalanine tetrafluoroborate was synthesized using an optimized
procedure based on the previously published general procedure.[208] Fmoc-L-4-aminophe
nylalanine (0.2 g, 0.497 mmol) was dissolved in 500 µL ethanol in a 5 mL glass scintilla-
tion vial. Next, approx. 125 µL HBF4 (50% aqueous) were added dropwise. The solution
was placed in an ice bath and stirred constantly while 135 µL tBu-ONO (2 eq., 1.1 mmol,
117 mg) were added drop-wise over the course of 30 min. Next, the solution was stirred
for two hours at room temperature. After the reaction was completed, a white/slightly
yellow precipitate was observed and transferred to a 2 mL Eppendorf tube using 1 mL
diethyl ether. The precipitate was centrifuged at 16100g for five minutes and the super-
natant discarded. This process was repeated five times and the crude product was dried
under reduced pressure at room temperature.
6.2.2. Defect introduction
In this thesis a defect introduction protocol based on a 96-LED array for SWCNT illumina-
tion was used. The steps for generation of a defect-carrying SWCNT-dispersion consisted
of:
1. Dispersion of (6,5)-enriched SWCNTs in an aqueous 1% SDBS solution
2. Addition of 180 µL of a 10 nM SWCNT/SDBS dispersion and 20 µL of a Fmoc-Phe-
Dz solution (10x the final concentration) to one well of a 96-well plate
3. 15 minutes of illumination using the 96-LED array (placed on top of the 96-well
plate)
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4. Control of the degree of defect introduction using NIR-fluorescence spectroscopy
(either directly in the 96-well plate or a glass-bottom 96-well plate suitable for
fluorescence spectroscopy)
5. Removal of excess Fmoc-Phe-Dz using spin-filtration (optional)
6. Redispersion using a surfactant of choice (e.g. 1% SDBS or PL-PEG5000)
To generate a SWCNT-SDBS dispersion (1% SDBS), 500 µL of an aqueous 2% SDBS
solution were added to 500 µL of a 2 mg mL-1 SWCNT/water suspension. This solution
was tip-sonicated for 15 minutes (Fisher ScientificTM Model 120 Sonic Dismembrator,
30% amplitude, 36 W) followed by centrifugation (2x, 16100g) and only the super-
natant (top 80%) used for further studies. In the next step, the supernatant was diluted
using 1% SDBS to yield a 10 nM solution. In a 96well-plate, 180 µL of this solution
were added to 15 wells followed by the addition of different concentrations of Fmoc-
Phe-N +2 BF
–
4 (0 nM-100 µM). After careful mixing via repeating pipetting, the solutions
were irradiated using a green 96-LED-array irradiator (LumidoxTM, Analytical Sales &
Services, Inc., Flanders, NJ, USA) at 25 mA for 15 minutes to yield solutions of SWCNT-
Phe-Fmoc. The solutions were analyzed by nIR fluorescence spectroscopy for the degree
of defect-introduction. The excess diazonium salt was removed via repeated 300kDa-
cut-off spin filtration (5x 600 µL dH2O washing) and the remaining SWCNT* were re-
suspended in 500 µL dH2O. In the last step, supernatant and pellet were then separated
by centrifugation (16100g, 15 minutes) and the pellet containing SWCNT*-Phe-Fmoc
was used for downstream experiments.
6.2.3. SWCNT* peptide synthesis
For the synthesis of SWCNT*-Phe-Peptides or the coupling of the fluorophore 5(6)-
carboxyfluorescein directly to the unprotected Phe, two different methods were em-
ployed in the course of this thesis. First, 2 mL syringes equipped with a 20 µm pore
size frit were used resembling the standard procedure in solid-phase peptide synthesis
(for SWCNT*-F-CF and SWCNT*-F-R6-CF). Here it was also tested to place a 0.2 µm
filter on top or below the frit, however, this system did not the display the necessary
mechanical stability for the following deprotection and coupling reactions as well as the
washing steps, which all involve shaking and uptake and release of solvent to and from
the syringe reactor. To circumvent this problem and still achieve smaller pore sizes (to
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prevent a ’loss’ of smaller SWCNTs) and a format compatible with peptide synthesis, it
was switched to a higher throughput format consisting of a 96-well plate equipped with
0.2 µm pore size filters (Chromafil Multi 96 plate with PTFE filters, Macherey-Nagel,
Germany). In the following, the two methods will be described in more detail for the
synthesis of SWCNT*-F-R6-CF and other SWCNT*-F-Peptides.
6.2.3.1. SWCNT*-F-R6-CF synthesis
The solutions of 20 wells from the Fmoc-Phe defect introduction process (v = 4 mL, ap-
prox. 36 pmol SWCNT*-Phe-Fmoc) were pooled, mixed with 6 mL EtOH for SWCNT pre-
cipitation in a glass vial and the suspension subsequently transferred to a frit (20 µm pore
size)-equipped syringe reactor (v = 2 mL). Residual SDBS surfactant and excess Fmoc-
Phe-Dz were removed via washing (5x 1 mL dH2O, 3x DMF, 3x DCM, 3x DMF). Deprotec-
tion of the Fmoc-group was achieved via incubation with 200 µL of 20% piperidine/DMF
(2x 15 min). Fmoc-based solid-phase peptide synthesis (SPPS) couplings to Fmoc-
Arg(Pbf)-OH (11.7 mg, 18 µmol) and 5(6)-CF (6.8 mg, 18 µmol) were carried out for 30
minutes at room temperature with 6.8 mg 1-[Bis(dimethylamino)methylene]-1H-1,2,3-
triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU, 18 µmol) and 6.3 µL DI-
PEA (36 µmol) in 100 µL DMF. Excess reagents were removed by repeated washing with
DMF/DCM/DMF (3x 1 mL). After 5(6)-CF coupling and washing, the side-chain protect-
ing groups ((2,2,4,6,7-pentamethyldihydrobenzofuran-5-sulfonyl), Pbf) were cleaved upon
gentle shaking with the cleavage cocktail (75% TFA/20% DCM/2.5% dH2O/2.5% TIS,
vtotal = 500 µL) for one hour. Subsequently, the crude product was washed again with
DMF and 10x DCM and then scraped off the frit using 100 µL dH2O, transferred to a
1.5 mL microcentrifuge tube and stored in the dark at 4 C. For fluorescence microscopy
and spectroscopy applications, the product in 100 µL dH2O was submitted to ultrason-
ication (5 min, 30% amp, 4 C) followed by separation of supernatant and pellet by
centrifugation (16100g, 30 min). The supernatant was used for fluorescence microscopy
and spectroscopy applications.
6.2.3.2. 96-well SWCNT*-F-Peptide synthesis
Approx. 30 pmol SWCNT*-Phe-Fmoc (c = 10 nM, V = 3 mL) were added to and filtered
through individual wells of a 96-well plate equipped with 0.2 µm pore size filters (Chro-
mafil Multi 96 plate with PTFE filters, Macherey-Nagel, Germany). The samples were
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washed (with 5x dH2O, 3x DMF, 3x DCM, 3x DMF)) followed by standard Fmoc/OtBu
SPPS (2x15 min Fmoc deprotection [20% Piperidine/DMF], 30min amino acid coupling
[13.5 µmol amino acid/HATU, 27 µmol DIPEA]) and final deprotection of side-chain
protecting groups using the deprotection cocktail (375 µL TFA, 100 µL DCM, 12.5 µL
TIS, 12.5 µL dH2O, 60 min). All steps were carried out under mild agitation of the 96-
well plate on a shaker (150 rpm). After final deprotection, the SWCNT samples were
again washed (using 3xDCM, 3xDMF, 10xDCM) and then resuspended using 600 µL
dH2O and transferred to 1.5 mL centrifuge tubes. Next, the samples were spun down
(16100g, 30 min), resuspended in 200 µL 1% sodium deoxycholate (DOC) solution and
submitted to tip-sonication (5 min, 4 C, 30% amplitude). After centrifugation, the top
80% of the supernatant were again transferred to fresh microcentrifuge tubes and used
for absorbance/fluorescence spectroscopy applications.
The following Fmoc-protected amino acids were used:
Table 6.10.: Gel composition
Fmoc-Asn(Trt)-OH Fmoc-Gly-OH Fmoc-Tyr(tBu)-OH Fmoc-Asp(OtBu)-OH
Fmoc-His(Trt)-OH Fmoc-Gln(Trt)-OH Fmoc-Ser(tBu)-OH Fmoc-Glu(OtBu)-OH
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AFM Atomic Force Microscopy




BSA Bovine serum albumine





CoMoCAT Cobalt-Molybdenum catalyzed process
Cos7 ’CV-1 in Origin’ cells
CMC Critical micelle concentration





DOS Density of states
DWCNT Double-walled carbon nanotube
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride
EGFR Epidermal growth factor receptor
EPL Expressed protein ligation
ESI-MS Electrospray ionization mass spectrometry







FSCV Fast scan cyclic voltammetry
GABA  -Aminobutyric acid
GBP GFP-binding protein
GFP Green fluorescent protein
HALO-tag Protein-tag binding haloalkane ligands
HB Helical barrel
hcAb Heavy-chain antibody
HE4 Human epididymis protein 4
HiPCO High-pressure carbon monoxide process
HPLC High-performance liquid chromatography
IgG Immunoglobulin G
Kin-5 Kinesin 5
LED Light emitting diode
LOD Limit of detection
LUMO Lowest unoccupied molecular orbital




mRNA Messenger ribonucleic acid
MWCNT Multi-walled carbon nanotube
MWCO Molecular weight cut-off
NCL Native chemical ligation
NHS N-hydroxysuccinimid
NIR Near infrared
NMR Nuclear magnetic resonance
NP Nanoparticle
NTA Nitrilotriacetic acid
PAGE Polyacrylamide gel electrophoresis








PLQY Photoluminescence quantum yield
PNT Peptide nanotube




RFP Red fluorescent protein
RNA Ribonucleic acid
RNS Reactive nitrogen species
ROS Reactive oxygen species
SC Sodium cholate
scFv Single chain variable fragment
SDBS Sodium dodecylbenzenesulfonate
SDS Sodium dodecylsulfate
SET Single electron transfer
SIMS Secondary-ion mass spectrometry
SNAP tag Protein-tag binding benzylguanine derivatives
SPPS Solid phase peptide synthesis
SPR Surface plasmon resonance
Sulfo-SMCC Sulfosuccinimidyl-4-(N-maleimidomethyl)cyclohexan-1-carboxylate
SWCNT Single-walled carbon nanotube








UAA Unnatural amino acid
uPA Urokinase plasminogen activator
UV Ultraviolet
VH Variable region of the antibody’s heavy chain




VL Variable region of the antibody’s light chain
VP1 Viral envelope protein VP1
Amino acids are abbreviated with the three-letter code. For peptide sequences the
one-letter code is used.
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